wednesday januari 12 1994 part iv environment protect agenc 40 cfr part 372 addit certain chemic toxic chemic releas report commun right know propos rule feder regist vol 59 8 wednesday januari 12 1994 propos rule usdept environment protect agenc usdept usdept 40 cfr part 372 usdept rindock oppts400082 frl46456 rindock rindock rin 2070ac47 rindock addit certain chemic toxic chemic releas report commun right know agenc agenc environment protect agenc epa agenc action action propos rule action summari summari epa propos add 313 chemic chemic categori list toxic chemic requir report section 313 emerg plan commun right know act 1986 section 6607 pollut prevent act 1990 propos addit chemic chemic categori base acut human health effect carcinogen chronic human health effect environment effect epa believ chemic chemic categori meet epcra section 313 2 criteria addit list toxic chemic summari date date written comment propos rule must receiv april 12 1994 public meet take place march 2 1994 1 p adjourn 5 p date address address written comment submit triplic oppt docket clerk tsca document receipt offic 7407 offic pollut prevent toxic environment protect agenc rm eg99 401 st sw washington dc 20460 comment contain inform claim confidenti must clearli mark confidenti busi inform cbi cbi claim three addit sanit copi must also submit nonconfidenti version comment propos rule place rulemak record avail public inspect comment includ docket control number propos oppts400082 unit vi preambl contain addit inform submit comment contain inform claim cbi public meet held environment protect agenc auditorium educ center 401 st sw washington dc address inform contact maria j doa emerg plan commun right know inform hotlin environment protect agenc mail stop 5101 401 st sw washington dc 20460 toll free 8005350202 toll free tdd 8005537672 attent docket number oppts400082 supplem supplementari inform introduct statutori author propos rule issu section 313 e 1 emerg plan commun right know act 1986 epcra 42 u c 11023 epcra also refer titl iii superfund amend reauthor act 1986 b background section 313 epcra requir certain facil manufactur process otherwis use list toxic chemic report environment releas chemic annual begin 1991 report year facil also must report pollut prevent recycl data chemic pursuant section 6607 pollut prevent act 42 u c 13106 enact section 313 establish initi list toxic chemic compris 300 chemic 20 chemic categori section 313 author epa add chemic delet chemic list set forth criteria action section 313 e person may petit epa add chemic delet chemic list epa ad delet chemic origin statutori list epa issu statement petit polici guidanc feder regist februari 4 1987 52 fr 3479 provid guidanc regard recommend content format submit petit epa must respond petit within 180 day either initi rulemak publish explan petit deni may 23 1991 56 fr 23703 epa issu guidanc regard recommend content petit delet individu member section 313 metal compound categori ii explan expans epcra section 313 chemic list gener rational toxic releas inventori tri public access provis epcra proven one power forc empow feder govern state govern industri environment group gener public fulli particip inform dialogu environment impact toxic chemic unit state major section epcra congress pass 1986 result creation toxic releas inventori tri publicli avail data base provid quantit inform toxic chemic releas transfer recycl dispos collect inform first time 1987 came abil public govern regul commun understand magnitud chemic emiss unit state compar chemic releas transfer chemic wast among state industri facil environment media perhap importantli assess need reduc possibl elimin releas transfer tri enabl interest environment progress establish credibl baselin set realist goal measur progress time meet goal tri system becom neutral yardstick progress measur interest parti origin list chemic report requir consist 320 chemic chemic categori list combin maryland chemic inventori report list toxic hazard substanc new jersey environment hazard substanc list combin two list provid sound logic start point nation tri program recogn howev list would need dynam one epcra specif author addit delet list date epa ad 16 chemic list delet 12 chemic list 5 year experi behind program epa feder agenc congress public recogn need expand tri list beyond origin chemic chemic categori beyond rel limit report univers current report requir facil fall within manufactur standard industri classif sic code 20 39 meet certain threshold data chemic cover allow public privat sector inform involv environment decisionmak never becom increasingli evid constitu access inform rel small number import chemic congress echo recognit right know bill put forward 102nd congress epa state regulatori agenc integr tri inform critic compon environment decisionmak mani case constrain lack similar inform chemic concern cover tri tri success focus attent initi list chemic mani case foster emiss reduct prevent activ focu highlight need expand beyond initi list includ addit chemic exhibit similar toxic characterist propos one first seri action epa plan use expand coverag tri first phase focu ad chemic follow second phase identifi addit facil inclus epa consid third phase would look modif data element current requir tri conjunct expans activ epa consid whether adjust need scope tri program epa receiv petit small busi administr american feed industri associ seek exempt small sourc e facil file tri form zero small releas estim epa previous put petit public comment review believ substanti merit gener concern rais petit agenc plan proceed small sourc issu would includ follow step epa examin four option establish small releas exempt tri report oblig cutoff zero 500 pound 1 000 pound 5 000 pound epa provid public report four option end januari analysi consid data might avail nation commun level cost save govern industri four exempt level epa plan hold public meet februari discuss report base feedback epa design regulatori strategi align small sourc issu final action today propos agenc object minim unnecessari data collect report facil includ chemic identifi today propos b develop chemic addit candid start point screen candid addit toxic chemic list epcra section 313 epa chose examin list chemic regul identifi concern variou environment statut includ 1 section 112 b clean air act caa amend 1990 hazard air pollut 2 section 602 b caa class ii ozon deplet substanc 3 section 307 clean water act cwa prioriti pollut list 4 feder insecticid fungicid rodenticid act fifra activ ingredi includ special review cancel deni suspend restrict use pesticid 5 section 302 epcra extrem hazard substanc 6 section 102 comprehens environment respons compens liabil act cercla 7 section 3001 resourc conserv recoveri act rcra chemic list 40 cfr 261 33 e f appendix viii 8 section 1412 safe drink water act amend 9 certain chemic subject toxic substanc control act exist chemic 10 state california safe drink water toxic enforc act 1986 proposit 65 list chemic known state caus reproduct toxic addit epa consid chemic design possibl probabl known carcinogen monograph intern agenc research cancer iarc 6th annual report carcinogen nation toxicolog program ntp u depart health human servic dhh initi group substanc epa exclud chemic alreadi list section 313 alreadi report one epcra section 313 categori exampl cyanid total list section 307 cwa list consid subset epcra section 313 cyanid compound categori hydrogen cyanid list epa decid propos list type chemic separ alreadi report one exist section 313 categori priorit chemic possibl addit epcra section 313 epa appli human health ecotox screen product volum screen describ result toxic screen subset chemic present public meet may 29 1992 ref 4 chemic also remov consider rulemak subject two recent publish epcra petit respons march 4 1992 epa receiv petit governor mario cuomo new york natur resourc defens council nrdc add 80 chemic 2 chemic categori list toxic chemic section 313 epcra chemic chemic categori appear rcra list hazard wast 40 cfr 261 33 f subset chemic screen epa epa respond petit propos rulemak septemb 8 1992 57 fr 41020 final rule ad 22 chemic novemb 30 1993 58 fr 63500 decemb 3 1991 epa receiv petit nrdc friend earth environment defens fund add hydrochlorofluorocarbon hcfc list toxic chemic section 313 epcra hcfc list section 602 b caa class ii ozon deplet substanc subset chemic screen epa epa respond petit propos rulemak june 24 1992 57 fr 28159 final rule ad 11 hcfc novemb 30 1993 58 fr 63496 addit 16 hcfc ad tri list novemb 30 1993 final rule propos addit rulemak see unit iv b 135 preambl 1 toxic screen toxic screen limit review readili avail toxic data e g inform data base secondari sourc use preliminari categor chemic process select candid possibl list epcra section 313 toxic screen use identifi chemic consider reflect final determin list chemic epcra section 313 determin made hazard assess conduct see unit ii b 3 preambl chemic identifi screen four gener effect categori acut human health effect cancer chronic human health effect ecolog effect screen criteria associ effect area use toxic screen discuss detail revis draft hazard assess guidelin list chemic toxic releas inventori draft hazard assess guidelin ref 6 numer screen valu reflect draft hazard assess guidelin develop captur suffici list screen categori major chemic alreadi list variou cercla epcra list thu known suspect toxic hazard draft hazard assess guidelin contain guidanc screen hazard assess chemic avail review docket associ rulemak draft document distribut public meet may 29 1992 final version guidelin yet develop request inform draft guidelin address person identifi inform contact base result screen chemic preliminarili place one three screen categori defin draft hazard assess guidelin suffici may suffici insuffici epa receiv comment respons draft hazard assess guidelin object agenc use term suffici may suffici insuffici titl toxic screen categori comment claim term appropri result hazard assess comment state term use screen categori toxic screen identifi chemic consider epa agre screen categori reflect preliminari determin chemic therefor avoid confus refer screen categori high prioriti medium prioriti low prioriti reflect differ toxic screen hazard assess term use throughout document refer toxic screen categori chemic categor low prioriti screen process consid candid addit epcra section 313 list rulemak 2 product volum screen epcra section 313 f establish report threshold relat amount chemic manufactur process otherwis use epcra section 313 manufactur includ import process threshold 25 000 pound per facil per year otherwis use threshold 10 000 pound per facil per year epa anticip addit chemic manufactur import process use quantiti less epcra section 313 volum threshold would result submiss tri report thu epa elect initi focu attent chemic like yield report accordingli epa also screen potenti candid likelihood meet epcra section 313 volum threshold chemic data indic chemic like meet exceed epcra section 313 volum threshold consid possibl candid addit section 313 list time product volum data chemic gather primarili two sourc 1 tsca chemic updat system 1990 2 fifra section 7 track system june 12 1986 51 fr 21438 epa promulg rule pursuant section 8 tsca requir manufactur import report everi 4 year subject certain threshold product quantiti exclus quantiti chemic produc 40 cfr part 710 among except inventori updat rule iur report polym biolog product inorgan substanc chemic produc less 10 000 pound certain limit data iur maintain epa tsca chemic updat system cu section 7 fifra provid agenc annual product inform regist pesticid epa regul implement fifra section 7 40 cfr part 167 requir manufactur pesticid product includ formul pesticid activ ingredi devic submit annual report detail amount type pesticid product manufactur sold distribut past year estim manufactur import process current year 40 cfr 167 85 industri inorgan compound subject fifra avail cu inform public literatur use supplement inform compani 3 hazard evalu epa conduct hazard evalu addit candid result analys determin base weight evid suffici evid establish candid chemic met statutori criteria addit epcra section 313 make determin epa senior scientist review readili avail toxic inform chemic follow effect area acut human health effect cancer chronic human effect environment effect addit epa review appropri inform environment fate chemic hazard assess conduct accord relev epa guidelin advers human health environment effect e g appropri guidelin hazard evalu chemic carcinogen type evid requir substanti determin carcinogen guidelin carcinogen risk assess ref 2 guidelin use effect agenc guidelin identifi draft hazard assess guidelin ref 6 assess sever signific effect induc chemic dose level caus effect qualiti quantiti avail data includ natur data e g human epidemiolog laboratori anim field workplac studi confid level exist data base consid care review scientif data particular chemic result high level confid chemic caus advers effect rel low dose level epa believ evid suffici list chemic section 313 hand review scientif data indic chemic caus variou advers effect moder dose level epa believ base total weight evid suffici evid list chemic epcra section 313 epa also conduct analysi exposur chemic chemic categori propos list epcra section 313 2 e base advers acut human health effect appropri section 313 2 c e base advers ecolog effect chemic list epcra section 313 2 analysi includ estim concentr chemic beyond facil site boundari use estim releas model techniqu epa request comment approach consid exposur part evalu chemic section 313 2 c base analysi chemic propos list epa determin one statutori criteria met discuss epa interpret epcra section 313 criteria given unit iii preambl discuss evid support epa propos add chemic epcra section 313 present unit iv preambl record support propos rule 4 consider epa exclud certain chemic chemic categori consider propos list epcra section 313 rulemak number reason chemic identifi environment degrad product rather chemic manufactur process otherwis use facil chemic present environ result releas environ precursor chemic degrad product meet toxic criteria epcra section 313 precursor chemic may consid list epcra section 313 degrad product would consid list epcra section 313 facil subject epcra section 313 requir file tri report chemic manufactur process otherwis use within facil boundari therefor epa believ appropri consid list chemic time list review epa includ list repres wast stream particular process wast stream coke oven emiss discret chemic chemic categori contain wide rang chemic mani current list individu epcra section 313 focu rulemak addit specif chemic chemic categori epa believ wast stream inappropri list epcra section 313 time epa also exclud chemic whose identifi toxic concern result statu volatil organ compound voc voc contribut format tropospher ozon caus number health relat environment problem epa continu believ voc meet list criteria epcra section 313 howev epa intend address issu voc list epcra section 313 separ therefor chemic whose identifi toxic concern due statu voc exclud consider time epa also identifi chemic routin manufactur process otherwis use level far report threshold epcra section 313 chemic expect ever manufactur process otherwis use quantiti report threshold propos rulemak epa attempt add chemic epcra section 313 manufactur process otherwis use quantiti greater epcra section 313 volum threshold thu would result submiss tri report consequ chemic manufactur process otherwis use quantiti less epcra section 313 volum threshold exclud consider time report would file epcra section 313 chemic chemic manufactur process otherwis use epcra section 313 activ threshold particularli chemic manufactur trace amount wast stream highli toxic low dose level physic chemic biolog properti make chemic persist extend period environ bioaccumul food chain persist bioaccumul toxic chemic dioxin particular concern ecosystem great lake basin due long retent time individu lake cycl chemic one compon ecosystem anoth epa may reconsid futur issu list chemic manner would result submiss tri report epa request comment follow appropri list chemic epcra section 313 epa add type chemic epcra section 313 modif epcra section 313 lower report threshold modifi de minimi mixtur exempt 40 cfr part 372 38 would requir insur releas transfer inform would collect iii epcra section 313 statutori criteria epcra section 313 2 set criteria ad chemic list chemic subject report section 313 chemic categori chemic ad epcra section 313 c list toxic chemic administr must determin whether judgement suffici evid establish one follow chemic known caus reason anticip caus signific advers acut human health effect concentr level reason like exist beyond facil site boundari result continu frequent recur releas b chemic known caus reason anticip caus human cancer teratogen effect ii seriou irrevers reproduct dysfunct ii neurolog disord iii herit genet mutat iv chronic health effect c chemic known caus reason anticip caus toxic ii toxic persist environ iii toxic tendenc bioaccumul environ signific advers effect environ suffici serious judgement administr warrant report section remov chemic section 313 c list administr must determin suffici evid establish criteria describ requir epcra section 313 3 thu criteria list delist chemic ident howev wherea epa add chemic one criteria met delet chemic none criteria met ascertain whether suffici insuffici evid determin statutori criteria met list chemic epa conduct hazard assess chemic determin base weight evid whether chemic reason anticip caus advers effect specifi epcra section 313 2 hazard analysi describ unit ii b 3 preambl epa interpret specif statutori criteria follow 1 section 313 2 acut human health effect determin whether section 313 2 acut human health effect criterion met epa must examin advers effect associ chemic concentr level would caus acut human health effect likelihood level exist beyond facil site boundari result continu frequent recur releas determin may includ among factor consider product process workplac procedur pollut control volum pattern product use releas well chemic specif factor epa believ make section 313 2 determin must demonstr chemic reason anticip releas quantiti result concentr level within reason margin exposur concentr level would expect caus acut human health effect beyond facil site boundari margin exposur appli depend upon type hazard data e g data anim versu human confid hazard data base acut effect e g suffici hazard data howev epa requir make facil specif find necessari epa demonstr concentr level effect occur near particular facil ref 1 furthermor epa may requir conduct new studi risk assess perform site specif analys establish actual ambient concentr document advers effect particular locat ref 1 epa limit consid concentr level potenti acut human health effect fencelin rather phrase beyond facil site boundari reflect congress recognit highest concentr person outsid site boundari may expos could occur point outsid boundari site facil locat includ exampl air emiss plume cool settl ground ref 1 therefor epa believ make find epcra section 313 2 agenc may estim concentr beyond facil site boundari use estim releas model techniqu term continu frequent recur releas includ distinguish routin releas normal consequ oper facil episod accident releas subject epcra section 304 ref 1 epa believ episod accident releas pertin determin chemic meet section 313 2 criterion 2 section 313 2 b chronic human health effect contrast section 313 2 criterion section 313 2 b requir consider either natur frequenc releas concentr level facil site boundari rather section 313 2 b focus sole whether chemic known reason anticip caus cancer teratogen seriou irrevers chronic human health effect consequ epa believ suffici consid toxic subject chemic make section 313 2 b determin 3 section 313 2 c environment effect section 313 2 c criterion requir epa consid chemic potenti caus signific advers effect environ statut direct epa base determin consider toxic chemic either alon combin persist chemic potenti chemic bioaccumul congress intend epa consid broad rang environment effect make determin section 313 2 c determin constitut signific advers effect environ administr consid extent toxic chemic caus reason anticip caus follow advers reaction even restrict immedi vicin adjac site 1 gradual sudden chang composit anim life plant life includ fungal microbi organ area 2 abnorm number death organ e g fish kill 3 reduct reproduct success vigor speci 4 reduct agricultur product whether crop livestock 5 alter behavior distribut speci 6 long last irrevers contamin compon physic environ especi case groundwat surfac water soil resourc limit self cleans capabl ref 1 epa believ environment effect criterion inher contain limit exposur compon statutori requir epa find signific advers effect environ suffici serious judgment administr warrant report epcra section 313 unlik section 313 2 b epa determin whether certain kind effect known reason anticip occur section 313 2 c requir epa find effect suffici serious warrant report impli possibl certain circumst chemic could theoret caus signific advers effect environ unlik caus one magnitud warrant list extent exposur factor epa determin depend upon inher toxic chemic varieti chemic specif characterist epa believ chemic inher extrem toxic toxic low dose level exposur assess necessari even minim releas chemic may reason anticip result signific advers environment effect case epa could reli toxic alon section 313 2 c basi list howev chemic exhibit advers effect upon environ sole base toxic moder low dose epa believ consider potenti exposur warrant minim releas may result signific advers effect upon environ exposur consider may includ among factor pollut control volum pattern product use releas environment fate well chemic specif factor use estim releas model techniqu epcra section 313 2 c ii iii allow epa consid impact characterist chemic chemic exhibit signific advers effect environ base toxic persist toxic bioaccumul low moder low dose level epa believ exposur consider requir addit consider implicit evalu chemic potenti persist bioaccumul even minim releas chemic may result elev concentr environ organ reason anticip result signific advers effect reflect increas likelihood exposur chemic persist due longer resid time environ repeat minim releas persist chemic may result elev concentr environ chemic bioaccumul even low level chemic environ may result increas concentr organ therefor evalu chemic persist bioaccumul potenti may consid function equival exposur analysi addit chemic induc well establish advers effect e g chlorofluorocarbon caus stratospher ozon deplet epa believ exposur assess unnecessari epa believ chemic typic affect sole one two speci rather affect chang across whole ecosystem epa believ effect suffici serious addit exposur consider warrant scope impact well document evid support advers effect epa request comment approach consid exposur part evalu list chemic section 313 2 c unit iv b preambl epa identifi chemic propos addit epcra section 313 specif statutori criteria upon propos addit base iv epa technic review introduct data chemic chemic categori review evid indic advers acut chronic toxic carcinogen mutagen development reproduct effect neurotox environment effect inform environment fate also review chemic propos addit epcra section 313 rulemak epa conduct extens hazard assess appropri analysi exposur determin whether chemic met one epcra section 313 2 list criteria hazard assess discuss detail unit ii b 3 preambl care review final determin made whether one epcra section 313 2 list criteria met individu chemic chemic categori propos list epa need show one list criteria met order list chemic chemic categori epcra section 313 inform summar chemic chemic categori repres key data element lead epa believ suffici evid establish one section 313 2 list criteria met extens review exist data base chemic chemic categori propos list reflect entir weight evid consid epa contain follow support document support document addit chemic feder insecticid fungicid rodenticid act fifra activ ingredi epcra section 313 ref 3 physic properti environment fate tri expans chemic ref 5 support document addit chemic section 112 b clean air act amend chlorin paraffin epcra section 313 ref 7 support document health ecolog toxic review tri expans chemic ref 8 support document contain complet list refer found public record propos rulemak use support propos addit list 313 chemic chemic categori chemic abstract servic ca number appropri follow 1 abamectin avermectin b1 ca 071751 41 2 2 aceph acetylphosphoramidothio acid dimethyl ester ca 030560 19 1 3 acifluorfen sodium salt 5 2 chloro 4 triflouromethyl phenoxi 2 nitro benzoic acid sodium salt ca 062476 59 9 4 alachlor ca 015972 60 8 5 aldicarb ca 000116 06 3 6 tran allethrin tran chrysanthem acid allethron ca 028057 48 9 7 allylamin ca 000107 11 9 8 aluminum phosphid ca 020859 73 8 9 ametryn n ethyl n 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin ca 000834 12 8 10 amitraz ca 033089 61 1 11 anilazin 4 6 dichloro n 2 chlorophenyl 1 3 5 triazin 2 amin ca 000101 05 3 12 atrazin 6 chloro n ethyl n 1 methylethyl 1 3 5 triazin 2 4 diamin ca 001912 24 9 13 bendiocarb 2 2 dimethyl 1 3 benzodioxol 4 ol methylcarbam ca 022781 23 3 14 benfluralin n butyl n ethyl 2 6 dinitro 4 trifluoromethyl benzenamin ca 001861 40 1 15 benomyl ca 017804 35 2 16 benzyl p chlorophenol ca 000120 32 1 17 bifenthrin ca 082657 04 3 18 bi tributyltin oxid ca 000056 35 9 19 boron trichlorid ca 010294 34 5 20 boron trifluorid ca 007637 07 2 21 bromacil 5 bromo 6 methyl 3 1 methylpropyl 2 4 1h 3h pyrimidinedion ca 000314 40 9 22 bromacil lithium salt 2 4 1h 3h pyrimidinedion 5 bromo 6 methyl 3 1 methylpropyl lithium salt ca 053404 19 6 23 bromin ca 007726 95 6 24 1 bromo 1 bromomethyl 1 3 propanedicarbonitril ca 035691 65 7 25 2 bromo 2 nitropropan 1 3 diol bronopol ca 000052 51 7 26 bromoxynil 3 5 dibromo 4 hydroxybenzonitril ca 001689 84 5 27 bromoxynil octano octano acid 2 6 dibromo 4 cyanophenyl ester ca 001689 99 2 28 brucin ca 000357 57 3 29 butyl bi 2 methylpropyl carbamothio acid ethyl ester ca 002008 41 5 30 butyl hydroxyanisol ca 025013 16 5 31 c acid red 114 ca 006459 94 5 32 c direct blue 218 ca 028407 37 6 33 calcium hypochlorit ca 007778 54 3 34 caprolactam ca 000105 60 2 35 carbofuran ca 001563 66 2 36 carbon monoxid ca 000630 08 0 37 carboxin 5 6 dihydro 2 methyl n phenyl 1 4 oxathiin 3 carboxamid ca 005234 68 4 38 chinomethionat 6 methyl 1 3 dithiolo 4 5 b quinoxalin 2 one ca 002439 01 2 39 chlorend acid ca 000115 28 6 40 chlorimuron ethyl ethyl 2 4 chloro 6 methoxyprimidin 2 yl carbonyl amino sulfonyl benzoat ca 090982 32 4 41 chlorin paraffin 42 1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan chlorid ca 004080 31 3 43 p chloroanilin ca 000106 47 8 44 5 chloro 2 2 4 dichlorophenoxi phenol ca 003380 34 5 45 3 chloro 2 methyl 1 propen ca 000563 47 3 46 p chlorophenyl isocyan ca 000104 12 1 47 chloropicrin ca 000076 06 2 48 3 chloropropionitril ca 000542 76 7 49 p chloro toluidin ca 000095 69 2 50 chlorotrifluoromethan cfc 13 ca 000075 72 9 51 chlorpyrifo methyl dimethyl 3 5 6 trichloro 2 pyridyl phosphorothio ca 005598 13 0 52 chlorsulfuron 2 chloro n 4 methoxi 6 methyl 1 3 5 triazin 2 yl amino carbonyl benzenesulfonamid ca 064902 72 3 53 clomazon 2 2 chlorophenyl methyl 4 4 dimethyl 3 isoxazolidinon ca 081777 89 1 54 crotonaldehyd ca 004170 30 3 55 cyanazin ca 021725 46 2 56 cycloat ca 001134 23 2 57 cyclohexanol ca 000108 93 0 58 cyfluthrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 4 fluoro 3 phenoxyphenyl methyl ester ca 068359 37 5 59 cyhalothrin 3 2 chloro 3 3 3 trifluoro 1 propenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 3 phenoxyphenyl methyl ester ca 068085 85 8 60 cyromazin n cyclopropyl 1 3 5 triazin 2 4 6 triamin ca 066215 27 8 61 dazomet tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion ca 000533 74 4 62 dazomet sodium salt 2h 1 3 5 thiadiazin 2 thion tetrahydro 3 5 dimethyl ion 1 sodium ca 053404 60 7 63 2 4 db ca 000094 82 6 64 2 4 butoxyethyl ester ca 001929 73 3 65 2 4 butyl ester ca 000094 80 4 66 2 4 chlorocrotyl ester ca 002971 38 2 67 desmedipham ca 013684 56 5 68 2 4 2 ethylhexyl ester ca 001928 43 4 69 2 4 2 ethyl 4 methylpentyl ester ca 053404 37 8 70 diazinon ca 000333 41 5 71 2 2 dibromo 3 nitrilopropionamid ca 010222 01 2 72 dicamba 3 6 dichloro 2 methyoxybenzo acid ca 001918 00 9 73 dichloran 2 6 dichloro 4 nitroanilin ca 000099 30 9 74 3 3 dichlorobenzidin dihydrochlorid ca 000612 83 9 75 3 3 dichlorobenzidin sulfat ca 064969 34 2 76 tran 1 4 dichloro 2 buten ca 000110 57 6 77 dichloromethylphenylsilan ca 000149 74 6 78 dichlorophen 2 2 methylenebi 4 chlorophenol ca 000097 23 4 79 tran 1 3 dichloropropen ca 010061 02 6 80 diclofop methyl 2 4 2 4 dichlorophenoxi phenoxi propano acid methyl ester ca 051338 27 3 81 dicyclopentadien ca 000077 73 6 82 diethatyl ethyl ca 038727 55 8 83 diflubenzuron ca 035367 38 5 84 diglycidyl resorcinol ether ca 000101 90 6 85 dimethipin 2 3 dihydro 5 6 dimethyl 1 4 dithiin 1 1 4 4 tetraoxid ca 055290 64 7 86 dimetho ca 000060 51 5 87 3 3 dimethoxybenzidin dihydrochlorid dianisidin dihydrochlorid ca 020325 40 0 88 3 3 dimethoxybenzidin hydrochlorid dianisidin hydrochlorid ca 111984 09 9 89 dimethylamin ca 000124 40 3 90 dimethylamin dicamba ca 002300 66 5 91 3 3 dimethylbenzidin dihydrochlorid tolidin dihydrochlorid ca 000612 82 8 92 3 3 dimethylbenzidin dihydrofluorid tolidin dihydrofluorid ca 041766 75 0 93 dimethyl chlorothiophosph ca 002524 03 0 94 dimethyldichlorosilan ca 000075 78 5 95 n n dimethylformamid ca 000068 12 2 96 2 6 dimethylphenol ca 000576 26 1 97 dinocap ca 039300 45 3 98 dinoseb ca 000088 85 7 99 diphenamid ca 000957 51 7 100 diphenylamin ca 000122 39 4 101 dipotassium endothal 7 oxabicyclo 2 2 1 heptan 2 3 dicarboxyl acid dipotassium salt ca 002164 07 0 102 dipropyl isocinchomeron ca 000136 45 8 103 disodium cyanodithioimidocarbon ca 000138 93 2 104 2 4 isopropyl ester ca 000094 11 1 105 2 4 dithiobiuret ca 000541 53 7 106 dithiopyr 2 difluoromethyl 4 2 methylpropyl 6 trifluoromethyl 3 5 pyridinedicarbothio acid dimethyl ester ca 097886 45 8 107 diuron ca 000330 54 1 108 2 4 2 octyl ester ca 001917 97 1 109 dodin dodecylguanidin monoacet ca 002439 10 3 110 2 4 dp dichlorprop ca 000120 36 5 111 2 4 propylen glycol butyl ether ester ca 001320 18 9 112 2 4 sodium salt ca 002702 72 9 113 ethoprop phosphorodithio acid ethyl dipropyl ester ca 013194 48 4 114 ethyl dipropylthiocarbam eptc ca 000759 94 4 115 famphur ca 000052 85 7 116 fenarimol alpha 2 chlorophenyl alpha 4 chlorophenyl 5 pyrimidinemethanol ca 060168 88 9 117 fenbutatin oxid hexaki 2 methyl 2 phenylpropyl distannoxan ca 013356 08 6 118 fenoxaprop ethyl 2 4 6 chloro 2 benzoxazolylen oxi phenoxi propano acid ethyl ester ca 066441 23 4 119 fenoxycarb 2 4 phenoxyphenoxi ethyl carbam acid ethyl ester ca 072490 01 8 120 fenpropathrin 2 2 3 3 tetramethylcyclopropan carboxyl acid cyano 3 phenoxyphenyl methyl ester ca 039515 41 8 121 fenthion dimethyl 3 methyl 4 methylthio phenyl ester phosphorothio acid ca 000055 38 9 122 fenvaler 4 chloro alpha 1 methylethyl benzeneacet acid cyano 3 phenoxyphenyl methyl ester ca 051630 58 1 123 ferbam tri dimethylcarbamodithioato iron ca 014484 64 1 124 fluazifop butyl 2 4 5 trifluoromethyl 2 pyridinyl oxi phenoxi propano acid butyl ester ca 069806 50 4 125 flumetralin 2 chloro n 2 6 dinitro 4 trifluoromethyl phenyl n ethyl 6 fluorobenzenemethanamin ca 062924 70 3 126 fluorin ca 007782 41 4 127 fluorouracil 5 fluorouracil ca 000051 21 8 128 fluvalin n 2 chloro 4 trifluoromethyl phenyl dl valin cyano 3 phenoxyphenyl methyl ester ca 069409 94 5 129 folpet ca 000133 07 3 130 fomesafen 5 2 chloro 4 trifluoromethyl phenoxi n methylsulfonyl 2 nitrobenzamid ca 072178 02 0 131 alpha hexachlorocyclohexan ca 000319 84 6 132 hexamethylen 1 6 diisocyan ca 000822 60 0 133 n hexan ca 000110 54 3 134 hexazinon ca 051235 04 2 135 hydramethylnon tetrahydro 5 5 dimethyl 2 1h pyrimidinon 3 4 trifluoromethyl phenyl 1 2 4 trifluoromethyl phenyl ethenyl 2 propenyliden hydrazon ca 067485 29 4 136_151 hydrochlorofluorocarbon specif 136 dichloropentafluoropropan ca 127564 92 5 137 1 3 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225ea ca 136013 79 1 138 2 2 dichloro 1 1 1 3 3 pentafluoropropan hcfc 225aa ca 128903 21 9 139 1 1 dichloro 1 2 3 3 3 pentafluoropropan hcfc 225eb ca 111512 56 2 140 1 1 dichloro 1 2 2 3 3 pentafluoropropan hcfc 225cc ca 13474 88 9 141 1 3 dichloro 1 1 2 2 3 pentafluoropropan hcfc 225cb ca 000507 55 1 142 1 2 dichloro 1 1 3 3 3 pentafluoropropan hcfc 225da ca 000431 86 7 143 3 3 dichloro 1 1 1 2 2 pentafluoropropan hcfc 225ca ca 000422 56 0 144 2 3 dichloro 1 1 1 2 3 pentafluoropropan hcfc 225ba ca 000422 48 0 145 1 2 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225bb ca 000422 44 6 146 dichlorofluoromethan hcfc 21 ca 000075 43 4 147 1 1 1 2 tetrachloro 2 fluoroethan hcfc 121a ca 000354 11 0 148 1 1 2 2 tetrachloro 1 fluoroethan hcfc 121 ca 000354 14 3 149 1 2 dichloro 1 1 difluoroethan hcfc 132b ca 001649 08 7 150 2 chloro 1 1 1 trifluoroethan hcfc 133a ca 000075 88 7 151 3 chloro 1 1 1 trifluoropropan hcfc 253fb ca 000460 35 5 152 imazalil 1 2 2 4 dichlorophenyl 2 2 propenyloxi ethyl 1h imidazol ca 035554 44 0 153 3 iodo 2 propynyl butylcarbam ca 055406 53 6 154 iprodion 3 3 5 dichlorophenyl n 1 methylethyl 2 4 dioxo 1 imidazolidinecarboxamid ca 036734 19 7 155 iron pentacarbonyl ca 013463 40 6 156 isodrin ca 000465 73 6 157 isofenpho 2 ethoxyl 1 methylethyl amino phosphinothioyl oxi benzoic acid 1 methylethyl ester ca 025311 71 1 158 isophoron ca 000078 59 1 159 isophoron diisocyan ca 004098 71 9 160 lactofen 5 2 chloro 4 trifluoromethyl phenoxi 2 nitro 2 ethoxi 1 methyl 2 oxoethyl ester ca 077501 63 4 161 linuron ca 000330 55 2 162 lithium carbon ca 000554 13 2 163 malathion ca 000121 75 5 164 man made miner fiber 165 mecoprop ca 000093 65 2 166 2 mercaptobenzothiazol mbt ca 000149 30 4 167 merpho ca 000150 50 5 168 metham sodium sodium methyldithiocarbam ca 000137 42 8 169 methazol 2 3 4 dichlorophenyl 4 methyl 1 2 4 oxadiazolidin 3 5 dion ca 020354 26 1 170 methiocarb ca 002032 65 7 171 methoxon 4 chloro 2 methylphenoxi acet acid mcpa ca 000094 74 6 172 methoxon sodium salt 4 chloro 2 methylphenoxi acet sodium salt ca 003653 48 3 173 1 1 methylen bi 4 isocyanatocyclohexan ca 005124 30 1 174 methylen bi thiocyan ca 006317 18 6 175 methyl isothiocyan ca 00556 61 6 176 2 methyllactonitril ca 000075 86 5 177 n methylolacrylamid ca 000924 42 5 178 methyl parathion ca 000298 00 0 179 n methyl 2 pyrrolidon ca 000872 50 4 180 methyltrichlorosilan ca 000075 79 6 181 metiram ca 009006 42 2 182 metribuzin ca 021087 64 5 183 mevinpho ca 007786 34 7 184 molin 1h azepin 1 carbothio acid hexahydro ethyl ester ca 002212 67 1 185 monuron ca 000150 68 5 186 myclobutanil alpha butyl alpha 4 chlorophenyl 1h 1 2 4 triazol 1 propanenitril ca 088671 89 0 187 nabam ca 000142 59 6 188 nale ca 000300 76 5 189 nicotin salt 190 nitrapyrin 2 chloro 6 trichloromethyl pyridin ca 001929 82 4 191 nitrat ion ca 014797 55 8 192 nitric oxid ca 010102 43 9 193 p nitroanilin ca 000100 01 6 194 nitrogen dioxid ca 010102 44 0 195 norflurazon 4 chloro 5 methylamino 2 3 trifluoromethyl phenyl 3 2h pyridazinon ca 027314 13 2 196 oryzalin 4 dipropylamino 3 5 dinitrobenzenesulfonamid ca 019044 88 3 197 oxydemeton methyl 2 ethylsulfinyl ethyl dimethyl ester phosphorothio acid ca 000301 12 2 198 oxydiazon 3 2 4 dichloro 5 1 methylethoxi phenyl 5 1 1 dimethylethyl 1 3 4 oxadiazol 2 3h one ca 019666 30 9 199 oxyfluorfen ca 042874 03 3 200 ozon ca 010028 15 6 201 paraquat dichlorid ca 001910 42 5 202 pebul butylethylcarbamothio acid propyl ester ca 001114 71 2 203 pendimethalin n 1 ethylpropyl 3 4 dimethyl 2 6 dinitrobenzenamin ca 040487 42 1 204 pentobarbit sodium ca 000057 33 0 205 perchloromethyl mercaptan ca 000594 42 3 206 permethrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester ca 052645 53 1 207 phenanthren ca 000085 01 8 208 phenothrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester ca 026002 80 2 209 1 2 phenylenediamin ca 000095 54 5 210 1 3 phenylenediamin ca 000108 45 2 211 1 2 phenylenediamin dihydrochlorid ca 000615 28 1 212 1 4 phenylenediamin dihydrochlorid ca 000624 18 0 213 phenytoin ca 000057 41 0 214 phosphin ca 007803 51 2 215 phosphoru oxychlorid ca 010025 87 3 216 phosphoru pentachlorid ca 010026 13 8 217 phosphoru pentasulfid ca 001314 80 3 218 phosphoru pentoxid ca 001314 56 3 219 picloram ca 001918 02 1 220 piperonyl butoxid ca 000051 03 6 221 pirimipho methyl 2 diethylamino 6 methyl 4 pyrimidinyl dimethyl phosphorothio ca 029232 93 7 222_ 249 polycycl aromat compound pac includ 222 benz anthracen ca 000056 55 3 223 benzo phenanthren ca 000218 01 9 224 benzo pyren ca 000050 32 8 225 benzo b fluoranthen ca 000205 99 2 226 benzo j fluoranthen ca 000205 82 3 227 benzo k fluoranthen ca 000207 08 9 228 benzo rst pentaphen ca 000189 55 9 229 carbazol ca 000086 74 8 230 cyclopenta cd pyren ca 027208 37 3 231 dibenz h acridin ca 000226 36 8 232 dibenz j acridin ca 000224 42 0 233 dibenz c anthracen ca 000215 58 7 234 dibenz j anthracen ca 000224 41 9 235 dibenzo h anthracen ca 000053 70 3 236 dibenzo e fluoranthen ca 005385 75 1 237 dibenzo e pyren ca 000192 65 4 238 dibenzo h pyren ca 000189 64 0 239 dibenzo l pyren ca 000191 30 0 240 7h dibenzo c g carbazol ca 000194 59 2 241 7 12 dimethylbenz anthracen ca 000057 976 242 indeno 1 2 3 cd pyren ca 000193 39 5 243 2 methylchrysen ca 003351 32 4 244 3 methylchrysen ca 003351 31 3 245 4 methylchrysen ca 003351 30 2 246 5 methylchrysen ca 003697 24 3 247 6 methylchrysen ca 001705 85 7 248 2 methylfluoranthen ca 033543 31 6 249 1 nitropyren ca 005522 43 0 250 potassium bromat ca 007758 01 2 251 potassium dimethyldithiocarbam ca 000128 03 0 252 potassium n methyldithiocarbam ca 000137 41 7 253 primisulfuron methyl 2 4 6 bi difluoromethoxi 2pyrimidinyl amino carbonyl amino sulfonyl benzoat ca 086209 51 0 254 profenofo 4 bromo 2 chlorophenyl ethyl propyl phosphorothio ca 041198 08 7 255 prometryn n n bi 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin ca 007287 19 6 256 propachlor 2 chloro n 1 methylethyl n phenylacetamid ca 001918 16 7 257 propanil n 3 4 dichlorophenyl propanamid ca 000709 98 8 258 propargit ca 002312 35 8 259 propargyl alcohol ca 000107 19 7 260 propetampho 3 ethylamino methoxyphosphinothioyl oxi 2 buteno acid 1 methylethyl ester ca 031218 83 4 261 propiconazol 1 2 2 4 dichlorophenyl 4 propyl 1 3 dioxolan 2 yl methyl 1h 1 2 4 triazol ca 060207 90 1 262 quizalofop ethyl 2 4 6 chloro 2 quinoxalinyl oxi phenoxi propano acid ethyl ester ca 076578 14 8 263 resmethrin 5 phenylmethyl 3 furanyl methyl 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl ca 010453 86 8 264 sethoxydim 2 1 ethoxyimino butyl 5 2 ethylthio propyl 3 hydroxyl 2 cyclohexen 1 one ca 074051 80 2 265 simazin ca 000122 34 9 266 sodium azid ca 026628 22 8 267 sodium chlorit ca 007758 19 2 268 sodium dicamba 3 6 dichloro 2 methoxybenzo acid sodium salt ca 001982 69 0 269 sodium dimethyldithiocarbam ca 000128 04 1 270 sodium fluoroacet ca 000062 74 8 271 sodium hypochlorit ca 007681 52 9 272 sodium nitrit ca 007632 00 0 273 sodium pentachlorophen ca 000131 52 2 274 sodium phenylphenoxid ca 000132 27 4 275 sodium 2 pyridinethiol 1 oxid ca 015922 78 8 276 strychnin salt 277 sulfur dioxid ca 007446 09 5 278 sulfur trioxid ca 007446 11 9 279 sulfuryl fluorid vikan ca 002699 79 8 280 sulprofo ethyl 4 methylthio phenyl phosphorodithio acid propyl ester ca 035400 43 2 281 tebuthiuron n 5 1 1 dimethylethyl 1 3 4 thiadiazol 2 yl n n dimethylurea ca 034014 18 1 282 tefluthrin ca 079538 32 2 283 temepho ca 003383 96 8 284 terbacil 5 chloro 3 1 1 dimethylethyl 6 methyl 2 4 1h 3h pyrimidinedion ca 005902 51 2 285 tetracyclin hydrochlorid ca 000064 75 5 286 tetramethrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 1 3 4 5 6 7 hexahydro 1 3 dioxo 2h isoindol 2 yl methyl ester ca 007696 12 0 287 tetrasodium ethylenediaminetetraacet ca 000064 02 8 288 thiabendazol 2 4 thiazolyl 1h benzimidazol ca 000148 79 8 289 thiabendazol hypophosphit salt 2 4 thiazolyl benzimidazol hypophosphit salt ca 028558 32 9 290 thiobencarb carbam acid diethylthio p chlorobenzyl ca 028249 77 6 291 thiodicarb ca 059669 26 0 292 thiophan ethyl 1 2 phenylenebi iminocarbonothioyl biscarbam acid diethyl ester ca 023564 06 9 293 thiophan methyl ca 023564 05 8 294 thiosemicarbazid ca 000079 19 6 295 triadimefon 1 4 chlorophenoxi 3 3 dimethyl 1 1h 1 2 4 triazol 1 yl 2 butanon ca 043121 43 3 296 triallat ca 002303 17 5 297 tribenuron methyl 2 4 methoxi 6 methyl 1 3 5 triazin 2 yl methylamino carbonyl amino sulfonyl methyl ester ca 101200 48 0 298 tributyltin fluorid ca 001983 10 4 299 tributyltin methacryl ca 002155 70 6 300 tributyltrithiophosph def ca 000078 48 8 301 trichloroacetyl chlorid ca 000076 02 8 302 trichloroethylsilan ca 000115 21 9 303 trichlorophenylsilan ca 000098 13 5 304 1 2 3 trichloropropan ca 000096 18 4 305 triclopyr triethylammonium salt ca 057213 69 1 306 triethylamin ca 000121 44 8 307 triforin n n 1 4 piperazinediylbi 2 2 2 trichloroethyliden bisformamid ca 026644 46 2 308 trimethylchlorosilan ca 000075 77 4 309 2 3 5 trimethylphenyl methylcarbam ca 002655 15 4 310 triphenyltin chlorid ca 000639 58 7 311 triphenyltin hydroxid ca 000076 87 9 312 vanadium pentoxid ca 001314 62 1 313 vinclozolin 3 3 5 dichlorophenyl 5 ethenyl 5 methyl 2 4 oxazolidinedion ca 050471 44 8 limit discuss health environment effect associ 313 chemic chemic categori provid unit iv b preambl chemic identifi chemic name ca list chemic origin list design follow caa hap clean air act section 112 b hazard air pollut caa od clean air act section 602 b class ii ozon deplet cal state california safe drink water toxic enforc act 1986 proposit 65 list chemic known state caus reproduct toxic cercla comprehens environment respons compens liabil act section 102 cwa ppl clean water act section 307 prioriti pollut list epcra eh epcra section 302 extrem hazard substanc fifra ai feder insecticid fungicid rodenticid act fifra activ ingredi fifra sr fifra special review cancel deni suspend restrict use pesticid iarc monograph intern agenc research cancer ntp 6th annual report carcinogen nation toxicolog program rcra app8 resourc conserv recoveri act rcra chemic list 40 cfr part 261 appendix viii rcra p rcra chemic list 40 cfr part 261 33 e sdwa safe drink water act section 1412 tsca toxic substanc control act exist chemic epa request comment suffici evid chemic propos addit addit epa request comment issu may specif individu chemic chemic categori exampl chemic list epcra section 313 meet epcra section 313 criteria whose use drug product b chemic propos addit epcra section 313 1 abamectin avermectin b1 ca 071751 41 2 fifra ai ref 3 compound induc development toxic sever speci mous sensit speci increas retin fold weanl decreas viabil lactat indic decreas bodi weight note two gener rat reproduct studi lowest observ effect level loel 0 4 milligram per kilogram per day mg kg day observ effect level noel 0 12 mg kg day base noel epa deriv refer dose rfd 0 0004 mg kg day epa believ suffici evid list abamectin epcra section 313 pursuant epcra section 313 2 b base avail development toxic data aquat acut toxic valu abamectin includ bluegil 96hour lc 50 9 6 part per billion ppb rainbow trout 96hour lc 50 3 6 ppb daphnid 48hour lc 50 0 34 ppb epa believ suffici evid list abamectin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 2 aceph acetylphosphoramidothio acid dimethyl ester ca 030560 19 1 fifra ai ref 3 28month feed studi rat inhibit brain plasma red blood cell cholinesteras activ observ 50 part per million ppm 2 5 mg kg day noel studi 5 ppm 0 25 mg kg day similar find note 2year feed studi dog loel studi 100 ppm 2 5 mg kg day noel 30 ppm 0 75 mg kg day epa believ suffici evid list aceph epcra section 313 pursuant epcra section 313 2 b base avail neurotox data chemic 3 acifluorfen sodium salt 5 2 chloro 4 triflouromethyl phenoxi 2 nitro benzoic acid sodium salt ca 062476 59 9 fifra ai ref 3 acifluorfen classifi group b2 compound e chemic probabl human carcinogen acifluorfen produc increas incid combin malign benign liver tumor two differ strain mice compound also display posit mutagen activ sever non mammalian test system structur similar four diphenyl ether herbicid compound caus increas incid liver tumor two differ strain mice epa believ suffici evid list acifluorfen sodium salt epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data 4 alachlor ca 015972 60 8 fifra sr ref 8 alachlor anilin type herbicid dose relat hemolyt anemia reduct red blood cell count hematocrit hemoglobin well hemosiderosi liver spleen kidney occur male dog oral expos alachlor 1year loel base effect 3 0 mg kg day noel 1 0 mg kg day effect femal dog studi demonstr clearli male consid suggest anemia epa deriv oral rfd 0 01 mg kg day studi three gener reproduct studi rat chronic nephriti increas rel absolut kidney weight report f 2 adult male f 3 pup loel 10 mg kg day noel 3 mg kg day rabbit dutch belt strain receiv alachlor via oral gavag gestat day 6 27 increas rate preimplant loss 49 percent offspr increas incid development malform includ major vessel variat presacr vertebra rudimentari full 13th rib increas incid rudimentari full 13th rib dose relat lowest observ advers effect level loael 10 mg kg day determin base effect observ advers effect level noael determin epa classifi alachlor categori group b2 compound e chemic probabl human carcinogen 2year rat feed studi long evan rat increas incid nasal turbin tumor malign stomach tumor thyroid follicular adenoma carcinoma sex dose greater equal 42 mg kg day 18month studi femal cd 1 mice bronchiolar tumor occur increas incid 200 mg kg day epa believ suffici evid list alachlor epcra section 313 pursuant epcra section 313 2 b base chronic toxic carcinogen data chemic 5 aldicarb ca 000116 06 3 cercla epcra eh fifra sr rcra app8 rcra p ref 8 aquat acut toxic test data aldicarb includ measur 96hour lc 50 50 ppb bluegil measur 48hour lc 50 70 ppb daphnid addit measur 48hour ec 50 daphnid 51 ppb measur terrestri acut toxic data wildlif includ oral ld 50 femal mallard duck 3 4 milligram per kilogram mg kg oral ld 50 california quail 2 58 mg kg male 4 67 mg kg femal epa believ suffici evid list aldicarb epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 6 tran allethrin tran chrysanthem acid dallethron ca 028057 48 9 fifra ai ref 3 centrilobular hydrop degener liver loel 1 000 ppm 25 mg kg day noel 200 ppm 5 mg kg day seen dog fed allethrin 3 month increas serum liver enzym femal rat increas liver weight male femal rat loel 250 mg kg day noel 1 500 ppm 75 mg kg day observ rat fed allethrin 3 month histopatholog data present studi taken togeth result studi indic hepatotox potenti tran allethrin epa believ suffici evid list tran allethrin epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data 7 allylamin ca 000107 11 9 epcra eh ref 8 repeat inhal exposur 5 ppm 0 011 mg l allylamin 50 exposur 7 hour caus liver renal damag myocard rat congest liver kidney observ rat rabbit dog expos 5 20 ppm 0 011 0 044 milligram per liter mg l allylamin 8 hour day 5 day week 1year epa believ suffici evid list allylamin epcra section 313 pursuant epcra section 313 2 b base hepatotox nephrotox data chemic 8 aluminum phosphid ca 020859 73 8 cercla epcra eh rcra app8 rcra p ref 8 median lethal dose aluminum phosphid human 20 mg kg acut inhal toxic aluminum phosphid attribut phosphin ga result decomposit aluminum phosphid contact moistur air symptom phosphin poison includ restless headach dizzi fatigu chest tight nausea vomit lethargi stupor coma convuls lower blood pressur pulmonari edema respiratori failur disord kidney liver heart brain also occur femal cft wistar rat expos phosphin ga gener aluminum phosphid pellet distil water 100 percent mortal observ 6hour exposur 40 ppm 0 1 mg l exposur 20 40 ppm 0 05 0 1 mg l 6 hour result 33 percent mortal symptom toxic report anim includ dyspnea loss muscular coordin polyuria paralysi epa exposur analysi indic aluminum phosphid concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list aluminum phosphid epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 9 ametryn n ethyl n 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin ca 000834 12 8 fifra ai ref 3 fatti degener liver observ rat administ 100 mg kg day ametryn gavag 6 day per week 13 week noel 10 mg kg day 8 6 mg kg day adjust durat anoth studi hepat effect sever vascular congest centrilobular liver necrosi fatti degener individu liver cell observ rat die follow gavag administr 500 mg kg day ametryn 6 day per week 28 day noel 250 mg kg day epa believ suffici evid list ametryn epcra section 313 pursuant epcra section 313 2 b base avail hepatotox data chemic 72 hour ec 50 green alga 14 ppb ametryn herbicid may expect affect nontarget plant alga epa believ suffici evid list ametryn epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 10 amitraz ca 033089 61 1 fifra sr ref 8 amitraz anilin type insecticid 2year beagl dog feed studi effect note loael dose 1 0 mg kg day variou time studi includ significantli increas mean blood glucos concentr slight hypothermia slight central nervou system depress latter effect occur immedi dose day 1 2 noael studi 0 25 mg kg day oral rfd deriv noael 0 0025 mg kg day find support similar result obtain 90day feed studi dog studi rat mice expos amitraz 90 day 2 year loael less equal 12 mg kg day deriv base effect includ decreas bodi weight gain chang organ brain heart weight noel less equal 3 mg kg day three gener reproduct studi rat demonstr decreas litter size increas mortal suckl fetotox loael studi 5 mg kg day noael 1 6 mg kg day teratolog studi rabbit fetotox loael 5 mg kg day noael 1 mg kg day base incid cleft palat meningocoel associ small ear displac toe epa believ suffici evid list amitraz epcra section 313 pursuant epcra section 313 2 b base chronic toxic development toxic data chemic 11 anilazin 4 6 dichloro n 2 chlorophenyl 1 3 5 triazin 2 amin ca 000101 05 3 fifra ai ref 3 anilazin administ rat matern reproduct paramet affect system matern noel 150 mg kg loel 500 mg kg base decreas bodi weight gain development noel 1 500 mg kg highest dose test rabbit matern toxic noel 15 mg kg loel 40 mg kg base increas mortal decreas bodi weight gain also decreas percentag pregnant 75 mg kg development noel 40 mg kg loel 75 mg kg base increas fetal mortal decreas fetal weight increas postimplant loss inhibit ossif phalang epa believ suffici evid list anilazin epcra section 313 pursuant epcra section 313 2 b base avail development toxic data aquat acut toxic valu anilazin includ scud gammaru 96hour lc 50 0 27 ppb oyster 96hour ec 50 growth 46 ppb epa believ suffici evid list anilazin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 12 atrazin 6 chloro n ethyl n 1 methylethyl 1 3 5 triazin 2 4 diamin ca 001912 24 9 fifra ai ref 3 base suffici evid carcinogen anim intern agenc research cancer iarc classifi atrazin group 2b compound e chemic possibl carcinogen human administr atrazin spragu dawley rat associ increas incid mammari gland fibroadenoma adenocarcinoma femal rat hormon mechan may involv induct mammari tumor atrazin therefor suffici evid list atrazin epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 13 bendiocarb 2 2 dimethyl 1 3 benzodioxol 4 ol methylcarbam ca 022781 23 3 fifra ai ref 3 depress blood cholinesteras level report numer speci development toxic studi rat cholinerg sign observ matern anim 4 mg kg day loel matern noel 1 mg kg day advers effect observ fetus loel 2 5 mg kg day cholinesteras inhibit report dog 4month dietari studi noel 0 5 mg kg day decreas cholinesteras activ observ femal rat fed 20 30 40 mg kg day 28 day noel establish studi howev detail regard clinic sign histopatholog chang neural tissu report epa believ suffici evid list bendiocarb epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic aquat acut toxic valu bendiocarb includ mysid 96hour ec 50 6 7 ppb daphnid 48hour ec 50 29 2 ppb avian acut toxic valu includ mallard duck ld 50 3 1 mg kg epa believ suffici evid list bendiocarb epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 14 benfluralin n butyl n ethyl 2 6 dinitro 4 trifluoromethyl benzenamin ca 001861 40 1 fifra ai ref 3 increas rel liver weight decreas red blood cell count decreas hematocrit hemoglobin level observ dog oral administ benfluralin dose 125 mg kg day 2 year noael 25 mg kg day base noael epa establish oral rfd 0 003 mg kg day epa believ suffici evid list benfluralin epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data chemic 15 benomyl ca 017804 35 2 cal fifra sr ref 8 three gener studi rat dietari level 25 mg kg day benomyl result decreas weanl weight effect level 5 mg kg day microphthalmia loel 62 5 mg kg day noel 30 mg kg day report rat development toxic studi decreas fetal weight loel 62 5 mg kg day noel 30 mg kg day observ anoth rat development toxic studi development effect observ dose toxic matern anim anomali consist supra occipit scar subnorm vertebr centrum supernumari rib cleft palat report oral development toxic studi mice loel 100 mg kg day noel 50 mg kg day increas incid anomali includ encephalocel hydrocephalu microphthalmia anophthalmia note follow administr benomyl rat intub first 20 day pregnanc dose 125 250 500 mg kg development effect alway associ death consid caus death epa believ suffici evid list benomyl epcra section 313 pursuant epcra section 313 2 b base development toxic data chemic 16 benzyl p chlorophenol ca 000120 32 1 fifra ai ref 3 16day oral rat studi dose relat increas liver kidney weight absolut rel nephrosi observ dose level greater equal 62 5 mg kg day noel establish compound administ gavag 13 week rat develop multifoc dilat renal tubul increas liver weight 16 percent 240 mg kg day noel 120 mg kg day 90day oral studi mice receiv 30 mg kg day develop kidney lesion increas liver weight also note noel establish studi epa believ suffici evid list benzyl p chlorophenol epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data chemic 17 bifenthrin ca 082657 04 3 fifra ai ref 3 tremor head forelimb twitch note dog rat rabbit expos variou dose noel valu base appear tremor often transient rang 1 2 67 mg kg day oral rfd bifenthrin base 1year beagl dog feed studi loel base tremor observ week 15 29 3 0 mg kg day noel 1 5 mg kg day rfd base noel 0 015 mg kg day rat teratolog studi increas incid hydrouret without hydronephrosi note fetus 2 mg kg day loel noel 1 mg kg day epa believ suffici evid list bifenthrin epcra section 313 pursuant epcra section 313 2 b base avail neurolog development toxic data aquat acut toxic valu bifenthrin includ bluegil 96hour lc 50 0 35 ppb rainbow trout 96hour lc 50 0 15 ppb sheepshead minnow lc 50 17 5 ppb daphnid 48hour ec 50 1 6 ppb epa believ suffici evid list bifenthrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 18 bi tributyltin oxid ca 000056 35 9 fifra ai ref 3 advers effect immun system report rat expos variou dose bi tributyltin oxid durat short 4 week spf deriv wistar rat fed compound 17 month studi loel 0 25 mg kg day noel 0 025 mg kg day base immunotox manifest decreas resist trichinella spirali reduc natur killer nk cell activ spleen reduc macrophag function rfd deriv noel 0 00003 mg kg day similar immunolog effect report 4 6 week rat feed studi 20 80 ppm 1 4 mg kg day loel 1 mg kg day rat receiv dietari level rang dose includ 50 mg kg day 106 week kidney function decreas serum level alanin aminotransferas aspart aminotransferas alkalin phosphatas increas end 2year studi nephrosi vacuol pigment proxim tubular epithelium report anim administ 50 mg kg day basi margin effect 5 mg kg day loel noel 0 5 mg kg day establish epa believ suffici evid list bi tributyltin oxid epcra section 313 pursuant epcra section 313 2 b base avail immunolog renal toxic data aquat acut toxic valu bi tributyltin oxid includ bluegil 96hour lc 50 7 6 ppb rainbow trout 96hour lc 50 6 9 ppb measur fathead minnow 96hour lc 50 2 7 ppb daphnid 48hour lc 50 1 67 ppb epa believ suffici evid list bi tributyltin oxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 19 boron trichlorid ca 010294 34 5 epcra eh ref 8 boron trichlorid corros skin mucos tissu due rapid hydrolysi hydrochlor acid boric acid former acid corros speci singl rel larg dose boron administ rout affect central nervou system caus depress circul diarrhea vomit shock coma kidney sever affect organ symptom acut irrit upper airway observ human exposur level greater equal 0 004 mg l inhal 0 48 mg l boron trichlorid prove fatal certain laboratori anim inhal 0 096 mg l boron trichlorid 7 hour produc advers effect respiratori tract weight loss epa exposur analysi indic boron trichlorid concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list boron trichlorid epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 20 boron trifluorid ca 007637 07 2 epcra eh ref 8 boron trifluorid colorless ga corros tissu due rapid hydrolysi hydrofluor acid boric acid princip acut effect anim irrit mucou membran respiratori tract eye post mortem examin also reveal pneumonia degen chang renal tubul kidney sever affect boric acid concentr organ exposur six anim speci 0 28 mg l boron trifluorid 4 7 hour day 5 day week kill anim within 30 day rat rabbit guinea pig expos boron trifluorid via inhal guinea pig die respiratori failur expos 0 036 mg l 19 day rat experienc fluorosi teeth concentr three speci minim affect 0 004 mg l 2 week rat inhal studi anim die 6 daili exposur 0 18 mg l rat expos 0 024 mg l show sign respiratori irrit increas lung weight depress liver weight rat expos 0 17 mg l boron trifluorid 6 hour day 5 day week 13 week develop necrosi proxim tubular epithelium kidney guinea pig expos 0 035 mg l 7 hour day 5 day week 3 month develop sever pneumon pulmonari chang indic chemic irrit epa believ suffici evid list boron trifluorid epcra section 313 pursuant section 313 2 b base avail chronic toxic data chemic 21 bromacil 5 bromo 6 methyl 3 1 methylpropyl 2 4 1h 3h pyrimidinedion ca 000314 40 9 fifra ai ref 3 increas thyroid activ seen male femal rat fed 5 000 ppm 250 mg kg day bromacil 90 day 2year dietari studi thyroid hyperplasia seen femal rat fed 1 250 ppm 62 5 mg kg day thyroid follicular adenoma observ one femal epa believ suffici evid list bromacil epcra section 313 pursuant epcra section 313 2 b base avail thyroid toxic data chemic 22 bromacil lithium salt 2 4 1h 3h pyrimidinedion 5 bromo 6 methyl 3 1 methylpropyl lithium salt ca 05340419 6 fifra ai ref 3 bromacil lithium salt dissoci bromacil solubl aqueou system lithium ion defect palat eye extern ear report offspr rat administ 50 mg lithium chlorid intraperiton gestat day 1 4 7 9 follow 20 mg day day 17 cleft palat also observ mous fetus mother gavag 300 465 mg kg day lithium carbon gestat day 6 15 increas ebstein anomali report among offspr women take lithium cardiovascular defect found 212 offspr expos utero lithium therapi increas thyroid activ seen male femal rat fed 5 000 ppm 250 mg kg day bromacil 90 day 2year dietari studi thyroid hyperplasia seen femal rat fed 1 250 ppm 62 5 mg kg day thyroid follicular adenoma observ one femal epa believ suffici evid list bromacil lithium salt epcra section 313 pursuant epcra section 313 2 b base avail development thyroid toxic data 23 bromin ca 007726 95 6 epcra eh ref 8 rat fed bromin dose 0 01 mg kg day 6 month experienc chang reflex blood index rat mice rabbit inhal 0 001 mg kg day 4 month develop function abnorm respiratori nervou endocrin system data acut chronic effect bromin human limit bromin corros eye skin mucou membran either liquid vapor form concentr 10 ppm bromin air intoler human caus sever irrit upper respiratori tract clinic symptom includ neurolog dermatolog gastrointestin effect maximum concentr allow human 0 5 1 hour exposur bromin 4 ppm bromin caus lacrim concentr less 1 ppm chronic exposur bromin estim concentr 0 6 ppm result eye irrit upper respiratori irrit cough headach neurolog symptom also report follow chronic exposur bromin epa believ suffici evid list bromin epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data chemic 24 1 bromo 1 bromomethyl 1 3 propanedicarbonitril ca 035691 65 7 fifra ai ref 3 3month dietari studi rat administ 83 5 500 3 000 ppm 4 25 150 mg kg day 1 bromo 1 bromomethyl 1 3 propanedicarbonitril noel 83 5 ppm 4 mg kg day loel 500 ppm 25 mg kg day establish base neonat splenic hematopoiesi decreas parent bodi weight food consumpt increas male urinari epitheli cell amorph cast crystal 3 000 ppm 150 mg kg day decreas lactas dehydrogenas increas total cholesterol total protein albumin elev femal organ bodi weight ratio thyroid liver spleen ovari pituitari 13 week dietari studi beagl dog administ 167 1 000 4 000 ppm 4 25 100 mg kg day loel greater 167 ppm 4 mg kg day increas male thyroid femal ovari organ bodi weight ratio 1 000 ppm 25 mg kg day sign seen 167 ppm 4 mg kg day plu diarrhea increas organ bodi weight ratio thyroid heart liver adren 4 000 ppm 100 mg kg day emesi ataxia male decreas bodi weight gain food consumpt decreas hematocrit hemoglobin immatur red blood cell alkalin phosphatas extramedullari hematopoiesi liver spleen thyroid enlarg follicular cell hyperplasia increas organ bodi weight ratio thyroid adren liver spleen seen 13week dietari studi beagl dog administ 167 ppm 4 mg kg day thyroid stimul hormon tsh stimul t3 t4 increas sex thyroid enlarg sex absolut weight organ bodi weight ratio increas femal epa believ suffici evid list 1 bromo 1 bromomethyl 1 3 propanedicarbonitril epcra section 313 pursuant epcra section 313 2 b base avail toxic data chemic 25 2 bromo 2 nitropropan 1 3 diol bronopol ca 000052 51 7 fifra ai ref 3 sever irrit report gastrointestin tract rat mice dog administ singl multipl oral dose 2 bromo 2 nitropropan 1 3 diol acut oral studi mice ld 50 374 mg kg result ulcer stomach duodenum thicken intestin wall adhes stomach liver sever gastric irrit report dog administ singl oral dose 250 mg kg noel 100 mg kg superfici ulcer epitheli hyperplasia hyperkeratosi congest vessel gastrointestin mucosa observ rat fed 80 mg kg day loel diet 13 week noel 20 mg kg day vomit note dog fed 20 mg kg day diet 13 week noel studi 8 mg kg day addit blood note urin dog mortal irrit gastrointestin tract ulcer stomach lesion report 2year dietari studi rat fed 40 mg kg day noel 10 mg kg day epa believ suffici evid list 2 bromo 2 nitropropan 1 3 diol epcra section 313 pursuant epcra section 313 2 b base avail toxic data 26 bromoxynil 3 5 dibromo 4 hydroxybenzonitril ca 001689 84 5 fifra ai ref 3 development effect hydrocephalu microphthalmia anophthalmia sever defect ossif skull observ rabbit administ 60 mg kg day bromoxynil gavag noel 30 mg kg day development toxic increas form supernumerari rib also observ rat 5 mg kg day noel 1 5 mg kg day matern loel base bodi weight loss 30 mg kg day sever development studi indic potenti development toxic bromoxynil epa believ suffici evid list bromoxynil epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 27 bromoxynil octano octano acid 2 6 dibromo 4 cyanophenyl ester ca 001689 99 2 fifra ai ref 3 bromoxynil octano hydrolyz yield bromoxynil octanol dermal development toxic studi bromoxynil octano development toxic rat fetus increas incid supernumerari rib 15 mg kg day loel noel 10 mg kg day matern loel decreas bodi weight gain 20 mg kg day noel 15 mg kg day development effect hydrocephalu microphthalmia anophthalmia sever defect ossif skull observ rabbit administ 60 mg kg day bromoxynil gavag noel 30 mg kg day development toxic increas form supernumerari rib also observ rat 5 mg kg day noel 1 5 mg kg day matern loel base bodi weight loss 30 mg kg day epa believ suffici evid list bromoxynil octano epcra section 313 pursuant epcra section 313 2 b base avail development toxic data bromoxynil bromoxynil octano 28 brucin ca 000357 57 3 cercla rcra app8 rcra p ref 8 brucin alkaloid similar structur strychnin capabl caus death perman injuri due exposur normal use human brucin caus central peripher paralysi convuls respiratori failur potenti lethal oral dose small children 5 10 mg lethal oral dose adult may low 30 mg acut oral ld 50 rabbit 4 mg kg epa exposur analysi indic brucin concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list brucin epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 29 butyl bi 2 methylpropyl carbamothio acid ethyl ester ca 002008 41 5 fifra ai ref 3 2year feed studi mice hepat cellular infiltr focal necrosi renal effect amyloidosi chronic nephriti lymphocyt foci observ 80 mg kg day noel 20 mg kg day separ studi liver pericholang observ rat fed 180 mg kg day 56 week noel 30 mg kg day increas rel liver weight observ male dog fed 25 mg kg day 1year noel 5 mg kg day base noel epa establish chronic oral rfd 0 05 mg kg day epa believ suffici evid list butyl epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data chemic 30 butyl hydroxyanisol ca 025013 16 5 cal iarc ntp ref 8 butyl hydroxyanisol classifi iarc group 2b compound e chemic possibl carcinogen human butyl hydroxyanisol shown induc gastrointestin tumor rat hamster epa believ suffici evid list butyl hydroxyanisol epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 31 c acid red 114 ca 006459 94 5 tsca ref 8 2year bioassay conduct nation toxicolog program ntp f344 rat expos c acid red 114 via drink water hepatocellular carcinoma liver tumor skin adenoma carcinoma zymbal gland sex observ studi femal rat also increas incid adenoma carcinoma clitor gland squamou cell papilloma carcinoma oral caviti exposur concentr studi rang 70 300 ppm 9 8 42 mg kg day male 150 600 ppm 21 84 mg kg day femal epa believ suffici evid list c acid red 114 epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 32 c direct blue 218 ca 028407 37 6 ntp ref 8 ntp bioassay clear evid carcinogen c direct blue 218 male femal b6c3f1 mice base significantli increas incid hepatocellular adenoma carcinoma 2year ntp feed studi rat evid carcinogen male f344 rat base signific increas incid squamou cell papilloma pharynx high dose group 500 mg kg day epa believ suffici evid list c direct blue 218 epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 33 calcium hypochlorit ca 007778 54 3 cercla ref 8 aquat acut toxic data calcium hypochlorit includ 96hour measur lc 50 rainbow trout 60 ppb 96hour measur lc 50 atlant silversid 37 ppb epa believ suffici evid list calcium hypochlorit epcra section 313 pursuant epcra section 313 2 c base avail ecotox data chemic 34 caprolactam ca 000105 60 2 caa hap ref 7 rat administ caprolactam oral gavag dose 0 100 500 1 000 mg kg day gestat day 6 20 result loael 1 000 mg kg day noael 500 mg kg day fetal resorpt rabbit administ caprolactam oral gavag dose 0 50 150 250 mg kg day gestat day 6 28 result loael 150 mg kg day matern fetal bodi weight depress addit slight increas sever spontan nephropathi 10 000 ppm observ male rat first parent gener fed 10 000 ppm caprolactam three gener reproduct studi result noael 1 000 ppm 50 mg kg day mean bodi weight food consumpt reduc parent gener 5 000 10 000 ppm bodi weight offspr also reduc dietari concentr loael 250 mg kg day epa believ suffici evid list caprolactam epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 35 carbofuran ca 001563 66 2 cercla epcra eh fifra sr ref 8 aquat acut toxic test data carbofuran includ measur 96hour lc 50 bluegil 80 ppb addit measur 48hour ec 50 daphnid 35 ppb measur terrestri acut toxic data wildlif includ oral ld 50 mallard duck 0 397 mg kg femal 0 480 mg kg male oral ld 50 femal ring neck pheasant 4 15 mg kg epa believ suffici evid list carbofuran epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 36 carbon monoxid ca 000630 08 0 cal ref 8 cardiovascular e g electrocardiograph chang atrial fibril ventricular arrhythmia neurolog e g headach dizzi convuls coma effect report human expos carbon monoxid human histolog effect brain includ extens demyelin white matter necrosi neuropsychiatr disord also report persist electrocardiograph chang degener myocardi muscl fiber hemorrhag necrosi observ follow inhal exposur dog 100 ppm 0 11 mg l carbon monoxid 5 5 hour day 6 day week 11 week dog show disturb gait postur posit reflex toxic carbon monoxid result combin hemoglobin blood form carboxyhemoglobin poor oxygen carrier thu oxygen deliveri blood sever compromis lead tissu hypoxia possibl tissu poison result toxic effect includ death known substanc infant born women surviv acut exposur high concentr carbon monoxid pregnanc often display neurolog sequela gross brain damag exposur pregnant rat 150 ppm 0 17 mg l carbon monoxid caus reduc pup growth rate alter behavior poor perform neg geotaxi home test pup epa believ suffici evid list carbon monoxid epcra section 313 pursuant epcra section 313 2 b base avail chronic neurolog myocardi development toxic data chemic carbon monoxid regul titl caa provis attain mainten nation ambient air qualiti standard addit propos add carbon monoxid epcra section 313 unit iv b 179 235 epa propos add two chemic nitrogen dioxid sulfur dioxid regul titl caa sulfur dioxid also regul titl iv caa acid deposit control extens data highli technic collect chemic requir caa epa request comment follow 1 inform collect caa suffici public right know purpos 2 suggest data collect chemic pursuant caa titl iv could use meet purpos epcra section 313 37 carboxin 5 6 dihydro 2 methyl n phenyl 1 4 oxathiin 3 carboxamid ca 005234 68 4 fifra ai ref 3 decreas bodi weight gain food consumpt increas mortal reduc kidney heart spleen weight observ rat fed 600 ppm 30 mg kg day carboxin 2 year noel 200 ppm 10 mg kg day similar noel establish three gener rat reproduct studi base noel epa establish oral rfd 0 01 mg kg day 90day feed studi rat degener kidney seen 600 ppm 30 mg kg day noel 10 mg kg day epa believ suffici evid list carboxin epcra section 313 pursuant epcra section 313 2 b base avail renal toxic data chemic 38 chinomethionat 6 methyl 1 3 dithiolo 4 5 b quinoxalin 2 one ca 002439 01 2 fifra ai ref 3 increas liver weight liver protein total liver microsom rna level well inhibit mix function oxidas enzym e g n demethylas cytochrom p 450 note rat administ 75 mg kg day oral gavag 4 day femal rat administ 75 mg kg day diet 21 day liver enlarg report rat fed 10 mg kg day diet 35 day increas liver size attribut increas cellular protein increas water content rat expos oral 2 700 mg kg 90 day 30 mg kg day chang liver weight effect hepat microsom oxidas well weight loss decreas bodi weight gain 1 year dog studi noel establish 0 6 mg kg day test materi diet loel 1 9 mg kg day indic extra medullari hematopoiet nodul liver development toxic studi rat increas resorpt decreas fetal weight report 37 5 mg kg day highest dose test noel 12 5 mg kg day anoth development studi rat given 30 mg kg day carboxi methyl cellulos gavag gestat day 6 20 cleft palat anasarca micrognathia observ epa believ suffici evid list chinomethionat epcra section 313 pursuant epcra section 313 2 b base avail hepat development toxic data 39 chlorend acid ca 000115 28 6 ntp ref 8 base suffici evid carcinogen anim iarc classifi chlorend acid group 2b compound e possibl carcinogen human ntp bioassay clear evid liver carcinogen rat mice epa believ suffici evid list chlorend acid epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 40 chlorimuron ethyl ethyl 2 4 chloro 6 methoxyprimidin 2 yl carbonyl amino sulfonyl benzoat ca 090982 32 4 fifra ai ref 3 1year dog studi dietari administr 37 5 mg kg day loel produc increas white blood cell sex decreas red blood cell hematocrit hemoglobin femal increas alkalin phosphatas male noel 6 25 mg kg day base noel oral rfd 0 02 mg kg day deriv studi given high confid rate 2year rat feed studi chang hematolog paramet observ loel 125 mg kg day noel 12 5 mg kg day 18month mous feed studi centrilobular hepatocellular hypertrophi observ 90 day 187 5 mg kg day loel noel 18 75 mg kg day epa believ suffici evid list chlorimuron ethyl epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data 41 chlorin paraffin categori caa hap ref 7 chlorin paraffin defin mixtur linear satur chlorin hydrocarbon obtain partial chlorin paraffin olefin acetylen feedstock averag chain length 10 30 carbon atom contain averag chlorin level rang 40 70 percent weight chlorin paraffin describ gener formula c x h 2x 2 cl x rang 10 30 rang 3 26 58 percent chlorin short chain 10 12 carbon 43 percent chlorin long chain 22 26 carbon chlorin paraffin test rat mice gavag 2year bioassay 58 percent chlorin short chain 10 12 carbon chlorin paraffin carcinogen rat mice dose male femal mice show increas incid liver tumor dose male rat increas incid kidney tubular cell hyperplasia adenoma adenocarcinoma combin dose femal rat mice show increas thyroid gland follicular cell neoplasm indic epa group b2 classif e probabl human carcinogen 43 percent chlorin long chain 22 26 carbon chlorin paraffin carcinogen male mice show increas incid malign lymphoma margin increas hepatocellular neoplasm femal mice adren gland pheochromocytoma femal rat indic epa group b2 categori classif e chemic probabl human carcinogen epa believ suffici evid list chlorin paraffin epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic follow ecotox data lc 50 follow experi durat parenthesi report short chain 10 13 carbon intermedi chlorin 59 percent chlorin chlorin paraffin daphnid 46 ppb 48hour mysid shrimp 14 ppb 96hour marin alga 42 ppb 96hour daphnid 2 ppb 9 ppb 21day chronic studi midg 78 ppb 49day chronic studi rang chronic toxic valu follow freshwat invertebr 2 162 ppb freshwat fish 3 17 2 ppb marin invertebr 2 4 24 ppb marin fish 2 4 ppb 620 5 ppm chlorin paraffin persist half life greater 30 day environ epa believ suffici evid list categori chlorin paraffin epcra section 313 pursuant epcra section 313 2 c base avail ecotox data chemic persist environ epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form 42 1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan chlorid ca 004080 31 3 fifra ai ref 3 decreas heart weight oblit vascul perivascul hepat blood vessel observ dog oral administ 1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan 90 day noel 7 5 mg kg day loel 15 mg kg day epa believ suffici evid list 1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan chlorid epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data 1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan 43 p chloroanilin ca 000106 47 8 cercla rcra app8 rcra p ref 8 78week studi rat fed p chloroanilin non neoplast prolif lesion splenic capsul focal fibrosi subcapsular mesenchym prolifer observ loael 12 5 mg kg day lowest dose test rfd deriv data 0 004 mg kg day epa believ suffici evid list p chloroanilin epcra section 313 pursuant section 313 2 b base chronic toxic data chemic 44 5 chloro 2 2 4 dichlorophenoxi phenol ca 003380 34 5 fifra ai ref 3 3month dog feed studi decreas red blood cell hemoglobin valu increas serum alkalin phosphatas jaundic increas liver weight observ 25 mg kg day loel noel could establish anoth 3month dog feed studi loel 25 mg kg day produc morpholog chang liver focal acidophil granular degener cytoplasm noel 12 5 mg kg day 3month rat feed studi 125 mg kg day loel produc increas liver weight male noel 50 mg kg day 150 mg kg day loel decreas triglycerid increas creatinin decreas red blood cell increas spleen heart weight cytomegali observ anoth 3month rat feed studi noel 50 mg kg day 2year studi dietari administr 15 mg kg day produc decreas red blood cell hemoglobin concentr hematocrit well hepat necrosi male 50 mg kg day decreas red blood cell femal epa believ suffici evid list 5 chloro 2 2 4 dichlorophenoxi phenol epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data chemic 45 3 chloro 2 methyl 1 propen ca 000563 47 3 ntp ref 8 ntp gavag bioassay clear evid carcinogen 3 chloro 2 methyl 1 propen rat mice substanc induc adren cortex testicular gastrointestin tumor rat adren cortex gastrointestin tumor mice epa believ suffici evid list 3 chloro 2 methyl 1 propen epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 46 p chlorophenyl isocyan ca 000104 12 1 tsca ref 8 p chlorophenyl isocyan lethal follow inhal 4hour mous inhal lc 50 valu 0 053 mg l addit isocyan class gener sever skin eye respiratori irrit follow acut exposur epa exposur analysi indic p chlorophenyl isocyan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list p chlorophenyl isocyan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 47 chloropicrin ca 000076 06 2 fifra ai ref 3 measur aquat acut toxic data chloropicrin includ rainbow trout 96hour lc 50 16 5 ppb bluegil 96hour lc 50 105 ppb 48hour ec 50 80 ppb epa believ suffici evid list chloropicrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 48 3 chloropropionitril ca 000542 76 7 cercla epcra eh rcra app8 rcra p ref 8 3 chloropropionitril metabol hepat cytochrom p450 enzym releas cyanid substanc readili absorb dermal oral mous oral ld 50 51 3 mg kg epa exposur analysi indic 3 chloropropionitril concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list 3 chloropropionitril epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 49 p chloro toluidin ca 000095 69 2 iarc ntp ref 8 p chloro toluidin classifi group b2 carcinogen epa e compound probabl human carcinogen classifi group 2b carcinogen iarc e possibl human carcinogen epidemiolog studi inadequ evalu carcinogen potenti 4 chloro toluidin hydrochlorid human long term feed studi nci p chloro toluidin hydrochlorid induc hemangioma hemangiosarcoma vascular tumor mice increas incid pituitari chromophob adenoma observ femal rat follow dietari administr epa believ suffici evid list p chloro toluidin epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 50 chlorotrifluoromethan cfc 13 ca 000075 72 9 caa od ref 8 chlorofluorocarbon includ chlorotrifluoromethan cfc 13 known releas chlorin radic stratospher chlorin radic act catalyst reduc net amount stratospher ozon stratospher ozon shield earth ultraviolet b uv b radiat e 290 320 nanomet decreas total column ozon increas percentag uv b radiat especi harm wavelength reach earth surfac exposur uv b radiat implic laboratori epidemiolog studi caus two type nonmelanoma skin cancer squamou cell cancer basal cell cancer studi predict everi 1 percent increas uv b radiat nonmelanoma skin cancer case would increas 1 3 percent recent epidemiolog studi includ larg case control studi suggest uv b radiat play import role caus malign melanoma skin cancer recent studi predict 1 percent chang uv b intens incid melanoma could increas 0 5 1 percent studi demonstr uv b radiat suppress immun respons system anim possibl human increas exposur uv b radiat like increas incid cataract could advers affect retina aquat organ particularli phytoplankton zooplankton larva mani fish appear suscept harm increas exposur uv b radiat spend least part time near surfac water inhabit increas uv b penetr shown result advers impact plant field studi soybean suggest yield reduct could occur cultivar soybean evid laboratori studi suggest two three cultivar sensit uv b increas uv b radiat reason anticip lead cancer chronic human health effect signific advers environment effect suffici evid list chlorotrifluoromethan cfc 13 epcra section 313 pursuant epcra section 313 2 b c 51 chlorpyrifo methyl dimethyl 3 5 6 trichloro 2 pyridyl phosphorothio ca 005598 13 0 fifra ai ref 3 human experienc 10 percent reduct plasma cholinesteras activ 10 dermal exposur 10 mg kg day 47 percent reduct 4 dermal exposur 25 mg kg day exposur 12 hour per day rabbit experienc 97 100 percent reduct plasma cholinesteras activ 5 dermal exposur 10 mg kg day 12 hour day 2 dermal exposur 25 mg kg day 12 hour day 2year rat feed studi red blood cell plasma cholinesteras inhibit observ 1 mg kg day loel noel 0 1 mg kg day 2year dog feed studi plasma cholinesteras inhibit observ 1 mg kg day loel noel 0 1 mg kg day oral rat ld 50 1 159 mg kg 3 833 mg kg lethargi ataxia diarrhea saliv tremor observ studi epa believ suffici evid list chlorpyrifo methyl epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data aquat acut toxic valu chlorpyrifo methyl includ daphnid 48hour lc 50 1 11 ppb rainbow trout 96hour lc 50 12 6 ppb epa believ suffici evid list chlorpyrifo methyl epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 52 chlorsulfuron 2 chloro n 4 methoxi 6 methyl 1 3 5 triazin 2 yl amino carbonyl benzenesulfonamid ca 064902 72 3 fifra ai ref 3 rabbit development studi increas incid fetal resorpt observ loel 75 mg kg day noel 25 mg kg day 3 gener rat reproduct studi decreas fertil index observ 125 mg kg day loel noel 25 mg kg day epa believ suffici evid list chlorsulfuron epcra section 313 pursuant epcra section 313 2 b base avail development reproduct toxic data chemic 53 clomazon 2 2 chlorophenyl methyl 4 4 dimethyl 3 isoxazolidinon ca 081777 89 1 fifra ai ref 3 90day dog feed studi increas cholesterol increas absolut rel liver weight observ 62 5 mg kg day loel noel 12 5 mg kg day dietari administr 62 5 mg kg day loel dog 1year also produc increas cholesterol increas liver weight noel 12 5 mg kg day 90day mous feed studi megalocytosi liver cell seen 2 6 mg kg day loel noel establish 2year rat feed studi elev cholesterol level liver bodi weight ratio observ 21 5 mg kg day loel noel 4 3 mg kg day dietari administr 62 5 mg kg day loel dog 1year increas cholesterol liver weight noel 12 5 mg kg day two gener reproduct studi decreas pup viabil reduc surviv decreas bodi weight nonfunct limb observ offspr rat oral administ 50 mg kg day loel noel 5 mg kg day epa believ suffici evid list clomazon epcra section 313 pursuant epcra section 313 2 b base avail hepat development toxic data 54 crotonaldehyd ca 004170 30 3 rcra app8 ref 8 crotonaldehyd test carcinogen one anim studi crotonaldehyd administ male f344 rat 0 42 421 mg l 113 week statist signific increas incid hepatocellular neoplasm benign malign combin low dose group lack tumorigen effect high dose group believ due hepatotox observ group high dose crotonaldehyd cytotox cell die neoplasm manifest crotonaldehyd alpha beta unsatur carbonyl chemic reactiv compound readili react cellular macromolecul dna protein mutagen studi slightli modifi preincub ame test clearli shown crotonaldehyd mutagen epa believ suffici evid list crotonaldehyd epcra section 313 pursuant epcra section 313 2 b base avail carcinogen mutagen data chemic 55 cyanazin ca 021725 46 2 cal fifra sr ref 8 cyanazin triazin type herbicid three gener reproduct studi long evan rat f 3 b femal weanl increas rel brain weight decreas rel kidney weight loael 4 05 mg kg day noael 1 35 mg kg day rabbit receiv cyanazin gelatin capsul gestat day 6 18 increas postimplant loss decreas litter size alter ossif addit increas malform offspr includ anophthalmia microphthalmia dilat brain ventricl dome cranium thoracoschisi loael 2 mg kg day noael 1 mg kg day similar development effect report fischer 344 rat administ cyanazin gestat day 6 15 loael 25 mg kg day noael 5 mg kg day epa believ suffici evid list cyanazin epcra section 313 pursuant epcra section 313 2 b base development toxic data chemic 56 cycloat ca 001134 23 2 fifra ai ref 3 cycloat carbam pesticid cholinesteras inhibitor symptom poison includ saliv lacrim convuls death depress plasma cholinesteras observ 9week rat inhal studi 0 0025 mg l noel less 0 0025 mg l decreas serum cholinesteras male femal wallerian degener nerv fiber spinal cord sciatic nerv femal observ 0 12 mg l 10 week rat inhal studi cholinesteras noel 0 012 mg l inhal studi anim expos 6 hour day 5 day week plasma red blood cell brain cholinesteras inhibit report rat fed 8 mg kg day 2 year noel less 8 mg kg day dose relat neuropathi muscl myopathi observ 2year rat feed studi distend myelin sheath demyelin nerv fiber loss occur 3 mg kg day loel noel 0 5 mg kg day decreas weight surviv observ offspr rat oral administ 24 mg kg day loel 72 mg kg day cycloat respect durat frequenc dose report reproduct noel 8 mg kg day decreas pup weight observ 20 mg kg day decreas pup surviv observ 50 mg kg day 2 gener rat reproduct studi noel valu endpoint 2 5 mg kg day 20 mg kg day respect epa believ suffici evid list cycloat epcra section 313 pursuant epcra section 313 2 b base avail neurolog development toxic data 57 cyclohexanol ca 000108 93 0 tsca ref 8 four rabbit expos 997 ppm 4 mg l 11 day 6 hour day 5 day week rabbit receiv dermal applic approxim 2 500 mg kg day 10 day 1 hour day develop tremor central nervou system depress lethargi hypothermia microscop degen chang observ liver kidney rabbit inhal 145 ppm 0 59 mg l cyclohexanol 50 day 6 hour day 5 day week repeat dose 272 ppm 1 1 mg l addit degen myocardi effect observ exposur level repeat inhal exposur higher dose 997 1 229 ppm 4 5 mg l rabbit result degen chang brain heart well liver kidney reproduct effect includ testicular atrophi loss type spermatogonia spermatocyt spermatozoa shrinkag seminifer tubul leydig cell reduct rna protein sialic acid glycogen test epididymi semin vesicl increas testicular cholesterol alkalin phosphatas observ male rat gerbil expos 15 mg kg cyclohexanol 21 37 day chang accompani decreas fertil occur exposur level effect liver kidney epa believ suffici evid list cyclohexanol epcra section 313 pursuant epcra section 313 2 b base chronic neurolog hepat renal myocardi reproduct toxic data chemic 58 cyfluthrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 4 fluoro 3 phenoxyphenyl methyl ester ca 068359 37 5 fifra ai ref 3 14day rat studi oral administr 60 mg kg day produc tremor uncoordin gait saliv slight brain hemorrhag necrosi skelet muscl fiber death noel defin anoth studi saliv straddl gait axon degener sciatic nerv microtubular dilat mitochondria degener sciatic femor nerv observ rat administ 80 mg kg day oral 5 day 40 mg kg day follow 9 day noel establish liver adren weight increas observ rat oral administ 40 80 mg kg day 28 day highest dose 80 mg kg day reduc 40 mg kg day noel 20 mg kg day liver weight chang urobilinogen keton bodi urin observ rat fed 15 mg kg day 28 day noel establish 28day mous feed studi increas liver weight observ 50 mg kg day loel noel 15 mg kg day inflammatori foci kidney femal observ 7 5 mg kg day 2year rat feed studi noel 2 5 mg kg day base noel studi oral rfd 0 025 mg kg day determin increas alkalin phosphatas activ observ male 7 5 mg kg day 23month mous feed studi epa believ suffici evid list cyfluthrin epcra section 313 pursuant epcra section 313 2 b base avail neurolog hepat renal toxic data aquat acut toxic valu cyfluthrin includ rainbow trout 96hour lc 50 0 68 ppb bluegil 96hour lc 50 1 5 ppb daphnid 48hour ec 50 0 14 ppb epa believ suffici evid list cyfluthrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 59 cyhalothrin 3 2 chloro 3 3 3 trifluoro 1 propenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 3 phenoxyphenyl methyl ester ca 068085 85 8 fifra ai ref 3 cyhalothrin administ oral capsul dog 10 mg kg day 26 week produc occasion disturb nervou system unsteadi muscular trembl noel effect defin 1year dog studi ataxia muscl tremor convuls observ follow oral administr 3 5 mg kg day abnorm gait convuls observ 0 5 mg kg day loel studi 0 5 mg kg day noel 0 1 mg kg day epa believ suffici evid list cyhalothrin epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data 60 cyromazin n cyclopropyl 1 3 5 triazin 2 4 6 triamin ca 066215 27 8 fifra ai ref 3 6month dog feed studi 7 5 mg kg day loel produc chang hematocrit hemoglobin level noel 0 75 mg kg day base noel oral rfd 0 0075 mg kg day deriv 90day dog feed studi loel 25 mg kg day produc increas rel liver weight male noel 7 5 mg kg day 90day rat feed studi loel 15 mg kg day produc decreas rel liver weight male noel 1 5 mg kg day epa believ suffici evid list cyromazin epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data 61 dazomet tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion ca 000533 74 4 fifra ai ref 3 anim fed dazomet dietari dose 40 ppm 2 year show focal necrosi fatti metamorphosi liver rat fed 30 3 mg kg day experienc decreas weight gain chang liver weight renal focal tubular necrosi seen rat fed 10 ppm 0 5 mg kg day 2 year epa believ suffici evid list dazomet epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data chemic 62 dazomet sodium salt tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion ion 1 sodium ca 053404 60 7 fifra ai ref 3 avail toxic data dazomet rat fed 80 ppm 2 year 4 mg kg day show focal necrosi fatti metamorphosi liver rat fed 30 3 mg kg day experienc decreas weight gain chang liver weight renal focal tubular necrosi seen rat fed 10 ppm 0 5 mg kg day 2 year epa believ suffici evid list dazomet sodium epcra section 313 pursuant epcra section 313 2 b base avail renal toxic data free acid dazomet 63 2 4 db ca 000094 82 6 fifra sr ref 8 2 4 db 4 2 4 dichlorophenoxi butano acid 2 4 dichlorophenoxi type herbicid studi involv beagl dog fed diet contain 2 4 db 90 day loael 25 mg kg day determin base intern hemorrhag mortal observ first 3 9 week treatment noael studi 8 mg kg day dose level slight increas liver weight observ unaccompani gross histopatholog lesion epa deriv oral rfd 0 008 mg kg day loael subchron rat feed studi loael noael valu determin higher loael approxim 80 100 mg kg day noael approxim 25 30 mg kg day base sever liver kidney damag mention subchron 90day dog feed studi observ anim expos dose 2 4 db 25 mg kg day loael higher exhibit aspermatogenesi within first 3 9 week treatment offspr rat oral expos 17 mg kg 2 4 db day 1 7 gestat develop abnorm also increas stillbirth dose level separ studi offspr rat oral expos 416 mg kg day 5 9 gestat exhibit increas preimplant loss development toxic epa believ suffici evid list 2 4 db epcra section 313 pursuant epcra section 313 2 b base hepat reproduct development toxic data chemic 64 2 4 butoxyethyl ester ca 001929 73 3 cercla fifra ai iarc ref 8 2 4 butoxyethyl ester 2 4 dichlorophenoxi type herbicid mammal butoxyethyl ester 2 4 hydrolyz yield free acid 2 4 therefor toxic 2 4 butoxyethyl ester expect similar 2 4 kidney liver nervou system primari target injuri epa believ suffici evid list 2 4 butoxyethyl ester epcra section 313 pursuant epcra section 313 2 b base known chronic effect metabolit 2 4 65 2 4 butyl ester ca 000094 80 4 cercla fifra ai iarc ref 8 2 4 butyl ester 2 4 dichlorophenoxytyp herbicid mammal butyl ester 2 4 hydrolyz yield free acid 2 4 therefor toxic 2 4 butyl ester expect similar 2 4 kidney liver nervou system primari target injuri epa believ suffici evid list 2 4 butyl ester epcra section 313 pursuant epcra section 313 2 b base known toxic effect metabolit 2 4 66 2 4 chlorocrotyl ester ca 002971 38 2 cercla fifra ai iarc ref 8 2 4 chlorocrotyl ester 2 4 dichlorophenoxi type herbicid mammal chlorocrotyl ester 2 4 hydrolyz yield free acid 2 4 therefor toxic 2 4 chlorocrotyl ester expect similar 2 4 kidney liver nervou system primari target injuri epa believ suffici evid list 2 4 chlorocrotyl ester epcra section 313 pursuant epcra section 313 2 b base known toxic effect metabolit 2 4 67 desmedipham ca 013684 56 5 fifra ai ref 3 90day dog studi group four beagl sex fed diet contain 0 5 24 mg kg day caus increas methemoglobin 5 24 mg kg day loel epa believ suffici evid list desmedipham epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data 68 2 4 2 ethylhexyl ester ca 001928 43 4 cercla fifra ai iarc ref 8 2 4 2 ethylhexyl ester 2 4 dichlorophenoxi type herbicid 2 ethylhexyl moieti contain eight carbon therefor isooctyl group development toxic follow matern exposur 2 4 isooctyl ester demonstr rat mous fetotox occur offspr rat expos 528 mg kg gestat day 8 11 rat oral expos dose low 302 mg kg gestat day 9 12 musculoskelet abnorm exposur lower dose 188 mg kg longer period gestat day 6 15 caus development effect homeostasi effect newborn growth statist mice 438 mg kg administ oral gestat day 8 12 also caus effect newborn growth statist epa believ suffici evid list 2 4 2 ethylhexyl ester epcra section 313 pursuant epcra section 313 2 b base development toxic data 2 4 isooctyl ester toxic effect metabolit 2 4 aquat acut toxic data 2 4 isooctyl ester includ measur 48hour lc 50 8 8 ppm bluegil addit 2 4 isooctyl ester expect bioaccumul base estim log k ow 6 6 epa believ suffici evid list 2 4 2 ethylhexyl ester epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data potenti bioaccumul 69 2 4 2 ethyl 4 methylpentyl ester ca 053404 37 8 cercla fifra ai iarc ref 8 2 4 2 ethyl 4 methylpentyl ester 2 4 dichlorophenoxi type herbicid 2 ethyl 4 methylpentyl ester moieti contain eight carbon therefor isooctyl group development toxic follow matern exposur 2 4 isooctyl ester demonstr rat mous fetotox occur offspr rat expos 528 mg kg gestat day 8 11 rat oral expos dose low 302 mg kg gestat day 9 12 musculoskelet abnorm exposur lower dose 188 mg kg longer period gestat day 6 15 caus development effect homeostasi effect newborn growth statist mice 438 mg kg administ oral gestat day 8 12 also caus effect newborn growth statist epa believ suffici evid list 2 4 2 ethyl 4 methylpentyl ester epcra section 313 pursuant epcra section 313 2 b base development toxic data 2 4 isooctyl ester toxic effect metabolit 2 4 aquat acut toxic data 2 4 isooctyl ester includ measur 48hour lc 50 8 8 ppm bluegil addit 2 4 isooctyl ester expect bioaccumul base estim log k ow 6 6 epa believ suffici evid list 2 4 2 ethyl 4 methylpentyl ester epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data potenti bioaccumul 70 diazinon ca 000333 41 5 cercla fifra sr ref 8 diazinon organophosph insecticid caus plasma cholinesteras inhibit central nervou system depress signific inhibit plasma cholinesteras observ two men administ five dose 0 025 mg kg day diazinon administ men dose 0 05 mg kg day 28 day caus 35 40 percent reduct plasma cholinesteras noel cholinesteras inhibit 0 02 mg kg day identifi sever control studi human clinic symptom diazinon poison includ headach nausea sweat vomit diarrhea indic neurotox plasma cholinesteras inhibit 93 percent red blood cell inhibit 90 percent occur monkey oral expos diazinon dose 5 mg kg day 52 week noel inhibit cholinesteras studi 0 05 mg kg day loel 0 5 mg kg day urogenit defect offspr femal rat oral administ diazinon dose 26 4 mg kg day 12 15 gestat report diazinon also induc musculoskelet abnorm offspr administ oral mother dose 45 mg kg day 8 12 gestat post implant mortal increas femal rat administ 63 5 mg kg day 10 gestat similar reproduct development effect observ mice oral administr 3 96 mg kg diazinon day 1 22 gestat caus decreas litter size delay behavior effect newborn dose 0 210 mg kg 3 78 mg kg administ oral day 1 21 gestat caus abnorm immun reticuloendotheli system biochem metabol abnorm offspr respect epa believ suffici evid list diazinon epcra section 313 pursuant epcra section 313 2 b base development chronic neurotox data chemic measur aquat acut toxic data diazinon includ 96hour lc 50 rainbow trout 90 ppb daphnid 96hour lc 50 0 90 ppb addit measur terrestri wildlif acut toxic data diazinon includ oral ld 50 male mallard duck 3 54 mg kg oral ld 50 male pheasant 4 33 mg kg epa believ suffici evid list diazinon epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 71 2 2 dibromo 3 nitrilopropionamid ca 010222 01 2 fifra ai ref 3 oral administr 50 mg kg day loel rat 4 week produc dyspnea weight loss noel 25 mg kg day oral administr 30 mg kg day rat 13 week produc dyspnea noel 13 mg kg day data may indic direct effect compound respiratori system epa believ suffici evid list 2 2 dibromo 3 nitrilopropionamid epcra section 313 pursuant epcra section 313 2 b base avail chronic respiratori data 72 dicamba 3 6 dichloro 2 methyoxybenzo acid ca 001918 00 9 fifra ai ref 3 decreas fetal bodi weight increas post implant loss observ offspr rabbit receiv 10 mg kg day dicamba day 6 18 gestat loel 10 mg kg day noel 3 mg kg day base noel epa deriv oral rfd valu 0 03 mg kg day separ studi disord oxid phosphoryl focal necrosi heart observ newborn rat follow transplacent exposur dicamba development toxic studi increas skelet malform seen offspr rat oral administ 64 mg kg day day 6 19 gestat epa believ suffici evid list dicamba epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 73 dichloran 2 6 dichloro 4 nitroanilin ca 000099 30 9 fifra ai ref 3 dichloran anilin potenti induc methemoglobinemia either singl repeat oral dose dichloran produc enlarg liver induct microsom enzym rat dog fed 21 mg kg day increas serum transaminas rhesu monkey dichloran induc hepat enzym 160 mg kg day 3 month caus hepat centrilobular fatti infiltr death inhal exposur 0 17 mg l produc elev cholesterol level increas liver weight 3month rabbit studi increas liver weight 21day rat studi 2year mous studi dietari administr 102 7 mg kg day loel produc centrilobular hepatocyt enlarg focal necrosi acut inflammatori cell infiltr vacuol centrilobular hepatocyt increas weight liver increas incid erythropoiesi male noel 30 mg kg day epa believ suffici evid list dichloran epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data 74 3 3 dichlorobenzidin dihydrochlorid ca 000612 83 9 tsca ref 8 iarc classifi 3 3 dichlorobenzidin dichlorobenzidin group 2b compound e chemic possibl carcinogen human iarc use gener name 3 3 dichlorobenzidin interchang 3 3 dichlorobenzidin dihydrochlorid dihydrochlorid salt 3 3 dichlorobenzidin expect equal toxic free base 3 3 dichlorobenzidin epa believ suffici evid list 3 3 dichlorobenzidin dihydrochlorid epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human 75 3 3 dichlorobenzidin sulfat ca 064969 34 2 tsca ref 8 iarc classifi 3 3 dichlorobenzidin dichlorobenzidin group 2b compound e chemic possibl carcinogen human sulfat salt 3 3 dichlorobenzidin expect equal toxic free base 3 3 dichlorobenzidin epa believ suffici evid list 3 3 dichlorobenzidin sulfat epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human 76 tran 1 4 dichloro 2 buten ca 000110 57 6 epcra eh ref 8 mortal two six rat observ follow inhal exposur 62 ppm 0 34 mg l 4 hour acut inhal lc 50 rat 86 ppm 0 44 mg l epa exposur analysi indic tran 1 4 dichloro 2 buten concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list tran 1 4 dichloro 2 buten epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 77 dichloromethylphenylsilan ca 000149 74 6 epcra eh ref 8 class chlorin silan corros skin mucou membran liber hydrochlor acid presenc water 2hour mous inhal lc 50 valu dichloromethylphenylsilan 0 17 mg l epa exposur analysi indic dichloromethylphenylsilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list dichloromethylphenylsilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 78 dichlorophen 2 2 methylenebi 4 chlorophenol ca 000097 23 4 fifra ai ref 3 increas incid microphthalmia observ offspr rat administ 25 mg kg day teratogen loel noel 5 0 mg kg day dose 75 mg kg day fetotox loel produc delay ossif vertebr centra sternaebra reduc bodi weight length increas resorpt rat fetus fetotox noel 5 0 mg kg day development studi avail epa believ suffici evid list dichlorophen epcra section 313 pursuant epcra section 313 2 b base avail development toxic data aquat acut toxic valu dichlorophen includ measur 48hour lc 50 50 ppb spicodioptomu calanoid copipod epa believ suffici evid list dichlorophen epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 79 tran 1 3 dichloropropen ca 010061 02 6 cercla cwa ppl ref 8 clinic report document occurr histiocyt lymphoma two firemen acut myelomonocyt leukemia farmer expos accid 1 3 dichloropropen inform isom isom mixtur e tran ci isom specifi lymphoma leukemia refractori treatment three men die evid 1 3 dichloropropen may caus cancer rat mice oral exposur 2year gavag studi rat treat 25 50 mg kg day 1 3 dichloropropen 53 percent ci isom 45 percent tran isom 1 percent epichlorhydrin develop squamou cell papilloma carcinoma forestomach male rat also develop neoplast nodul liver femal mice receiv 50 100 mg kg day develop squamou cell papilloma carcinoma forestomach transit cell carcinoma urinari bladder increas incid alveolar bronchiolar adenoma statist signific increas bronchioalveolar adenoma note male mice expos 60 ppm 272 mg l 1 3 dichloropropen vapor 50 percent ci isom 43 percent tran isom benign lung tumor seen femal mice male femal rat iarc assign 1 3 dichloropropen group 2b e possibl carcinogen human epa believ suffici evid list tran 1 3 dichloropropen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data 1 3 dichloropropen unspecifi isom 80 diclofop methyl 2 4 2 4 dichlorophenoxi phenoxi propano acid methyl ester ca 051338 27 3 fifra ai ref 3 rat teratolog studi increas resorpt reduc bodi weight dilat renal pelvi distens uret offspr report rat fed 1 6 mg kg day loel noel 0 5 mg kg day increas pup mortal observ 5 mg kg day loel 3 gener rat reproduct studi noel 1 5 mg kg day 30day rat feed studi increas rel heart liver kidney weight observ loel 4 mg kg day noel establish jaundic increas bilirubin increas serum glutam pyruv transaminas serum glutam oxaloacet transaminas increas liver kidney weight observ 30day dog feed studi 50 mg kg day noel 12 5 mg kg day 90day rat feed studi elev liver weight centrilobular enlarg hepat cell observ 4 mg kg day noel 1 6 mg kg day dog fed 6 25 mg kg day 90 day increas lipid content focal chang renal cortex noel 2 mg kg day epa believ suffici evid list diclofop methyl epcra section 313 pursuant epcra section 313 2 b base avail development hepat renal toxic data 81 dicyclopentadien ca 000077 73 6 tsca ref 8 convuls report rat mice follow inhal dicyclopentadien dosag level 332 145 ppm 1 8 0 78 mg l respect 1 2 day report acut oral ld 50 rat 353 mg kg anim dose level convuls muscl weak 90day inhal studi dog neurotox symptom observ includ diarrhea excess saliv lack control hind quarter noael studi 8 9 ppm 0 048 mg l loel report epa believ suffici evid list dicyclopentadien epcra section 313 pursuant epcra section 313 2 b base chronic neurotox data chemic 82 diethatyl ethyl ca 038727 55 8 fifra ai ref 3 2year studi group six beagl sex given dose oral 0 31 25 mg kg day lowest dose 0 25 mg kg day produc posit coomb test epa believ suffici evid list diethatyl ethyl epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data chemic 83 diflubenzuron ca 035367 38 5 fifra sr ref 8 2year studi beagl dog receiv diflubenzuron daili gelatin capsul loael increas sulfhemoglobin methemoglobin 10 mg kg day noael 2 mg kg day epa deriv oral rfd 0 02 mg kg day chemic studi similar effect note two separ 2year rat feed studi loael 7 8 8 mg kg day noael 2 mg kg day lifetim oral studi mice loael 12 mg kg day noael 2 4 mg kg day epa believ suffici evid list diflubenzuron epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data measur aquat acut toxic data diflubenzuron includ 48hour lc 50 4 55 ppb daphnid epa believ suffici evid list diflubenzuron epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 84 diglycidyl resorcinol ether ca 000101 90 6 iarc ntp ref 8 diglycidyl resorcinol ether classifi iarc group 2b compound e possibl carcinogen human ntp bioassay rat oral administ 12 mg kg diglycidyl resorcinol ether 5 day week 103 week develop squamou cell papilloma squamou cell carcinoma stomach mice oral administ 50 mg kg 5 day week 103 week develop squamou cell carcinoma squamou cell papilloma stomach mice oral administ 70 5 mg kg day diglycidyl resorcinol ether 2 year develop blood lymphoma hodgkin diseas mice receiv dermal applic diglycidyl resorcinol ether 1year develop skin tumor epa believ suffici evid list diglycidyl resorcinol ether epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 85 dimethipin 2 3 dihydro 5 6 dimethyl 1 4 dithiin 1 1 4 4 tetraoxid ca 055290 64 7 fifra ai ref 3 1year dog feed studi decreas erythrocyt hemoglobin hematocrit level well increas platelet level observ 75 mg kg day loel system toxic base decreas bodi weight 7 5 mg kg day noel could establish 2year rat feed studi increas absolut rel liver weight observ 10 mg kg day loel noel 2 mg kg day base noel studi epa establish oral rfd 0 02 mg kg day epa believ suffici evid list dimethipin epcra section 313 pursuant epcra section 313 2 b base avail hematolog hepat toxic data 86 dimetho ca 000060 51 5 cercla epcra eh fifra sr rcra app8 rcra p ref 8 dimetho organophosph insecticid human dimetho caus typic symptom cholinesteras inhibit sweat diarrhea saliv headach difficulti breath etc control human studi subject administ dimetho 57 day whole blood erythrocyt cholinesteras inhibit observ day 20 noel 0 202 mg kg day loel 0 434 mg kg day anoth studi human administ dimetho 57 day noel cholinesteras inhibit 15 mg day 0 2 mg kg base 70 kg person loel specifi cholinerg symptom reflect cholinesteras inhibit follow dimetho administr also observ laboratori anim 2year feed studi rat determin noel loel plasma brain cholinesteras inhibit 0 05 0 5 mg kg day respect dimetho test development effect wistar rat cygon 4e 47 3 percent dimetho 52 7 percent unspecifi constitu administ pregnant femal day 6 15 gestat noel development effect 6 mg kg day loel 12 mg kg day increas incid wavi rib observ fetus increas offspr mortal occur five gener chronic feed studi actual dose 9 5 10 5 mg kg day male femal cd 1 mice 12 mg kg day 120 mg kg gestat day 6 15 musculoskelet abnorm observ rat offspr epa believ suffici evid list dimetho epcra section 313 pursuant epcra section 313 2 b base avail development neurotox data chemic 87 3 3 dimethoxybenzidin dihydrochlorid dianisidin dihydrochlorid ca 020325 40 0 tsca ref 8 iarc classifi 3 3 dimethoxybenzidin dianisidin group 2b compound e chemic possibl carcinogen ntp carcinogen bioassay increas neoplasm skin oral caviti larg intestin liver uteru cervix note rat administ chemic drink water dose level 6 12 21 mg kg day male 7 14 23 mg kg day femal dihydrochlorid salt dianisidin expect equal toxic free base dianisidin epa believ suffici evid list 3 3 dimethoxybenzidin dihydrochlorid epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human 88 3 3 dimethoxybenzidin hydrochlorid dianisidin hydrochlorid ca 111984 09 9 tsca ref 8 iarc classifi 3 3 dimethoxybenzidin dianisidin group 2b compound e chemic possibl carcinogen ntp carcinogen bioassay increas neoplasm skin oral caviti larg intestin liver uteru cervix note rat administ chemic drink water dose level 6 12 21 mg kg day male 7 14 23 mg kg day femal hydrochlorid salt dianisidin expect equal toxic free base dianisidin epa believ suffici evid list 3 3 dimethoxybenzidin hydrochlorid epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human 89 dimethylamin ca 000124 40 3 tsca ref 8 dimethylamin corros mucou membran respiratori tract eye treat anim b6c3f1 mice f344 rat expos 10 175 ppm 0 018 0 32 mg l dimethylamin via inhal 6 12 month develop dose relat lesion respiratori olfactori epithelium signific decreas bodi weight occur high dose 175 ppm 0 32 mg l anim speci high dose mice die follow exposur centrilobular fatti degener necrosi parenchym cell report mice rat rabbit guinea pig administ 97 183 ppm 0 18 0 34 mg l dimethylamin via inhal 18 20 week increas liver weight without histopatholog chang report follow 8month oral exposur rat 0 35 mg kg day guinea pig expos 3 5 mg kg day rat administ oral dose dimethylamin low 0 035 mg kg 8 month exhibit chang condit reflex includ mark attenu excit process speedier extinct posit reflex epa believ suffici evid list dimethylamin epcra section 313 pursuant epcra section 313 2 b base chronic respiratori hepat neurolog toxic chemic 90 dimethylamin dicamba ca 002300 66 5 fifra ai ref 3 pilot rabbit development toxic studi increas earli late fetal resorpt observ anim receiv loel 1 0 mg kg day noel 0 5 mg kg day oral dose day 6 18 gestat anoth studi increas post implant loss observ rabbit receiv loel 10 mg kg day oral dose day 6 18 gestat development toxic also observ dose 10 mg kg day studi dicamba epa believ suffici evid list dimethylamin dicamba epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 91 3 3 dimethylbenzidin dihydrochlorid tolidin dihydrochlorid ca 000612 82 8 tsca ref 8 bioassay conduct ntp 3 3 dimethylbenzidin dihydrochlorid found carcinogen mice rat male femal mice expos concentr 5 140 ppm 0 95 26 6 mg kg day drink water 112 week develop lung alveolar cell adenoma adenocarcinoma male femal f344 rat expos concentr 30 150 ppm 4 2 21 mg kg day drink water 60 61 week develop tumor gastrointestin tract liver lung oral caviti tumor skin zymbal gland preputi gland male clitor gland mammari gland femal leukemia femal also note studi epa believ suffici evid list 3 3 dimethylbenzidin dihydrochlorid epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human 92 3 3 dimethylbenzidin dihydrofluorid tolidin dihydrofluorid ca 041766 75 0 tsca ref 8 neither iarc epa classifi 3 3 dimethylbenzidin dihydrofluorid respect carcinogen bioassay conduct ntp howev 3 3 dimethylbenzidin dihydrochlorid found carcinogen mice rat male femal mice expos concentr 5 140 ppm 0 952 6 6 mg kg day drink water 112 week develop lung alveolar cell adenoma adenocarcinoma male femal f344 rat expos concentr 30 150 ppm 4 2 21 mg kg day drink water 60 61 week develop tumor gastrointestin tract liver lung oral caviti tumor skin zymbal gland preputi gland male clitor gland mammari gland femal leukemia femal also note studi epa believ suffici evid list 3 3 dimethylbenzidin dihydrofluorid epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer human carcinogen data 3 3 dimethylbenzidin dihydrochlorid 93 dimethyl chlorothiophosph ca 002524 03 0 epcra eh ref 8 domin lethal studi male rat administ dimethyl chlorothiophosph gavag 5 consecut day mate untreat femal loel 7 5 mg kg day determin base increas preimplant loss dead implant noel dimethyl chlorothiophosph determin studi epa believ suffici evid list dimethyl chlorothiophosph epcra section 313 pursuant epcra section 313 2 b base development toxic data chemic 94 dimethyldichlorosilan ca 000075 78 5 cercla epcra eh ref 8 class howev chlorin silan corros skin mucou membran liber hydrochlor acid presenc water dimethyldichlorosilan caus sever burn vapor harm human 2hour mous inhal lc 50 valu 0 30 mg l epa exposur analysi indic dimethyldichlorosilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list dimethyldichlorosilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 95 n n dimethylformamid ca 000068 12 2 caa hap ref 7 human n n dimethylformamid dmf produc increas subject symptom suggest mild liver dysfunct worker chang object measur liver damag serum enzym liver enlarg via inhal exposur result loael 22 mg m3 adjust loael 7 9 mg m3 although sever addit studi gener inadequ consid individu taken togeth studi demonstr dmf exposur associ hepat toxic human sever anim inhal studi support hepatotox effect dmf epa believ suffici evid list n n dimethylformamid epcra section 313 pursuant epcra section 313 2 b base upon avail hepatotox data chemic 96 2 6 dimethylphenol 000576 26 1 tsca ref 8 oral administr 2 6 dimethylphenol rat 8 month produc histolog lesion loel 6 0 mg kg day noel 0 6 mg kg day liver kidney spleen anoth support oral studi rat also report histolog lesion liver kidney loel 6 0 mg kg day noel 0 06 mg kg day rat follow subchron oral administr 2 6 dimethylphenol epa believ suffici evid list 2 6 dimethylphenol epcra section 313 pursuant epcra section 313 2 b base hepatotox nephrotox data chemic 97 dinocap ca 039300 45 3 cal fifra sr ref 8 dinocap dinitrophenyl type fungicid mice oral administr 25 mg kg day dinocap day 7 16 gestat shown increas post implant mortal reduc newborn viabil oral administr 5 0 mg kg day pregnant mice produc development toxic offspr administr 10 mg kg day result abnorm musculoskelet hepatobiliari system offspr studi oral administr 20 mg kg day day 7 16 gestat produc craniofaci abnorm offspr studi behavior abnorm delay growth observ offspr mice receiv 12 mg kg day day 7 16 gestat epa believ suffici evid list dinocap epcra section 313 pursuant epcra section 313 2 b base development toxic data chemic measur aquat acut toxic data dinocap indic lc 50 rainbow trout 15 ppb lc 50 bluegil 20 ppb epa believ suffici evid list dinocap epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 98 dinoseb ca 000088 85 7 cal epcra eh fifra sr rcra app8 rcra p sdwa ref 8 dinoseb dinitrophenyl type herbicid insecticid three gener reproduct studi dinoseb produc decreas pup weight loel 1 mg kg day noel determin f 1b f 2a f 3a pup f 1b pup weight diminish combin sex day 21 dose level greater 1 mg kg day studi shown biolog statist signific increas development malform anomali loel 10 mg kg day noel 3 mg kg day increas incid absenc ossif number skelet site supernumerari rib loel specifi noel 3 mg kg day dinoseb administ gavag rabbit day 6 18 gestat produc neural tube defect loel 10 mg kg day noel 3 mg kg day fertil index male rat reduc reproduct studi anim fed dinoseb dose level 15 6 mg kg day 22 2 mg kg day 11week period decreas semin vesicl weight decreas sperm count increas incid abnorm sperm note dose level 9 1 mg kg day higher noel 3 8 mg kg day epa believ suffici evid list dinoseb epcra section 313 pursuant epcra section 313 2 b base development reproduct toxic data chemic aquat acut toxic data dinoseb includ measur fat head minnow 96hour lc 50 88 ppb epa believ suffici evid list dinoseb epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 99 diphenamid ca 000957 51 7 fifra sr ref 8 diphenamid diphenylacetamid type herbicid 2year studi dog fed diphenamid increas liver weight increas portal macrophag fibroblast seen loel 10 mg kg day noel 3 mg kg day base noel rfd 0 03 mg kg day deriv 2year studi rat fed diphenamid increas liver weight seen loel 30 mg kg day noel 10 mg kg day although histopatholog chang report studi biochem chang accompani histo patholog chang observ 2gener studi rat pup epa believ suffici evid list diphenamid epcra section 313 pursuant epcra section 313 2 b base avail hepatotox data chemic 100 diphenylamin ca 000122 39 4 rcra app8 ref 8 increas liver kidney weight note dog receiv 25 mg kg day loael diphenylamin feed 2 year noael studi 2 5 mg kg day oral rfd 0 025 mg kg day pronounc anemia decreas bodi weight gain also note anim hepatotox induc diphenylamin manifest peripherolobular fat chang increas lipid vacuolar degener hepatocyt necrosi report rat guinea pig receiv 2 4 percent e 1 000 2 000 mg kg day rat 800 1 600 mg kg day guinea pig diphenylamin diet 6 month anoth 2year rat studi chang report kidney diphenylamin fed anim includ epitheli necrosi proxim tubul cystic dilat tubul interstiti inflamm epa believ suffici evid list diphenylamin epcra section 313 pursuant epcra section 313 2 b base chronic hepat renal toxic data chemic 101 dipotassium endothal 7 oxabicyclo 2 2 1 heptan 2 3 dicarboxyl acid dipotassium salt ca 002164 07 0 fifra ai ref 3 2year dog feed studi increas absolut rel weight stomach small intestin observ 6 mg kg day loel noel 2 mg kg day oral rfd 0 02 mg kg day deriv base noel epa believ suffici evid list dipossium endothal epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data chemic 102 dipropyl isocinchomeron ca 000136 45 8 fifra ai ref 3 dipropyl isocinchomeron classifi epa group b2 compound e probabl human carcinogen classif base find multipl malign benign tumor rat liver adenoma carcinoma sex kidney carcinoma sex benign test tumor male uterin tumor femal multipl malign tumor mous liver adenoma carcinoma sex lung bronchiolar adenoma carcinoma male epa believ suffici evid list dipropyl isocinchomeron epcra section 313 pursuant epcra section 313 2 b base avail carcinogen toxic data 103 disodium cyanodithioimidocarbon ca 000138 93 2 fifra ai ref 3 rat administ disodium cyanodithioimidocarbon gavag gestat day 6 15 demonstr increas skelet variat offspr noel 6 mg kg loel 18 mg kg rabbit teratolog studi increas resorpt observ rabbit administ compound gavag gestat day 6 18 noel 3 mg kg loel 10 mg kg epa believ suffici evid list disodium cyanodithioimidocarbon epcra section 313 pursuant epcra section 313 2 b base avail development toxic data 104 2 4 isopropyl ester ca 000094 11 1 cercla fifra ai iarc ref 8 2 4 isopropyl ester 2 4 dichlorophenoxi type herbicid mammal isopropyl ester 2 4 hydrolyz yield free acid 2 4 therefor toxic 2 4 isopropyl ester expect similar 2 4 kidney liver nervou system primari target injuri 2 4 present includ epcra section 313 list toxic chemic epa believ suffici evid list 2 4 isopropyl ester epcra section 313 pursuant epcra section 313 2 b base known toxic effect metabolit 2 4 105 2 4 dithiobiuret ca 000541 53 7 cercla epcra eh rcra app8 rcra p ref 8 experiment anim 2 4 dithiobiuret highli toxic substanc caus death respiratori depress respiratori failur rat receiv 1 mg kg day 6 day suffer delay onset neuromuscular depress rat given 2 4 dithiobiuret 52 day show sign muscl weak latenc period 3 4 day noel determin 0 125 mg kg day loel 0 25 mg kg day caus muscl weak depress neuromuscular transmiss epa believ suffici evid list 2 4 dithiobiuret epcra section 313 pursuant epcra section 313 2 b base chronic neurotox data chemic 106 dithiopyr 2 difluoromethyl 4 2 methylpropyl 6 trifluoromethyl 3 5 pyridinedicarbothio acid dimethyl ester ca 097886 45 8 fifra ai ref 3 2 gener rat reproduct studi decreas bodi weight diffus hepatocellular swell white spot liver observ offspr rat administ greater equal 16 4 mg kg day noel valu 1 7 mg kg day 13week rat feed studi loel 6 62 mg kg day produc diffus hepatocellular swell noel 0 662 mg kg day 13 week dog feed studi increas alkalin phosphatas discolor liver cholestasi observ 10 mg kg day loel noel 1 mg kg day addit 30 mg kg day increas serum glutam pyruv transaminas serum glutam oxaloacet transaminas increas liver kidney weight decreas cholesterol albumin observ epa believ suffici evid list dithiopyr epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data 107 diuron ca 000330 54 1 cercla ref 8 2year studi dog administ diuron sulfhemoglobin abnorm blood pigment detect follow dose low 3 125 mg kg day loael noael 0 625 mg kg day higher dose 6 25 31 25 mg kg day caus decreas red blood cell hemoglobin hematocrit valu highest dose test 31 25 mg kg day also caus increas erythrogen activ bone marrow hemosiderosi spleen increas liver weight bodi weight loss epa deriv oral rfd 0 002 mg kg day chemic studi similar effect anemia increas erythrogen activ bone marrow abnorm pigment blood also observ rat expos oral dose low 6 25 mg kg day 2 year 250 mg kg day 90 day 7week studi rat receiv diuron dose greater equal 10 mg kg day decreas red blood cell significantli increas methemoglobinemia offspr wistar rat fed diuron day 6 15 gestat show development toxic includ malform rib extra rib delay ossif development loael studi 100 mg kg day noael determin matern fetal bodi weight decreas 400 mg kg day three gener reproduct studi rat fed diuron 6 25 mg kg day decreas bodi weight report f 2b f 3a litter epa believ suffici evid list diuron epcra section 313 pursuant epcra section 313 2 b base avail hematolog development toxic data chemic measur aquat toxic data diuron includ 1 5hour ec 50 0 010 ppm 10 ppb marin green alga epa believ suffici evid list diuron epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 108 2 4 2 octyl ester ca 001917 97 1 cercla fifra ai iarc ref 8 2 4 2 octyl ester 2 4 dichlorophenoxi type herbicid 2 octyl moieti contain eight carbon therefor isooctyl group development toxic follow matern exposur 2 4 isooctyl ester demonstr rat mous fetotox occur offspr rat expos 528 mg kg gestat day 8 11 rat oral expos dose low 302 mg kg gestat day 9 12 musculoskelet abnorm exposur lower dose 188 mg kg longer period gestat day 6 15 caus development effect homeostasi effect newborn growth statist mice 438 mg kg administ oral gestat day 8 12 also caus effect newborn growth statist epa believ suffici evid list 2 4 2 octyl ester epcra section 313 pursuant epcra section 313 2 b base development toxic data 2 4 isooctyl ester toxic effect metabolit 2 4 aquat acut toxic data 2 4 isooctyl ester includ measur 48hour lc 50 8 8 ppm bluegil addit 2 4 isooctyl ester expect bioaccumul base estim log k ow 6 6 epa believ suffici evid list 2 4 isooctyl ester epcra section 313 pursuant section epcra 313 2 c base avail environment toxic data potenti bioaccumul 109 dodin dodecylguanidin monoacet ca 002439 10 3 fifra ai ref 3 aquat acut toxic valu dodin includ daphnid 48hour ec 50 17 8 ppb epa believ suffici evid list dodin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 110 2 4 dp dichlorprop ca 000120 36 5 fifra sr iarc ref 8 2 4 dp 2 2 4 dichlorophenoxi propion acid 2 4 dichlorophenoxi type herbicid development toxic report rat mice administ oral dose 2 4 dp low 20 mg kg gestat day 4 18 behavior chang physic effect observ newborn rat increas post implant loss observ mother exposur mice much higher dose 3 000 4 000 mg kg shorter durat e gestat day 6 15 caus musculoskelet abnorm fetotox epa believ suffici evid list 2 4 dp epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 111 2 4 propylen glycol butyl ether ester ca 001320 18 9 cercla fifra ai iarc ref 8 2 4 propylen glycol butyl ether ester 2 4 dichlorophenoxi type herbicid mammal propylen glycol butyl ether ester expect hydrolyz yield free acid 2 4 therefor toxic 2 4 propylen glycol butyl ether ester expect similar 2 4 kidney liver nervou system primari target injuri epa believ suffici evid list 2 4 propylen glycol butyl ether ester epcra section 313 pursuant epcra section 313 2 b base chronic toxic data chemic 112 2 4 sodium salt ca 002702 72 9 cercla fifra ai iarc ref 8 2 4 sodium salt 2 4 dichlorophenoxi type herbicid mammal sodium salt expect hydrolyz yield free acid 2 4 therefor toxic 2 4 sodium salt expect similar 2 4 kidney liver nervou system primari target injuri 2 4 present includ epcra section 313 list toxic chemic epa believ suffici evid list 2 4 sodium salt ester epcra section 313 pursuant epcra section 313 2 b base system toxic data chemic 113 ethoprop phosphorodithio acid ethyl dipropyl ester ca 013194 48 4 fifra ai ref 3 ethoprop acut toxic anim acut oral ld 50 rat 5 62 mg kg day clinic sign toxic observ anim dose level includ depress saliv inact convuls prostrat similar sign report 4hour inhal lc 50 0 12 mg l rat 2year rat chronic feed studi plasma red blood cell brain cholinesteras inhibit observ sex 0 5 mg kg day noel 0 05 mg kg day similar result report chronic dietari studi mice 0 1 mg kg day noel 0 01 mg kg day two chronic studi togeth result acut studi indic potenti neurotox ethoprop epa believ suffici evid list ethoprop epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data aquat acut toxic valu ethoprop includ mysid 96hour lc 50 7 5 ppb shrimp 96hour lc 50 13 ppb daphnid 48hour ec 50 93 ppb avian acut dietari toxic data includ ring neck pheasant 14day ld 50 4 2 mg kg mallard duck 14day ld 50 12 6 mg kg epa believ suffici evid list ethoprop epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 114 ethyl dipropylthiocarbam eptc ca 000759 94 4 fifra ai ref 3 eptc cholinesteras inhibitor worker expos eptc complain headach malais nausea impair work abil poison anim exhibit saliv lacrim blepharospasm depress neuropathi observ rat oral administ 25 mg kg day 2 year loel 25 mg kg day noel 5 mg kg day decreas brain cholinesteras activ observ femal rat oral administ 15 mg kg day loel noel 3 mg kg day 4 hour inhal rat cat lowest lethal concentr valu 0 2 mg l 0 4 mg l respect somnol saliv observ expos anim dermal rabbit ld 50 10 000 mg kg depress right reflex prostrat clonic convuls observ 2year dietari rat studi degen cardiomyopathi observ male receiv 9 mg kg day eptc noel establish effect observ femal 36 mg kg day noel 18 mg kg day 2 gener rat reproduct studi parent toxic includ cardiomyopathi observ rat oral administ 10 mg kg day base noel 2 5 mg kg day epa deriv oral rfd 0 025 mg kg day 2year dietari rat studi chronic myocard observ loel 125 mg kg day noel 25 mg kg day increas incid fetal resorpt increas incid fetal retard decreas fetal bodi weight observ rat receiv 300 mg kg day eptc day 6 15 gestat loel 300 mg kg day noel 100 mg kg day noel 10 mg kg day 2 gener rat reproduct studi decreas pup weight observ gener 40 mg kg day noel 10 mg kg day epa believ suffici evid list eptc epcra section 313 pursuant epcra section 313 2 b base avail neurolog cardiovascular reproduct toxic data chemic 115 famphur ca 000052 85 7 cercla fifra ai rcra app8 rcra p ref 8 famphur thiophosph type cholinesteras inhibitor 90day feed studi rat given diet supplement famphur show decreas plasma brain cholinesteras activ 1 25 mg kg day decreas whole blood cholinesteras activ 0 15 mg kg day bull treat famphur 43 day sign neurotox appear symptom includ paresi four limb attribut focal cervic diffus spinal cord lesion calv receiv 60 75 mg kg show mark inhibit whole blood cholinesteras epa believ suffici evid list famphur epcra section 313 pursuant epcra section 313 2 b base chronic neurotox known chemic measur terrestri wildlif acut toxic data famphur indic oral ld 50 valu redwing blackbird starl 1 78 mg kg 4 22 mg kg respect addit measur oral ld 50 mallard duck 3 45 mg kg base 35 percent activ ingredi epa believ suffici evid list famphur epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 116 fenarimol alpha 2 chlorophenyl alpha 4 chlorophenyl 5 pyrimidinemethanol ca 060168 88 9 fifra ai ref 3 3month mous feed studi liver weight increas male level greater equal 620 ppm 80 6 mg kg day femal level greater 1 100 ppm 143 mg kg day higher dose 143 260 mg kg day decreas total bilirubin hepatomegali periport fatti liver chang observ mice expos dietari level 78 mg kg day 1year increas liver weight slight fatti chang one year feed studi wistar rat also result increas liver weight loel 17 5 mg kg day noel 6 5 mg kg day 2year feed studi wistar rat fatti chang liver observ 17 5 mg kg day loel noel 6 5 mg kg day 2year feed studi mice result fatti liver chang loel 78 mg kg day noel 22 1 mg kg day epa believ suffici evid list fenarimol epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data 117 fenbutatin oxid hexaki 2 methyl 2 phenylpropyl distannoxan ca 013356 08 6 fifra ai ref 3 rat teratolog studi loel development toxic toxic zygot 60 mg kg day noel 30 mg kg day rabbit teratolog studi oral administr 5 mg kg day produc intrauterin lethal also toxic matern anim noel 1 mg kg day 3 gener rat reproduct studi administr 15 mg kg day loel produc decreas viabil index noel 5 mg kg day epa believ suffici evid list fenbutatin oxid epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic aquat acut toxic valu fenbutatin oxid includ rainbow trout 96hour lc 50 1 7 ppb fathead minnow 96hour lc 50 1 9 ppb daphnid 48hour ec 50 3 1 ppb bluegil sunfish 96hour lc 50 4 8 ppb sheepshead minnow 96hour lc 50 20 8 ppb avian acut toxic valu includ quail oral ld 50 0 007 mg kg epa believ suffici evid list fenbutatin oxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 118 fenoxaprop ethyl 2 4 6 chloro 2 benzoxazolylen oxi phenoxi propano acid ethyl ester ca 066441 23 4 fifra ai ref 3 30day mous feed studi liver weight increas observ loel 20 ppm 2 6 mg kg day noel 10 ppm 1 3 mg kg day 32day rat feed studi chang liver kidney well alter lipid metabol decreas cholesterol observ loel rat studi 80 ppm 4 mg kg day noel 20 ppm 1 mg kg day inflammatori chang kidney chronic interstiti nephriti report dog receiv 3month feed 80 ppm 2 mg kg day loel noel 16 ppm 0 4 mg kg day decreas serum lipid cholesterol report rat expos 2 year dietari level greater equal 180 ppm 9 mg kg day loel noel studi 30 ppm 1 5 mg kg day development toxic studi fetotox effect slightli impair growth delay ossif report 100 mg kg day noel 32 mg kg day effect observ dose also toxic matern anim 2gener reproduct toxic feed studi rat decreas surviv decreas bodi weight studi termin signific chang kidney liver weight report f 2a f 2b litter fetotox loel studi 5 ppm 0 25 mg kg day lowest dose test loel noel matern toxic increas kidney liver weight 80 ppm 4 mg kg day 30 ppm 1 5 mg kg day respect thu fetotox effect observ dose lower produc matern toxic epa believ suffici evid list fenoxaprop ethyl epcra section 313 pursuant epcra section 313 2 b base avail renal development toxic data chemic aquat acut toxic valu fenoxaprop ethyl includ mysid 96hour ec 50 98 ppb epa believ suffici evid list fenoxaprop ethyl epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 119 fenoxycarb 2 4 phenoxyphenoxi ethyl carbam acid ethyl ester ca 072490 01 8 fifra ai ref 3 liver chang includ fatti chang glycogen deplet hepatocyt hypertrophi multinucl hepatocyt report mice loel 80 mg kg day noel determin rat loel 300 mg kg day noel 100 mg kg day follow 3month dietari exposur dose relat chang liver male rat includ increas rel liver weight focal necrosi centrilobular hypertrophi pigment histiocyt report first year 2year oncogen studi loel effect 600 ppm 30 mg kg day noel 200 ppm 10 mg kg day male femal rat expos higher dose 1 800 ppm 90 mg kg day studi increas alkalin phosphatas reduc platelet white blood cell fibrosi present hepat lesion male reproduct studi rat delay pinna unfold eye open report 10 mg kg day epa believ suffici evid list fenoxycarb epcra section 313 pursuant epcra section 313 2 b base avail hepat development toxic data chemic 120 fenpropathrin 2 2 3 3 tetramethylcyclopropan carboxyl acid cyano 3 phenoxyphenyl methyl ester ca 039515 41 8 fifra ai ref 3 1year feed studi tremor note dog expos 6 25 mg kg day noel 2 5 mg kg day development toxic studi rat sign neurotox report pregnant dam includ ataxia tremor convuls lacrim prostrat death loel matern toxic 10 mg kg day noel 6 mg kg day 2year dietari studi rat mice bodi tremor increas mortal observ male rat loel 30 mg kg day noel 22 5 mg kg day wherea margin increas hyperact note femal mice loel 65 2 mg kg day noel 16 2 mg kg day epa believ suffici evid list fenpropathrin epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic aquat acut toxic valu fenpropathrin includ rainbow trout 96hour lc 50 2 3 ppb bluegil 96hour lc 50 2 2 ppb sheepshead minnow 96hour lc 50 3 1 ppb daphnid 48hour ec 50 0 53 ppb epa believ suffici evid list fenpropathrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 121 fenthion dimethyl 3 methyl 4 methylthio phenyl ester phosphorothio acid ca 000055 38 9 fifra ai ref 3 case human poison fenthion exposur report cholinerg manifest includ follow man ingest 257 mg kg increas puls rate effect blood pressur gastrointestin symptom includ diarrhea nausea vomit woman ingest 525 mg kg experienc muscl contract spastic respiratori depress miosi woman ingest unspecifi amount fenthion exhibit initi cholinerg crisi 5 day postexposur symptom primarili psychosi recur 24 day later similar sign toxic characterist organophosph poison observ rat fed 300 ppm 15 mg kg day symptom report rat includ spasm nervous saliv diarrhea well ophthalmolog symptom eyebal protrus corneal turbid loel noel valu cholinesteras inhibit anim studi variou durat includ follow 28day feed studi rat loel 10 ppm 0 5 mg kg day noel 5 ppm 0 65 mg kg day brain cholinesteras inhibit anoth 28day rat feed studi plasma erythrocyt cholinesteras recov 2 week postexposur loel cholinesteras inhibit 30day inhal studi rat 0 163 mg l 63day rat feed studi signific cholinesteras inhibit occur day 3 25 mg kg day 16week feed studi rat loel cholinesteras inhibit 5 ppm femal 0 65 mg kg day noel 3 ppm 0 15 mg kg day epa believ suffici evid list fenthion epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic aquat acut toxic valu fenthion includ daphnid 48hour lc 50 0 62 ppb immobil acut toxic valu non standard aquat invertebr rang 48hour ec 50 0 024 ppb brown shrimp 96hour ec 50 110 ppb scud avian acut toxic valu includ male mallard duck oral ld 50 5 94 mg kg male bobwhit quail ld 50 4 mg kg mourn dove oral ld 50 4 63 mg kg epa believ suffici evid list fenthion epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 122 fenvaler 4 chloro alpha 1 methylethyl benzeneacet acid cyano 3 phenoxyphenyl methyl ester ca 051630 58 1 fifra ai ref 3 excit ataxia observ rat administ fenvaler oral ld 50 dose 70 2 mg kg oral mous ld 50 fenvaler 185 mg kg tremor convuls ataxia observ studi neurolog dysfunct consist jerki leg movement exagger flexion hind limb unsteadi gait observ rat fed 7 5 mg kg day loel fenvaler 13 week noel 2 5 mg kg day base noel studi epa deriv oral rfd 0 0025 mg kg day peripher nerv spinal cord lesion observ rat oral administ 360 mg kg 6month dog feed studi normocyt anemia increas serum cholesterol level hepat microgranulomatosi observ anim administ fenvaler 6 25 mg kg day loel noel defin 2year mous feed studi multifoc granulomata liver observ male femal fed fenvaler 7 5 37 5 mg kg day respect male noel 1 5 mg kg day femal noel 7 5 mg kg day 20month mous feed studi decreas erythrocyt count increas mean cell volum blood granulomat chang liver observ 15 mg kg day loel noel 4 5 mg kg day epa believ suffici evid list fenvaler epcra section 313 pursuant epcra section 313 2 b base avail neurolog hepat hematolog toxic data chemic measur aquat acut toxic data fenvaler includ bluegil 96hour lc 50 0 26 ppb fathead minnow 96hour lc 50 0 33 ppb rainbow trout 96hour lc 50 1 2 ppb atlant salmon 96hour lc 50 1 2 ppb sheepshead minnow 96hour lc 50 4 4 ppb addit 48hour lc 50 daphnid 0 05 ppb epa believ suffici evid list fenvaler epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 123 ferbam tri dimethylcarbamodithioato iron ca 014484 64 1 fifra ai ref 3 80week feed studi rat femal fed 96 mg kg day ataxia progress hind limb paralysi noel determin symptom neurotox report mice follow acut oral exposur includ somnol excit ataxia although dose sign occur much higher ld 50 studi 3 400 mg kg epa believ suffici evid list ferbam epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data aquat acut toxic valu ferbam includ daphnid 48hour lc 50 90 ppb 96hour lc 50 52 ppb eastern oyster guppi 96hour lc 50 90 ppb epa believ suffici evid list ferbam epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 124 fluazifop butyl 2 4 5 trifluoromethyl 2 pyridinyl oxi phenoxi propano acid butyl ester ca 069806 50 4 fifra ai ref 3 3month rat feed studi demonstr hepatocyt hypertrophi male loel 5 mg kg day noel 0 5 mg kg day 1year feed studi dog chang serum alkalin phosphatas alanin aminotransferas alanin sulfatransferas loel 25 mg kg day noel 5 mg kg day similar chang also report dog follow 3 month exposur diet loel 125 mg kg day carcinogen studi male mice fed 20 ppm 2 6 mg kg day loel increas incid hepatocyt hypertrophi noel 5 ppm 0 65 mg kg day male femal mice expos higher dose 80 ppm 10 4 mg kg day increas liver weight rel absolut hypertrophi periacin hepatocyt male dose group also increas pigment hepatocyt kupffer cell teratogen studi spragu dawley rat expos via oral gavag delay ossif increas incid hydrouret observ fetus fetotox loel 5 mg kg day noel 1 mg kg day teratogen loel 200 mg kg day noel 10 mg kg day determin base incid diaphragmat hernia matern toxic observ studi dose higher caus fetotox includ reduc bodi weight gain decreas gravid uteru matern loel 200 mg kg day noel 10 mg kg day 2 gener reproduct toxic dietari studi wistar rat reproduct loel 250 ppm 12 5 mg kg day noel 80 ppm 4 mg kg day base reduc litter size reduc viabil reduc testi epididymi weight tubular atrophi offspr fetotox delay ossif eye opac also demonstr new zealand white rabbit loel 30 mg kg day noel 10 mg kg day epa believ suffici evid list fluazifop butyl epcra section 313 pursuant epcra section 313 2 b base avail hepat development toxic data chemic 125 flumetralin 2 chloro n 2 6 dinitro 4 trifluoromethyl phenyl n ethyl 6 fluorobenzenemethanamin ca 062924 70 3 fifra ai ref 3 aquat acut toxic valu flumetralin includ daphnid 48hour ec 50 greater 2 8 ppb bluegil sunfish 96hour lc 50 greater 3 2 ppb rainbow trout 96hour lc 50 greater 3 2 ppb epa believ suffici evid list flumetralin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 126 fluorin ca 007782 41 4 cercla epcra eh rcra app8 rcra p ref 8 inhal fluorin caus initi cough choke chill follow 1 2 day later pulmonari edema fluorin strong caustic action mucou membran eye skin human volunt expos 100 ppm 0 16 mg l 30 second much irrit nose eye report acut inhal studi anim lethal occur fairli uniform level result pulmonari edema follow 1 hour exposur mice rat guinea pig inhal lc 50 valu rang 150 185 ppm 0 23 0 29 mg l lc 50 rabbit follow 30 minut exposur 270 ppm 0 42 mg l epa exposur analysi indic fluorin concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list fluorin epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 127 fluorouracil 5 fluorouracil ca 000051 21 8 cal epcra eh ref 8 major use fluorouracil palli treatment carcinoma colon rectum breast stomach pancrea amen surgeri irradi major toxic effect fluorouracil normal rapidli prolifer tissu particularli bone marrow line gastrointestin tract leukopenia predominantli granulocytopen type thrombocytopenia anemia occur commonli intraven fluorouracil therapi dose rang 6 12 mg kg pancytopenia agranulocytosi also occur development abnorm effect newborn report offspr women receiv 150 240 mg kg fluorouracil intraven week 11 14 20 31 pregnanc addit matern toxic reproduct organ toxic fetu development abnorm report mice rat hamster receiv oral intraperiton intramuscular dose fluorouracil rang 10 700 mg kg chronic neurotox effect note dog fed fluorouracil dietari dose 2 mg kg day 6 month studi anim examin end 3 month 6 month end experi death brain remov examin one dog surviv entir 6month period histolog section brain show presenc larg multipl monolocular vacuol wall fornix third ventricl epa believ suffici evid list fluorouracil epcra section 313 pursuant epcra section 313 2 b base toxic substanc bone marrow development chronic neurotox data chemic 128 fluvalin n 2 chloro 4 trifluoromethyl phenyl dl valin cyano 3 phenoxyphenyl methyl ester ca 069409 94 5 fifra ai ref 3 delay ossif decreas weight length fetus observ offspr rat oral administ 50 mg kg day loel day 6 15 gestat noel 10 mg kg day effect observ dose produc matern toxic curv tibia fibula observ offspr rabbit oral administ 125 mg kg day loel noel 25 mg kg day 2gener reproduct studi decreas pup weight growth observ offspr rat oral administ 5 mg kg day loel noel 1 mg kg day significantli decreas weight surviv observ offspr rat oral administ 25 mg kg day rang find studi dietari administr 50 mg kg day 30 day produc skin lesion rat noel determin 2year rat feed studi termin 64 week due dermal lesion produc anim 15 mg kg day noel 2 mg kg day dietari administr 10 mg kg day loel effect mice 2 year produc scab dermal abras noel effect establish increas plantar ulcer observ rat fed 2 5 mg kg day loel 2 year noel 1 mg kg day decreas bodi weight gain also observ studi base noel studi oral rfd 0 01 mg kg day deriv 2gener rat reproduct studi dietari administr 5 mg kg day produc decreas bodi weight gain skin lesion parent offspr dietari administr 2 5 mg kg day rat 13 week produc anemia blood paramet decreas hematocrit hemaglobin red blood cell noel 1 0 mg kg day dietari administr 30 mg kg day loel rat 3 month produc decreas hemoglobin hematocrit red blood cell count rat noel 3 mg kg day epa believ suffici evid list fluvin epcra section 313 pursuant epcra section 313 2 b base avail development dermal hematolog toxic data chemic aquat acut toxic valu fluvalin includ daphnid 48hour ec 50 0 40 ppb bluegil sunfish 96hour lc 50 0 9 ppb rainbow trout 96hour lc 50 2 9 ppb sheepshead minnow 96hour lc 50 10 8 ppb epa believ suffici evid list fluvin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 129 folpet ca 000133 07 3 cal ref 8 folpet classifi group b2 compound epa e substanc probabl human carcinogen folpet shown induc carcinoma adenoma duodenum sex cd 1 b6c3f1 mice epa believ suffici evid list folpet epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic aquat acut toxic test data folpet includ measur 96hour lc 50 39 ppb rainbow trout measur 96hour lc 50 72 ppb 0 072 ppm bluegil epa believ suffici evid list folpet epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 130 fomesafen 5 2 chloro 4 trifluoromethyl phenoxi n methylsulfonyl 2 nitrobenzamid ca 072178 02 0 fifra ai ref 3 decreas plasma cholesterol triglycerid increas liver weight revers 7 day post treatment observ 50 mg kg day dose test administ diet rat 4 week 90day rat studi dietari administr 5 mg kg day loel produc alter lipid metabol increas liver weight noel 0 25 mg kg day 26 week dog studi dietari administr 25 mg kg day loel produc alter lipid metabol liver chang chang defin noel 1 mg kg day liver toxic increas liver mass discolor hepatocyt pigment kupffer cell observ 2year rat feed studi 50 mg kg day loel noel 5 mg kg day metabol studi shown fomesafen accumul liver epa believ suffici evid list fomesafen epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data chemic 131 alpha hexachlorocyclohexan ca 000319 84 6 cercla cwa ppl fifra sr ref 8 alpha hexachlorocyclohexan classifi epa group b2 compound e substanc probabl human carcinogen although human data limit case report acut leukemia japanes sanit employe follow occup exposur alpha hexachlorocyclohexan ddt alpha hexachlorocyclohexan shown dietari studi caus increas incid liver tumor five mous strain wistar rat epa believ suffici evid list alpha hexachlorocyclohexan epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic measur aquat acut toxic test data alpha hexachlorocyclohexan includ 48hour ec 50 800 ppb daphnid chemic expect bioaccumul aquat system measur bioconcentr factor bcf rainbow trout 1950 epa believ suffici evid list alpha hexachlorocyclohexan epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic potenti bioaccumul 132 hexamethylen 1 6 diisocyan diisocyan categori ca 000822 60 0 caa hap ref 7 hexamethylen 1 6 diisocyan hdi extrem toxic via inhal rout rat lc 50 hdi rang 56 385 mg 3 45 ppm 310 mg 3 mous lc 50 hdi 4 ppm 30 mg 3 hdi also induc irrit upper respiratori tract mice acut exposur mous loael 0 062 ppm 0 43 mg 3 3hour exposur noael establish acut exposur hdi vapor may induc pulmonari irrit rat 60 mg 3 data insuffici gener loael noael effect although data insuffici evalu potenti hdi produc pulmonari hypersensit indirect evid suggest inhal monomer hdi may caus pulmonari sensit addit data insuffici evalu potenti hdi elicit allerg reaction previous sensit anim peopl howev indirect evid suggest inhal monomer hdi may elicit allerg respons e asthma alveol isocyan sensit individu epa exposur analysi indic hdi concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list hexamethylen 1 6 diisocyan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic epa propos list hdi individu chemic epcra section 313 addit unit iv b 144 158 preambl epa propos individu list isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan epcra section 313 altern propos individu list hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan epa propos creat diisocyan categori includ hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan 16 diisocyan epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form chemic select propos categori member diisocyan categori review epa offic pollut prevent toxic categori defin monomer diisocyan molecular weight less equal 300 plu polymer diphenylmethan diisocyan 40 60 percent polymer chemic includ categori base similar chronic acut advers respiratori effect follow chemic propos member epcra section 313 diisocyan categori 1 3 bi methylisocyan cyclohexan ca 038661 72 2 1 4 bi methylisocyan cyclohexan ca 010347 54 3 1 4 cyclohexan diisocyan ca 002556 36 7 diethyldiisocyanatobenzen ca 134190 37 7 4 4 diisocyanatodiphenyl ether ca 004128 73 8 2 4 diisocyanatodiphenyl sulfid ca 075790 87 3 3 3 dimethoxybenzidin 4 4 diisocyan ca 000091 93 0 3 3 dimethyl 4 4 diphenylen diisocyan ca 000091 97 4 3 3 dimethyldiphenylmethan 4 4 diisocyan ca 000139 25 3 hexamethylen 1 6 diisocyan ca 000822 06 0 isophoron diisocyan ca 004098 71 0 4 methyldiphenylmethan 3 4 diisocyan ca 075790 84 0 1 1 methylen bi 4 isocyanatocyclohexan ca 005124 30 1 1 5 naphthalen diisocyan ca 003173 72 6 1 3 phenylen diisocyan ca 000123 61 5 1 4 phenylen diisocyan ca 000104 49 4 polymer diphenylmethan diisocyan ca 009016 87 9 2 2 4 trimethylhexamethylen diisocyan ca 016938 22 0 2 4 4 trimethylhexamethylen diisocyan ca 015646 96 5 diisocyan repres categori chemic may effect mani organ system howev primari toxic target diisocyan upper lower respiratori tract result chronic pulmonari irrit diisocyan also known respiratori dermal sensit agent acut chronic effect may result acut chronic exposur effect may immun non immun mediat epa believ diisocyan list categori isocyan function respons observ chronic pulmonari irrit associ exposur member categori part molecul mitig larg degre observ toxic effect epa believ suffici evid list diisocyan categori epcra section 313 pursuant epcra section 313 2 b base avail toxic data member categori current four diisocyan list epcra section 313 toluen 2 4 diisocyan ca 000584 84 9 toluen 2 6 diisocyan ca 000091 08 7 toluenediisocyan mix isom ca 026471 62 5 methylenebi phenylisocyan ca 000101 68 8 epa intend maintain individu list three toluen diisocyan compound addit effect discuss compound classifi probabl carcinogen epa intend continu individu list diisocyan possibl probabl carcinogen methylenebi phenylisocyan shown carcinogen epa propos remov individu list chemic add diisocyan categori altern propos creation categori final epa request comment altern propos creat diisocyan categori diisocyan includ categori 133 n hexan ca 000110 54 3 caa hap ref 7 epidemiolog studi neurolog abnorm note worker howev neurophysiolog test show mean motor nerv conduct veloc expos group significantli decreas valu control group also residu latenc motor nerv conduct posterior tibial nerv expos group significantli slow compar nonexpos group loael 204 mg 3 58 ppm loael adj 73 mg 3 establish electrophysiolog alter human alter observ consist n hexan induc peripher neuropathi observ studi human anim epa believ suffici evid list n hexan epcra section 313 pursuant epcra section 313 2 b base upon avail neurotox data chemic 134 hexazinon ca 051235 04 2 fifra ai ref 3 2year mous feed studi liver hypertrophi hyperplast nodul focal necrosi observ 375 mg kg day loel noel 30 mg kg day 90day feed studi dog decreas bodi weight increas alkalin phosphatas activ decreas albumin globulin ratio increas absolut rel liver weight note sex 5 000 ppm 125 mg kg day loel noel 1 000 ppm 25 mg kg day epa believ suffici evid list hexazinon epcra section 313 pursuant epcra section 313 2 b base avail toxic data chemic measur aquat acut toxic test data hexazinon includ ec 50 7 ppb capricornutum epa believ suffici evid list hexazinon epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 135 hydramethylnon tetrahydro 5 5 dimethyl 2 1h pyrimidinon 3 4 trifluoromethyl phenyl 1 2 4 trifluoromethyl phenyl ethenyl 2 propenyliden hydrazon ca 067485 29 4 fifra ai ref 3 90day dog feed studi testicular atrophi observ 6 mg kg day loel noel 3 mg kg day 90day rat studi dietari administr 5 mg kg day loel produc testicular atrophi noel 2 5 mg kg day dietari administr 6 5 mg kg day 18 month produc testicular lesion mice noel 2 75 mg kg day 2year rat studi dietari administr 5 mg kg day produc decreas testicular weight testicular atrophi noel 2 5 mg kg day 3 gener rat reproduct studi oral administr 5 mg kg day produc male infertil noel 2 5 mg kg day decreas fetal weight observ offspr rat administ 30 mg kg day loel noel 10 mg kg day increas post implant loss decreas fetal viabil observ offspr rabbit administ 15 mg kg day loel noel 5 mg kg day vertebr anomali seen offspr rabbit administ 10 mg kg day loel noel 5 mg kg day dietari administr 1 mg kg day loel 6 month dog produc increas absolut rel liver weight noel 0 33 mg kg day base noel studi oral rfd 0 0003 mg kg day deriv epa believ suffici evid list hydramethylnon epcra section 313 pursuant epcra section 313 2 b base avail reproduct development hepat toxic data chemic 96hour lc 50 chanel catfish 90 ppb bioaccumul factor bluegil sunfish 1300 whole fish 780 fillet 1900 viscera epa believ suffici evid list hydramethylon epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data potenti bioaccumul 136 hydrochlorofluorocarbon caa od ref 8 hydrochlorofluorocarbon known releas chlorin radic stratospher chlorin radic act catalyst reduc net amount stratospher ozon stratospher ozon shield earth ultraviolet b uv b radiat e 290 320 nanomet decreas total column ozon increas percentag uv b radiat especi harm wavelength reach earth surfac exposur uv b radiat implic laboratori epidemiolog studi caus two type nonmelanoma skin cancer squamou cell cancer basal cell cancer studi predict everi 1 percent increas uv b radiat nonmelanoma skin cancer case would increas 1 3 percent recent epidemiolog studi includ larg case control studi suggest uv b radiat play import role caus malign melanoma skin cancer recent studi predict 1 percent chang uv b intens incid melanoma could increas 0 5 1 percent studi demonstr uv b radiat suppress immun respons system anim possibl human increas exposur uv b radiat like increas incid cataract could advers affect retina aquat organ particularli phytoplankton zooplankton larva mani fish appear suscept harm increas exposur uv b radiat spend least part time near surfac water inhabit increas uv b penetr shown result advers impact plant field studi soybean suggest yield reduct could occur cultivar soybean evid laboratori studi suggest two three cultivar sensit uv b increas uv b radiat reason anticip lead cancer chronic human health effect signific advers environment effect epa believ suffici evid list follow hcfc commerci viabl epcra section 313 pursuant epcra section 313 2 b c epa propos follow hcfc ad individu epcra section 313 dichloropentafluoropropan ca 127564 92 5 1 3 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225ea ca 136013 79 1 2 2 dichloro 1 1 1 3 3 pentafluoropropan hcfc 225aa ca 128903 21 9 1 1 dichloro 1 2 3 3 3 pentafluoropropan hcfc 225eb ca 111512 56 2 1 1 dichloro 1 2 2 3 3 pentafluoropropan hcfc 225cc ca 13474 88 9 1 3 dichloro 1 1 2 2 3 pentafluoropropan hcfc 225cb ca 000507 55 1 1 2 dichloro 1 1 3 3 3 pentafluoropropan hcfc 225da ca 000431 86 7 3 3 dichloro 1 1 1 2 2 pentafluoropropan hcfc 225ca ca 000422 56 0 2 3 dichloro 1 1 1 2 3 pentafluoropropan hcfc 225ba ca 000422 48 0 1 2 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225bb ca 000422 44 6 dichlorofluoromethan hcfc 21 ca 000075 43 4 1 1 1 2 tetrachloro 2 fluoroethan hcfc 121a ca 000354 11 0 1 1 2 2 tetrachloro 1 fluoroethan hcfc 121 ca 000354 14 3 1 2 dichloro 1 1 difluoroethan hcfc 132b ca 001649 08 7 2 chloro 1 1 1 trifluoroethan hcfc 133a ca 000075 88 7 3 chloro 1 1 1 trifluoropropan hcfc 253fb ca 000460 35 5 137 imazalil 1 2 2 4 dichlorophenyl 2 2 propenyloxi ethyl 1h imidazol ca 035554 44 0 fifra ai ref 3 rat teratolog studi increas matern mortal decreas litter size increas number dead fetus observ anim administ 40 mg kg day loel noel 10 mg kg day stillbirth alter live birth index observ rat oral administ 80 mg kg day day 16 22 gestat 21 day post gestat alter lactat index observ rat oral administ 20 mg kg day day 16 22 gestat 21 day post gestat post implant loss observ rabbit oral administ 0 63 mg kg day day 6 18 gestat alter viabil index observ rabbit oral administ 2 5 mg kg day day 6 18 gestat epa believ suffici evid list imazalil epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 138 3 iodo 2 propynyl butylcarbam ca 055406 53 6 fifra ai ref 3 90day rat studi oral administr 50 mg kg day loel produc increas liver bodi weight ratio noel 20 mg kg day 2year rat studi dietari administr 40 80 mg kg day produc signific non neoplast patholog chang stomach noel establish loel 20 mg kg day base studi epa deriv oral rfd 0 07 mg kg day epa believ suffici evid list 3 iodo 2 propynyl butylcarbam epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data chemic 139 iprodion 3 3 5 dichlorophenyl n 1 methylethyl 2 4 dioxo 1 imidazolidinecarboxamid ca 036734 19 7 fifra ai ref 3 increas red blood cell heinz bodi decreas prostat weight loel 15 mg kg day noel 4 2 mg kg day observ dog fed iprodion 1year increas heinz bodi also seen femal 15 mg kg day 90 mg kg day increas liver weight note male femal dog base noel oral rfd 0 04 mg kg day deriv anoth 1year feed studi dog decreas red blood cell count hemoglobin hematocrit level loel 600 ppm 15 mg kg day noel 100 ppm 2 5 mg kg day observ 3 600 ppm 90 mg kg day increas absolut rel liver weight increas liver alkalin phosphatas serum glutam pyruv transaminas serum glutam oxaloacet transaminas lactat dehydrogenas activ note decreas red blood cell count decreas hemoglobin hematocrit level loel 24 6 mg kg day male 26 4 mg kg day femal noel 17 5 mg kg day male 18 4 mg kg day femal epa believ suffici evid list iprodion epcra section 313 pursuant epcra section 313 2 b base avail hematolog hepat toxic data chemic acut aquat toxic data includ green alga 120hour ec 50 21 ppb epa believ suffici evid list iprodion epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 140 iron pentacarbonyl ca 013463 40 6 epcra eh ref 8 human expos high concentr iron pentacarbonyl immedi experi headach dizzi effect follow 12 36 hour exposur symptom fever cyanosi cough short breath human iron pentacarbonyl also known caus advers effect respiratori central nervou system liver kidney rat oral ld 50 25 mg kg rat inhal lc 50 valu 0 044 mg l 4hour inhal lc 100 mice 0 007 mg l rabbit oral ld 50 12 mg kg epa exposur analysi indic iron pentacarbonyl concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list iron pentacarbonyl epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 141 isodrin ca 000465 73 6 cercla epcra eh rcra app8 rcra p ref 8 measur aquat acut toxic data isodrin includ 24hour lc 50 12 ppb bluegil 24hour lc 50 6 ppb minnow epa believ suffici evid list isodrin epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 142 isofenpho 2 ethoxyl 1 methylethyl amino phosphinothioyl oxi benzoic acid 1 methylethyl ester ca 025311 71 1 fifra ai ref 3 108week feed studi mice inhibit brain cholinesteras loel 100 ppm 13 mg kg day noel 10 ppm 1 3 mg kg day plasma cholinesteras loel 10 ppm 1 3 mg kg day noel 0 13 mg kg day observ inhibit red blood cell cholinesteras loel 10 ppm 0 5 mg kg day noel 1 ppm 0 05 mg kg day seen 2year feed studi rat studi 14 90day feed studi dog 30 90day studi rat 3week inhal studi rat also demonstr cholinesteras plasma red blood cell brain inhibit rat dog epa believ suffici evid list isophenpho epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic aquat acut toxic valu isofenpho includ daphnid 48hour ec 50 1 6 ppb mysid 96hour ec 50 1 7 ppb epa believ suffici evid list isofenpho epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 143 isophoron ca 000078 59 1 caa hap ref 7 isophoron shown caus neurotox effect human expos atmospher concentr 5 8 ppm expos 1 month worker complain fatigu malais neurotox also observ human follow acut exposur 40 85 ppm effect includ nausea headach dizzi faint inebri feel suffoc increas exposur concentr result increas sever symptom irrit central nervou system cn depress observ concentr 200 400 ppm epa believ suffici evid list isophoron epcra section 313 pursuant epcra section 313 2 b base avail neurotox data chemic 144 isophoron diisocyan ca 004098 71 9 tsca ref 8 4hour inhal lc 50 valu isophoron diisocyan rat 0 123 mg l rat mous 3hour inhal rd 50 50 percent reduct respiratori rate valu 0 0046 mg l 0 0019 mg l respect 50year old man develop sever asthma exposur unspecifi amount paint contain isophoron diisocyan 1hour exposur unspecifi amount compound caus eczema three four worker addit isocyan class gener sever skin eye respiratori irrit epa exposur analysi indic isophoron diisocyan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list isophoron diisocyan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic detail unit iv b 132 preambl altern propos individu list hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan epa propos creat diisocyan categori includ hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan 16 diisocyan 145 lactofen 5 2 chloro 4 trifluoromethyl phenoxi 2 nitro 2 ethoxi 1 methyl 2 oxoethyl ester ca 077501 63 4 fifra ai ref 3 lactofen meet criteria epa group b2 compound e probabl human carcinogen conclus base increas incid hepatocellular carcinoma male combin incid hepatocellular adenoma carcinoma sex cd 1 mice follow dietari administr lactofen cd rat increas incid liver neoplast nodul sex four structur similar chemic acifluorfen nitrofen oxyfluorfen fomesafen produc hepatocellular tumor rodent result sever subchron chronic studi indic liver kidney target organ lactofen increas absolut rel liver weight hepatocytomegali loel 1 5 mg kg day noel determin observ male mice fed lactofen 78 week 37 5 mg kg day also increas incid cataract renal pigment base loel oral rfd 0 002 mg kg day deriv renal dysfunct decreas hemoglobin hematocrit level red blood cell count loel 25 75 mg kg day noel 5 mg kg day observ 1year feed studi dog increas renal hepat pigment loel 50 mg kg day noel 25 mg kg day note 2year feed studi rat 90day mous studi increas alkalin phosphatas serum glutam oxaloacet transaminas sgot serum gleutan pyruv transaminas sgpt activ increas liver weight hepat necrosi biliari hyperplasia decreas hematocrit hemoglobin level red blood cell count extramedullari hematopoiesi kidney nephrosi fibrosi loel 26 mg kg day noel determin seen decreas hemoglobin hematocrit level decreas red blood cell count brown pigment kidney liver loel 50 mg kg day note 90day feed studi rat epa believ suffici evid list lactofen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data hepat renal hematolog toxic data chemic 146 linuron ca 000330 55 2 fifra sr ref 8 appear sulfhemoglobin blood dog rat mice expos linuron report fact avail anim data feed studi variou durat 30 day 2 year linuron well studi structur similar urea base herbicid indic presenc sulfhemoglobin abnorm blood pigment morpholog chang red blood cell provid sensit indic exposur linuron 2year feed studi beagl dog loael base presenc sulfhemoglobin 0 625 mg kg day lowest dose test red blood cell count decreas dog expos higher dose linuron epa deriv oral rfd 0 002 mg kg day linuron studi similar find report two separ 2year rat feed studi one studi loael 31 25 mg kg day noael 6 25 mg kg day valu base spleen bone marrow chang indic hemolysi increas mortal growth retard 2year rat studi loael 2 5 mg kg day lowest dose test base decreas red blood cell count reticulocytosi elev sulfhemoglobin level report rat expos littl 30 day 150 mg kg day exposur level also caus sever growth retard increas mortal loael decreas bodi weight gain 15 mg kg day noael 3 mg kg day chronic administr linuron 4 mg kg day rat caus hypochrom anemia decreas cholinesteras peroxidas activ blood loael 31 25 mg kg day establish 3gener reproduct toxic studi linuron diet caus reduc weanl weight reduc liver kidney weight liver atrophi reduc pup surviv separ development toxic studi rat administ linuron oral loael 31 25 mg kg day base increas incid fetal resorpt loael matern toxic studi 6 25 mg kg day noael 2 50 mg kg day base decreas food consumpt decreas bodi weight gain oral teratolog studi rabbit indic loael 5 mg kg day lowest dose test base decreas fetal bodi weight decreas litter size increas skull malform epa believ suffici evid list linuron epcra section 313 pursuant epcra section 313 2 b base hematolog development toxic data chemic 147 lithium carbon ca 000554 13 2 cal ref 8 major use lithium carbon treatment manic episod manic depress ill decreas number implant number live fetus fetal bodi weight increas resorpt variou limb skelet anomali report offspr wistar rat receiv 100 mg kg fetotox loel fetotox noel 50 mg kg gestat day 6 15 offspr mice receiv 465 mg kg day gestat day 6 15 increas craniofaci abnorm fetal death reduct litter size also note epa believ suffici evid list lithium carbon epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 148 malathion ca 000121 75 5 cercla ref 8 malathion phosphorothio insecticid insecticid properti due cholinesteras inhibit 42year old woman ingest minimum 120 ml 50 percent solut approxim 850 mg kg quickli becam comatos cyanot flaccid devoid tendon reflex miotic serum cholinesteras activ 22 percent normal 9 day red blood cell cholinesteras activ 10 25 percent normal 45 day thirti five case poison ingest report india symptom observ cyanosi excess saliv pinpoint pupil pulmonari edema electrocardiograph abnorm indic cholinesteras inhibit autopsi fatal indic damag myocardium 56day studi men oral administ malathion noel neurotox effect 0 23 mg kg day loel 0 34 mg kg day plasma red blood cell cholinesteras inhibit observ 0 34 mg kg day howev clinic sign overt toxic note dose base noel epa deriv oral rfd 0 02 mg kg day chemic cholinesteras inhibit symptom also observ experiment anim expos malathion epa believ suffici evid list malathion epcra section 313 pursuant epcra section 313 2 b base chronic neurotox data chemic measur aquat acut toxic data malathion includ 96hour lc 50 68 ppb rainbow trout 96hour lc 50 51 ppb sheepshead minnow 96hour lc 50 76 ppb lake trout addit measur 48hour ec 50 daphnid 0 9 ppb epa believ suffici evid list malathion epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 149 man made miner fiber categori caa hap ref 7 man made miner fiber synthet amorph noncrystallin fiber consist three major group glass fiber miner wool fiber includ mainli rock wool slag wool refractori ceram fiber health concern fiber base morpholog toxicolog similar asbesto known human carcinogen caus lung cancer mesothelioma human non malign respiratori diseas e g lung fibrosi inject studi glass wool glass microfib directli place respiratori airway pleural abdomin caviti laboratori anim shown consist evid carcinogenesi experiment studi shown evid carcinogenesi inject rock wool slag wool iarc classifi glass wool rock wool slag wool fiber group 2b compound e possibl human carcinogen epa classifi refractori ceram fiber group b2 compound e probabl human carcinogen epa believ suffici evid list man made miner fiber categori epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data fiber epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form epa consid number option list man made miner fiber epcra section 313 1977 nation institut occup safeti health niosh recommend exposur fiber limit 3 fiber per cubic centimet f cc fiber less 3 5 micromet diamet longer 10 micromet length niosh sinc comment order protect worker lung cancer necessari lower exposur 0 2 f cc fibrou glass 1992 occup safeti health administr osha propos 1 f cc 8hour time weight averag twa limit respir fiber fibrou glass includ refractori ceram fiber respir fiber gener defin fiber diamet less 3 5 micromet whose length least 3 time diamet e aspect ratio fiber length divid fiber diamet 3 greater order eas burden report epa consid list fiber base aspect ratio simpli discrimin particl fiber howev seem overli inclus would cover nonrespir well respir fiber epa also consid use diamet criteria without aspect ratio option also appear inclus sinc may includ particl well fiber epa propos list man made miner fiber categori includ glass microfib glass wool fiber rock wool fiber slag wool fiber refractori ceram fiber diamet less 3 5 micromet aspect ratio greater 3 definit consist niosh osha recommend limit fiber respir epa request comment definit man made miner fiber option defin fiber categori 150 mecoprop ca 000093 65 2 iarc ref 8 mecoprop mono chloro mono methylphenoxi isopropano acid type herbicid iarc assign mecoprop group 2b e possibl carcinogen human sever anim studi chang liver kidney weight sensit indic mecoprop toxic 90day rat feed studi loael 9 mg kg day noael 3 mg kg day 26 mg kg day chang organ weight accompani decreas glucos level male increas creatinin level femal epa deriv oral rfd 0 001 mg kg day studi epa believ suffici evid list mecoprop epcra section 313 pursuant epcra section 313 2 b base hepat renal toxic data chemic 151 2 mercaptobenzothiazol mbt ca 000149 30 4 tsca ref 8 21day maximum accept toxic concentr matc daphnid rang 240 470 ppb 60 day matc rainbow trout rang 41 78 ppb epa exposur analysi indic releas 2 mercaptobenzothiazol result concentr level reason anticip caus signific advers environment effect epa believ suffici evid list 2 mercaptobenzothiazol epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data exposur data chemic 152 merpho ca 000150 50 5 fifra sr ref 8 merpho thiophosph type cholinesteras inhibitor delay neurotox effect report 28 year old man follow accident exposur chemic period 3 day fourteen day later develop complet facial diplegia decreas conduct veloc nerv fiber recov complet immedi delay neurotox effect follow exposur merpho report experiment anim 3month hen feed studi noel neurotox effect 0 1 mg kg day loel 0 5 mg kg day 0 5 mg kg hen show delay neurotox ataxia equivoc chang spinal cord peripher nerv base noel epa deriv oral rfd 0 00003 mg kg day chemic 112 day rat feed studi femal show red blood cell cholinesteras inhibit loel 0 25 mg kg day noel 0 1 mg kg day 90day rat feed studi anim show reduc brain cholinesteras activ loel 3 8 mg kg day noel 1 8 mg kg day 90day dog feed studi plasma cholinesteras inhibit observ loel 2 5 mg kg day noel 0 75 mg kg day fourteen cattl 20 sheep administ singl dose merpho 25 200 mg kg 10 daili dose merpho 2 5 mg kg day show emaci diarrhea depress blood cholinesteras ingest merpho rapidli metabol n butyl mercaptan within gastrointestin tract n butyl mercaptan shown respons acut neurotox effect merpho thu oral exposur merpho expect caus acut neurotox symptom dermal exposur merpho expect caus delay neurotox symptom epa believ suffici evid list merpho epcra section 313 pursuant epcra section 313 2 b base chronic neurotox data chemic 153 metham sodium sodium methyldithiocarbam ca 000137 42 8 fifra ai ref 3 postimplanat loss observ rabbit administ metham sodium 30 mg kg day loel day 6 18 gestat noel 10 mg kg day 4 2 mg kg day base activ ingredi rat fed metham sodium increas variat retard anomali report dose 10 mg kg day loel administ day 6 15 noel less equal 10 mg kg day less equal 4 2 mg kg day base activ ingredi although neither studi consid fulli adequ due studi design report defici weight evid indic metham sodium induc development toxic addit metham sodium metabol carbon disulfid potent development toxic epa believ suffici evid list metham sodium epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic metabolit carbon disulfid 154 methazol 2 3 4 dichlorophenyl 4 methyl 1 2 4 oxadiazolidin 3 5 dion ca 020354 26 1 fifra ai ref 3 rabbit receiv 30 60 mg kg day gavag day 6 18 gestat exhibit increas embryoleth noel 10 mg kg day epa believ suffici evid list methazol epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 155 methiocarb ca 002032 65 7 cercla epcra eh ref 8 measur terrestri acut toxic data wildlif includ oral ld 50 4 6 mg kg red wing blackbird epa believ suffici evid list methiocarb epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 156 methoxon 4 chloro 2 methylphenoxi acet acid mcpa ca 000094 74 6 fifra sr iarc ref 8 methoxon chlorophenoxi type herbicid anim studi indic kidney liver primari target organ methoxon toxic beagl dog fed diet contain methoxon 1year develop liver toxic demonstr increas liver weight associ alter serum glutam pyruv transaminas serum glutam oxaloacet transaminas bilirubin triglycerid cholesterol level effect occur dose 0 75 mg kg day loael higher noael 0 15 mg kg day kidney chang treat anim includ deposit kidney pigment proxim tubular epithelium loael 0 75 mg kg day noael 0 15 mg kg day accompani alter creatinin urea potassium level epa deriv oral rfd 0 0005 mg kg day studi similar chang suggest liver kidney toxic report anoth 90day dog feed studi loael 3 mg kg day noael 1 mg kg day rat 90day feed studi loael 7 5 mg kg day noael 2 5 mg kg day epa believ suffici evid list methoxon epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data chemic 157 methoxon sodium salt 4 chloro 2 methylphenoxi acet sodium salt ca 003653 48 3 fifra sr iarc ref 8 methoxon sodium salt chlorophenoxi type herbicid anim studi indic kidney liver primari target organ methoxon toxic beagl dog fed diet contain methoxon 1year develop liver toxic demonstr increas liver weight associ alter serum glutam pyruv transaminas serum glutam oxaloacet transaminas bilirubin triglycerid cholesterol level effect occur dose 0 75 mg kg day loael higher noael 0 15 mg kg day kidney chang treat anim includ deposit kidney pigment proxim tubular epithelium loael 0 75 mg kg day noael 0 15 mg kg day accompani alter creatinin urea potassium level epa deriv oral rfd 0 0005 mg kg day studi similar chang suggest liver kidney toxic report anoth 90day dog feed studi loael 3 mg kg day noael 1 mg kg day rat 90day feed studi loael 7 5 mg kg day noael 2 5 mg kg day epa believ suffici evid list methoxon sodium salt epcra section 313 pursuant epcra section 313 2 b base potenti caus cancer avail hepat renal toxic data chemic 158 1 1 methylen bi 4 isocyanatocyclohexan ca 005124 30 1 tsca ref 8 5hour rat inhal lc 50 valu 1 1 methylenebi 4 isocyanatocyclohexan 0 21 mg l 3hour mous inhal rd 50 50 percent reduct respiratori rate valu 0 027 mg l addit isocyan class gener sever skin eye respiratori irrit epa exposur analysi indic 1 1 methylenebi 4 isocyanatocyclohexan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list 1 1 methylenebi 4 isocyanatocyclohexan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic detail unit iv b 132 preambl altern propos individu list hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan epa propos creat diisocyan categori includ hdi isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan 16 diisocyan 159 methylen bi thiocyan ca 006317 18 6 fifra ai ref 3 minim human lethal dose methylen bi thiocyan 15 30 g 214 429 mg kg although fatal report 300 mg 4 3 mg kg clinic effect may includ decreas blood pressur apnea cerebr excit convuls coma vomit diarrhea abdomin cramp albuminuria skin rash exfoli dermat muscl weak goiter toxic psychosi intraven mous ld 50 3 6 mg kg subcutan rabbit dlo 20 mg kg convuls lower blood pressur observ studi epa believ suffici evid list methylen bi thiocyan epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic 160 methyl isothiocyan ca 00556 61 6 fifra ai ref 3 aquat acut toxic valu methyl isothiocyan includ fish 96hour lc 50 94 ppb 96hour lc 50 130 ppb bluegil daphnid 48hour lc 50 55 ppb epa believ suffici evid list methyl isothiocyan epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 161 2 methyllactonitril ca 000075 86 5 cercla epcra eh rcra app8 rcra p ref 8 2 methyllactonitril belong class substanc known cyanohydrin cyanohydrin gener quit toxic releas hydrogen cyanid oral dose 5 mg rat approxim 14 mg kg 2 methyllactonitril administ twice weekli 3 8 month produc liver kidney lesion inhal 10 2 mg l twice weekli 3 8 month durat individu exposur report produc kidney lesion desquam bronchial epithelium bronchial ulcer epa believ suffici evid list 2 methyllactonitril epcra section 313 pursuant epcra section 313 2 b base chronic toxic effect liver kidney bronchi caus chemic 162 n methylolacrylamid ca 000924 42 5 cal ref 8 clear evid carcinogen n methylolacrylamid 2year studi use b6c3f1 mice administ substanc oral gavag sex increas incid harderian gland adenoma carcinoma hepatocellular adenoma carcinoma alveolar bronchiolar adenoma carcinoma also increas ovarian granulosa cell tumor epa believ suffici evid list n methylolacrylamid epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 163 methyl parathion ca 000298 00 0 cercla fifra sr rcra app8 rcra p ref 8 methyl parathion thiophosph type cholinesteras inhibitor methyl parathion highli toxic administ experiment anim low dose rat mous oral ld 50 valu report 6 01 mg kg 18 mg kg respect rat mous 4 hour inhal lc 50 valu report 0 034 mg l 0 12 mg l respect symptom cholinesteras inhibit observ human volunt show 37 percent decreas red blood cell cholinesteras activ follow oral administr 0 43 mg kg day methyl parathion 10 day loel 0 43 mg kg day noel 0 31 mg kg day 90day dog feed studi brain red blood cell plasma cholinesteras inhibit observ loel 1 0 mg kg day noel 0 3 mg kg day chronic rat feed studi plasma erythrocyt cholinesteras inhibit throughout studi brain cholinesteras depress termin studi 2 5 mg kg day noel system toxic 0 025 mg kg day adequ noel neurolog chang defin overt sign cholinerg toxic tremor abnorm gait alopecia observ anim dose 2 5 mg kg day histolog examin reveal evid peripher neuropathi anim administ dose epa deriv oral rfd 0 00025 mg kg day base system noel chemic hepatocellular swell degener fatti chang observ human acut intox methyl parathion hepatocellular chang observ patient surviv 28 hour 9 day intox methyl parathion oral administ rat increas dose 36 day start 0 37 mg kg day increas factor 1 5 everi 4th day weight loss hyperglycemia macrocyt anemia secondari hepatotox observ epa believ suffici evid list methyl parathion epcra section 313 pursuant epcra section 313 2 b base chronic neurotox hepat toxic data chemic measur aquat acut toxic data methyl parathion includ 48hour ec 50 0 14 ppb daphnid 96hour lc 50 15 ppb crayfish epa believ suffici evid list methyl parathion epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 164 n methyl 2 pyrrolidon ca 000872 50 4 tsca ref 8 2gener reproduct studi evid reproduct toxic f 1 gener exposur 50 mg kg day loael noael establish exposur 50 mg kg day result signific reduct male fertil index femal fecund index addit exposur 500 mg kg day result increas incid dam decreas corpora lutea also evid development toxic gener exposur 500 mg kg day demonstr reduc litter size reduc postnat surviv reduc pup weight matern toxic signific reduct mean bodi weight gain observ rabbit receiv 175 mg kg gavag day 6 18 gestat noael 55 mg kg day exposur 540 mg kg day loael result development toxic demonstr signific increas resorpt malform misshapen skull bone cardiovascular malform noael development toxic 175 mg kg day epa believ suffici evid list n methylpyrrolidon epcra section 313 pursuant epcra section 313 2 b base avail development reproduct toxic data chemic 165 methyltrichlorosilan ca 000075 79 6 epcra eh ref 8 class chlorin silan corros skin mucou membran liber hydrochlor acid presenc water methyltrichlorosilan caus sever burn vapor harm human 2hour mous inhal lc 50 valu 0 180 mg l epa exposur analysi indic methyltrichlorosilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list methyltrichlorosilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 166 metiram ca 009006 42 2 fifra sr ref 8 metiram ethylen bisdithiocarbam ebdc fungicid evid suggest ethylen bisthiocarbam fungicid ethylenethiourea common contamin metabolit degrad product fungicid caus cancer advers development effect experiment anim 2year diet studi ethylenethiourea caus liver adenoma carcinoma mice thyroid follicular cell adenoma carcinoma mice rat noael less equal 5 mg kg report ethylenethiourea base rat development toxic studi ethylenethiourea caus delay ossif harden pariet bone pup epa believ suffici evid list metiram epcra section 313 pursuant epcra section 313 2 b base carcinogen development toxic data ethylenethiourea metabolit degrad product metiram unit iv b 172 preambl epa propos add anoth ethylen bisdithiocarbam ebdc nabam addit two ebdc zineb maneb current individu list epcra section 313 list toxic chemic categori ebdc recent ad epcra section 313 decemb 1 1993 58 fr 63500 epa request comment follow 1 individu ebdc metiram nabam ad individu epcra section 313 even though member ebdc categori list epcra section 313 2 individu list two ebdc zineb maneb delet ad member newli creat ebdc categori 167 metribuzin ca 021087 64 5 fifra ai ref 3 rabbit teratolog studi noel matern fetotox 15 mg kg day loel 45 mg kg day development effect includ irregular spinu process decreas pup bodi weight observ rat treat metribuzin sencor gestat day 7 19 85 mg kg day loel noel development toxic 30 mg kg day loel noel matern toxic 30 10 mg kg day respect 2year dog feed studi advers effect observ 1 500 ppm 37 5 mg kg day loel includ weight reduct increas mortal hematolog chang liver kidney damag system noel 100 ppm 2 5 mg kg day 2year rat feed studi decreas weight gain mortal patholog chang liver kidney observ 300 ppm 15 mg kg day noel 100 ppm 5 mg kg day epa believ suffici evid list metribuzin epcra section 313 pursuant epcra section 313 2 b base avail hepat renal development toxic data chemic 168 mevinpho ca 007786 34 7 cercla epcra eh ref 8 measur aquat acut toxic valu mevinpho includ 96hour lc 50 70 ppb bluegil 96hour lc 50 0 16 ppb daphnid measur acut avian toxic data includ pheasant oral ld 50 1 37 mg kg mallard duck oral ld 50 4 63 mg kg sharp tail grous oral ld 50 1 34 mg kg epa believ suffici evid list mevinpho epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 169 molin 1h azepin 1 carbothio acid hexahydro ethyl ester ca 002212 67 1 fifra ai ref 3 rat development toxic studi advers effect observ follow administr molin 35 mg kg day loel includ increas post implant loss lower fetal bodi weight increas incid runt extern soft tissu skelet variant noel 2 2 mg kg rabbit development studi advers effect increas number abort decreas number femal live fetus note 200 mg kg day noel 20 mg kg day development effect observ level toxic matern anim rat fertil test reduct fertil dose relat alter sperm morpholog reduct number viabl fetus observ follow administr molin noel 0 2 mg kg day loel 4 mg kg day base noel studi oral rfd 0 002 mg kg day deriv 90day studi male rat lowest toxic oral dose 324 mg kg produc advers effect spermatogenesi male fertil viabil index 20day inhal male rat lowest toxic contentr tclo 0 0006 mg l exposur level advers effect spermatogenesi male fertil index report 2 gener rat reproduct studi reproduct noel 0 3 mg kg day loel 2 5 mg kg day base reduc fecund increas incid ovarian vacuol hypertrophi 3month rat inhal studi testicular degener abnorm spermatozoa observ 0 002 mg l loel noel determin 2year studi rat fed molin advers effect seen 0 35 mg kg day includ degener demyelin sciatic nerv skelet muscl atrophi reserv cell hyperplasia noel determin 1year studi dog administ molin oral advers effect observ 50 mg kg day includ anemia loss abil bark ataxia splay hind limb vacuol medulla demyelin pon spinal cord tremor eosinophil bodi nervou system epa believ suffici evid list molin epcra section 313 pursuant epcra section 313 2 b base avail development reproduct neurolog toxic data chemic 170 monuron ca 000150 68 5 fifra sr ref 8 measur aquat toxic data monuron includ 1 5 hour ec 50 90 ppb 10 day ec 50 100 ppb marin alga epa believ suffici evid list monuron epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 171 myclobutanil alpha butyl alpha 4 chlorophenyl 1h 1 2 4 triazol 1 propanenitril ca 088671 89 0 fifra ai ref 3 hepatocellular hypertrophi loel 5 9 mg kg day noel 0 3 mg kg day seen 90day feed studi dog anoth 90day feed studi hepatocellular necrosi hypertrophi loel 147 2 mg kg day noel 49 1 mg kg day observ rat hepatocellular hypertrophi loel 14 3 mg kg day male 15 7 mg kg day femal noel 3 1 mg kg day male 3 83 mg kg day femal note 1year feed studi dog hepat effect centrilobular hepatocyt hypertrophi kupffer cell pigment periport vacuol alter foci observ mice fed 75 mg kg day myclobutanil 2 year 15 mg kg day increas liver mix function oxidas noel 3 mg kg day also seen testicular atrophi loel 9 84 mg kg day noel 2 49 mg kg day observ 2year chronic feed studi rat seminifer tubul frequent devoid spermatid format germin epitheli cell base noel oral rfd 0 025 mg kg day deriv testicular atrophi loel 46 4 mg kg day noel 9 28 mg kg day also note 2 gener reproduct studi development toxic studi rat increas resorpt decreas viabil observ 93 8 mg kg day loel noel 31 3 mg kg day development toxic studi rabbit increas number resorpt per litter reduc viabil index reduc litter size observ 200 mg kg day loel noel 60 mg kg day epa believ suffici evid list myclobutanil epcra section 313 pursuant epcra section 313 2 b base avail hepat reproduct development toxic data chemic 172 nabam ca 000142 59 6 fifra sr ref 8 nabam ethylen bisthiocarbam fungicid evid suggest ethylen bisthiocarbam fungicid ethylenethiourea common contamin metabolit degrad product fungicid caus cancer advers development effect experiment anim 2year diet studi ethylenethiourea caus liver adenoma carcinoma mice thyroid follicular cell adenoma carcinoma mice rat noael less equal 5 mg kg report ethylenethiourea base rat development toxic studi ethylenethiourea caus delay ossif harden pariet bone pup epa believ suffici evid list nabam epcra section 313 pursuant epcra section 313 2 b base carcinogen development toxic data ethylenethiourea metabolit degrad product nabam 173 nale ca 000300 76 5 cercla fifra sr ref 8 nale organophosph type cholinesteras inhibitor human acut poison case toxic symptom includ abdomin cramp hypersecret emesi perspir anxieti vertigo horizont nystagmu persist 4 month 2year rat feed studi noel neurotox effect 0 2 mg kg day loel 2 0 mg kg day observ studi 2 0 mg kg day brain cholinesteras activ inhibit approxim 24 percent 10 0 mg kg day brain cholinesteras activ inhibit approxim 60 percent plasma red blood cell cholinesteras also inhibit base noel epa oral rfd 0 002 mg kg day chemic 1 year feed studi use dog test speci plasma red blood cell cholinesteras activ inhibit 2 0 mg kg day noel 0 2 mg kg day loel 2 0 mg kg day 2 gener reproduct studi nale rat noel 6 mg kg day 18 mg kg day decreas litter size surviv pup bodi weight observ epa believ suffici evid list nale epcra section 313 pursuant epcra section 313 2 b base chronic neurotox reproduct toxic data chemic measur aquat acut toxic valu nale includ 48hour ec 50 0 35 ppb daphnid 96hour lc 50 87 ppb lake trout epa believ suffici evid list nale epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 174 nicotin salt cal cercla epcra eh fifra ai rcra app8 rcra p ref 8 nicotin salt dissoci aqueou solut yield solubl nicotin nicotin highli toxic human estim lethal oral dose adult approxim 40 60 mg onset toxic rapid symptom includ nausea saliv abdomin pain vomit diarrhea headach weak sweat confus nicotin markedli stimul central nervou system caus tremor convuls stimul follow depress death result paralysi respiratori muscl nicotin also activ parasympathet ganglia cholinerg nerv end result gastrointestin hyperact skelet defect occasion cleft palat observ mice inject 25 mg kg nicotin gestat day 9 11 reduc size newborn rat limb deform offspr swine report swine rat follow oral exposur 1 058 ppm nicotin approxim 53 mg kg day deform found rabbit fetus dam administ nicotin dose 20 mg kg 5 time pregnanc pregnant swine fed aqueou leaf extract tobacco rate 16 32 mg kg nicotin produc arthrogrypot newborn pig epa believ suffici evid list nicotin salt categori epcra section 313 pursuant epcra section 313 2 b base development toxic data substanc epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form 175 nitrapyrin 2 chloro 6 trichloromethyl pyridin ca 001929 82 4 fifra ai ref 3 1year studi dog fed nitrapyrin advers effect note includ increas cholesterol alkalin phosphatas increas absolut rel liver weight panlobular centrilobular hepatocellular hypertrophi noel 3 mg kg day loel 15 mg kg day 10week reproduct rat studi advers effect observ includ increas incid fetal liver hypertrophi vacuol 75 mg kg day loel noel 20 mg kg day 90day rat feed studi hepatocellular fatti chang necrosi renal tubul epitheli cell swell increasingli sever interstiti nephriti observ 50 mg kg day noel 15 mg kg day 2year rat feed studi increas glomerulonephropathi observ male dose 60 mg kg day increas hepat hypertrophi vacuol observ male femal dose 60 mg kg day noel 20 mg kg day increas incid crook hyoid bone craniofaci abnorm observ offspr rabbit oral administ nitrapyrin 30 mg kg day loel day 6 18 gestat noel 10 mg kg day decreas weight hypertrophi vacuol liver observ offspr rat dose 75 mg kg day loel 10 week prior mate noel 20 mg kg day epa believ suffici evid list nitrapyrin epcra section 313 pursuant epcra section 313 2 b base avail renal hepat development toxic data chemic 176 nitrat ion ca 014797 55 8 sdwa ref 8 nitrat refer nitrat ion 3 infantil methemoglobinemia occur human infant expos aqueou solut nitrat ion progress cyanosi death base numer epidemiolog clinic studi epa determin loael 1 8 3 2 mg kg day noael rfd 1 6 mg kg day correspond 10 mg l nitrat nitrogen 44 mg l nitrat ion drink water infant weigh averag 4 kg 0 3 month age sensit popul nitrat induc methemoglobinemia primarili due higher stomach ph favor growth nitrat reduc bacteria immatur metabol enzym system reduc capac erythrocyt reduc methemoglobin hemoglobin epa believ suffici evid list nitrat ion epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data chemic nitrogen limit water nitrat potenti caus increas algal growth lead eutroph aquat environ nitrat nitrogen form nitrogen avail plant studi estuarin water sever locat along eastern coast unit state indic low concentr dissolv nitrogen e g nitrat limit primari product plant addit nitrat estuarin system stimul primari product plant produc chang domin speci plant lead cultur eutroph ultim deterior water qualiti includ algal bloom determin lake spring maximum concentr 300 ug l inorgan nitrogen e g nitrat could expect algal nuisanc summer toxic effect result oxygen deplet alga die decay toxic effect also relat releas decay product direct excret toxic substanc sourc blue green alga epa believ suffici evid list nitrat ion epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 177 nitric oxid ca 010102 43 9 cercla epcra eh rcra app8 rcra p ref 8 acut toxic nitric oxid rate high nitric oxid caus death perman injuri short exposur small quantiti exposur nitric oxid result acut chronic chang pulmonari system includ pulmonari edema pneumon bronchiti bronchiol emphysema methemoglobinemia neurolog effect fatigu restless anxieti mental confus lethargi loss conscious also report effect nitric oxid may relat format methemoglobin epa believ suffici evid list nitric oxid epcra section 313 pursuant epcra section 313 2 b base avail neurolog hematolog toxic data chemic 178 p nitroanilin ca 000100 01 6 cercla rcra app8 rcra p ref 8 14day studi mice fed p nitroanilin dose low 10 mg kg 5 day per week methemoglobin concentr found significantli higher control anim studi hematocrit valu mice receiv 300 mg kg total erythrocyt count mice receiv 100 300 mg kg significantli lower control anim similar effect observ 13week 2year mous studi 2year studi lesion relat administr p nitroanilin occur spleen liver bone marrow primarili mice receiv 30 100 mg kg observ 9 15 month addit increas incid sever splenic congest hematopoiesi pigment hemosiderin accumul kupffer cell pigment liver bone marrow hypercellular hyperplasia epa believ suffici evid list p nitroanilin epcra section 313 pursuant epcra section 313 2 b base chronic toxic data chemic 179 nitrogen dioxid ca 010102 44 0 cercla epcra eh rcra app8 rcra p ref 8 acid precipit occur larg region eastern unit state canada europ japan widespread occurr acid precipit dri deposit result larg part man made emiss oxid sulfur nitrogen e g nitrogen dioxid substanc transform atmospher sulfur acid nitric acid transport great distanc deposit veget soil surfac water materi substanc transfer atmospher ecosystem absorpt gase impact gravit settl fine aerosol coars particl precipit acid contain pollut snow releas contamin meltwat result releas pollut caus major rapid chang acid stream lake water interfer normal reproduct fish popul induc acid lake stream water reproduct frog salamand also inhibit atmospher acidif surfac water atmospher deposit sulfur acid nitric acid caus seriou damag crop forest biolog effect includ induct necrot lesion loss nutrient due leach foliar organ acceler eros wax leaf surfac interfer normal reproduct process acidif also decreas rate mani soil process nitrogen fixat breakdown organ matter epa believ suffici evid list nitrogen dioxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic nitrogen dioxid regul titl caa provis attain mainten nation ambient air qualiti standard addit propos add nitrogen dioxid epcra section 313 unit iv b 36 235 epa propos add two chemic carbon monoxid sulfur dioxid regul titl caa sulfur dioxid also regul titl iv caa acid deposit control extens data highli technic collect chemic requir caa epa request comment follow 1 inform collect caa suffici public right know purpos 2 suggest data collect chemic pursuant caa titl iv could use meet purpos epcra section 313 180 norflurazon 4 chloro 5 methylamino 2 3 trifluoromethyl phenyl 3 2h pyridazinon ca 027314 13 2 fifra ai ref 3 congest liver hepatocyt swell increas liver weight increas colloid vacuol thyroid observ dog fed 450 ppm 10 25 mg kg day norflurazon 6 month noel 150 ppm 3 75 mg kg day oral rfd 0 04 mg kg day determin increas rel liver weight hypertrophi thyroid deplet colloid seen rat fed 2 500 ppm 125 mg kg day norflurazon 90 day noel 500 ppm 25 mg kg day hepat hyperplasia hypertrophi increas rel liver weight note 28day feed studi rat loel 1 000 ppm 50 mg kg day noel 500 ppm 25 mg kg day increas rel liver weight diffus smooth granular liver seen 28day feed studi mice loel 2 520 ppm 328 mg kg day noel 420 ppm 55 mg kg day epa believ suffici evid list norflurazon epcra section 313 pursuant epcra section 313 2 b base avail hepat thyroid toxic data 181 oryzalin 4 dipropylamino 3 5 dinitrobenzen sulfonamid ca 019044 88 3 fifra ai ref 3 reduc hemoglobin hematocrit level decreas red blood cell count increas blood urea nitrogen bun alkalin phosphatas sgpt anemia hepat chang splenic hematopoiesi hyperplast bone marrow observ dog fed 56 25 mg kg day noel 18 75 mg kg day 3 month increas serum cholesterol level alkalin phosphatas activ rel liver kidney weight decreas alanin transaminas loel 50 mg kg day noel 5 mg kg day observ dog fed oryzalin 1year decreas red blood cell count hematocrit hemoglobin level loel 45 mg kg day noel 15 mg kg day note 1 year feed studi rat 2year feed studi rat decreas red blood cell count hematocrit hemoglobin level increas bun liver kidney weight loel 45 mg kg day noel 15 mg kg day observ epa believ suffici evid list oryzalin epcra section 313 pursuant epcra section 313 2 b base avail hepat hematolog toxic data chemic 182 oxydemeton methyl 2 ethylsulfinyl ethyl dimethyl ester phosphorothio acid ca 000301 12 2 fifra ai ref 3 two multigener reproduct studi indic varieti reproduct effect 2 1 2 5 mg kg day effect includ decreas litter size viabil decreas weight test ovari increas epididym vacuol noel 0 38 0 5 mg kg day noel 0 9 mg kg day determin 5day studi rat loel decreas fertil epididym sperm motil 5 mg kg day oxydemeton methyl caus inhibit brain plasma red blood cell cholinesteras 2 gener reproduct studi statist signific inhibit red blood cell brain cholinesteras activ noel less 0 043 mg kg day observ adult male femal f 0 f 1 gener 5day feed domin lethal plu studi inhibit plasma cholinesteras activ loel 1 5 mg kg day noel 0 45 mg kg day observ epa believ suffici evid list oxydemeton methyl epcra section 313 pursuant epcra section 313 2 b base avail reproduct neurolog toxic data chemic 183 oxydiazon 3 2 4 dichloro 5 1 methylethoxi phenyl 5 1 1 dimethylethyl 1 3 4 oxadiazol 2 3h one ca 019666 30 9 fifra ai ref 3 rat given 40 mg kg day gavag day 6 15 gestat exhibit increas fetal resorpt noel 12 mg kg day increas liver kidney weight associ patholog increas alkalin phosphatas activ observ rat fed 100 mg kg day noel 25 mg kg day 90 day increas level sgpt alkalin phosphatas activ increas liver weight loel 5 mg kg day noel 0 5 mg kg day observ 2year feed studi rat effect note 150 mg kg day includ liver patholog hemolyt anemia increas kidney weight pigment nephrosi base noel oral rfd 0 005 mg kg day deriv epa believ suffici evid list oxydiazon epcra section 313 pursuant epcra section 313 2 b base avail development hepat renal toxic data chemic 184 oxyfluorfen ca 042874 03 3 fifra sr ref 8 oxyfluorfen phenoxyphenyl type herbicid sever chronic oral toxic studi suggest oxyfluorfen may hepatotox hepat effect e g increas absolut liver weight necrosi regener hyperplast nodul observ mice fed diet contain greater 3 mg kg day oxyfluorfen 20 month noel 0 3 mg kg day base find oral rfd valu 0 003 mg kg day deriv studi support chronic feed studi demonstr increas liver weight alkalin phosphatas activ bile pigment hepatocyt loel 15 mg kg day noel 2 5 mg kg day dog minim hypertrophi centrilobular hepatocyt loel 40 mg kg day noel 2 mg kg day rat epa believ suffici evid list oxyfluorfen epcra section 313 pursuant epcra section 313 2 b base hepatotox effect chemic estim chronic matc valu fish daphnid 9 ppb 20 ppb oxyfluorfen respect estim log k ow 6 1 epa believ suffici evid list oxyfluorfen epcra section 313 pursuant epcra section 313 2 c base environment toxic data potenti bioaccumul chemic 185 ozon ca 010028 15 6 epcra eh ref 8 inform larg number studi human anim indic ozon affect structur function metabol pulmonari defens bacteri infect extrapulmonari effect among extrapulmonari effect 1 cardiovascular effect 2 reproduct teratolog effect 3 central nervou system effect 4 alter red blood cell morpholog 5 enzymat activ 6 cytogenet effect circul lymphocyt epa believ suffici evid list ozon epcra section 313 pursuant epcra section 313 2 b base avail toxic data chemic effect ozon green plant includ injuri foliag reduct growth loss yield alter reproduct capac alter suscept pest pathogen base known interrelationship differ compon ecosystem effect suffici magnitud may potenti lead irrevers chang sweep natur ecosystem measur aquat acut toxic valu ozon includ 96hour lc 50 80 ppb stripe bass 96hour lc 50 30 ppb channel catfish 96hour lc 50 9 3 ppb rainbow trout epa believ suffici evid list ozon epcra section 313 pursuant epcra section 313 2 c base avail ecotox data chemic 186 paraquat dichlorid ca 001910 42 5 epcra eh fifra sr ref 8 paraquat caus death human consequ sever injuri lung result kidney liver heart failur follow exposur death may occur 24 hour less acut oral ld 50 valu paraquat report 57 120 25 50 35 mg kg rat mous dog monkey cat respect chronic pneumon loel 0 93 mg kg day noel 0 45 mg kg day report dog fed diet contain paraquat dichlorid 52 week result support result 2year feed studi rat loel 3 75 mg kg day base nonneoplast lung lesion noel 1 25 mg kg day 90day feed studi dog loel 1 5 mg kg day base increas lung weight alveol alveolar collaps noel 0 5 mg kg day epa believ suffici evid list paraquat dichlorid epcra section 313 pursuant epcra section 313 2 b base chronic toxic data chemic 187 pebul butylethylcarbamothio acid propyl ester ca 001114 71 2 fifra ai ref 3 1 year dog feed studi noel greater 5 mg kg day establish due abnorm behavior ataxia convuls neurolog effect brain spinal cord 100 mg kg day epa believ suffici evid list pebul epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data 188 pendimethalin n 1 ethylpropyl 3 4 dimethyl 2 6 dinitrobenzenamin ca 040487 42 1 fifra ai ref 3 increas liver weight alkalin phosphatas activ hepat lesion loel 50 mg kg day noel 12 5 mg kg day observ dog fed pendimethalin 2 year epa deriv oral rfd 0 04 mg kg day hypertrophi liver increas liver weight observ rat fed 5 000 ppm 250 mg kg day 3 month noel 25 mg kg day epa believ suffici evid list pendimethalin epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data 189 pentobarbit sodium ca 000057 33 0 cal ref 8 pentobarbit sodium commonli use sed hypnot averag adult sed dose 20 40 mg oral averag adult hypnot dose 100 200 mg oral pentobarbit also use parenter rectal provid basal hypnosi gener spinal region anesthesia like barbitur common advers effect use pentobabit sodium central nervou system depress chronic exposur pentobarbit sodium may lead psycholog physic depend intraperiton inject 20 mg kg day 1 pregnanc produc advers effect fertil rat intraperiton inject 80 mg kg rat day 1 pregnanc caus preimplant loss intraperiton inject 94 5 mg kg day 2 pregnanc decreas fertil caus fetal death rat intraperiton inject 22 mg kg day 10 pregnanc caus advers effect rat fetus detail studi report subcutan inject 520 mg kg pentobarbit sodium day 9 21 administr 30 mg kg day 19 pregnanc produc abnorm behavior effect rat offspr exposur pentobarbit sodium pregnanc caus fetal addict substanc epa believ suffici evid list pentobarbit sodium epcra section 313 pursuant epcra section 313 2 b base development reproduct chronic neurolog toxic data chemic 190 perchloromethyl mercaptan ca 000594 42 3 cercla epcra eh ref 8 rat oral ld 50 4hour rat inhal lc 50 valu perchloromethyl mercaptan 8 26 mg kg 0 26 mg l respect 2hour mous inhal lc 50 valu report 0 296 mg l eye irrit test 50 microgram g 0 13 mg kg day place rabbit eye 24 hour produc sever reaction epa exposur analysi indic perchloromethyl mercaptan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list perchloromethyl mercaptan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 191 permethrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester ca 052645 53 1 fifra ai ref 3 increas liver weight loel 500 ppm 25 mg kg day noel 100 ppm 5 mg kg day observ rat fed permethrin 2 year base noel epa deriv oral rfd 0 05 mg kg day decreas alkalin phosphatas activ hepatocellular swell increas liver weight loel 100 mg kg day noel 5 mg kg day observ dog oral administ capsul permethrin 1year tremor excess saliv convuls incoordin note 1 000 mg kg day epa believ suffici evid list permethrin epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data aquat acut toxic valu permethrin includ fathead minnow 96hour lc 50 3 5 ppb rainbow trout 96hour measur lc 50 0 62 ppb bluegil 96hour lc 50 2 52 ppb atlant silversid 96hour measur lc 50 2 2 ppb daphnid 48hour lc 50 0 32 ppb epa believ suffici evid list permethrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 192 phenanthren ca 000085 01 8 cercla cwa pp ref 8 measur aquat acut toxic data phenanthren includ 48hour lc 50 700 ppb daphnid measur 28day lc 50 rainbow trout 40 ppb teratogenet effect note measur bioconcentr factor bcf valu includ fathead minnow 28day bcf 5 100 daphnid 24hour bcf 1 165 epa believ suffici evid list phenanthren epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic potenti bioaccumul 193 phenothrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester ca 026002 80 2 fifra ai ref 3 hepatocellular enlarg increas absolut rel liver weight observ chronic feed studi dog loel 27 7 mg kg day male 26 8 mg kg day femal noel 8 2 mg kg day male 7 1 mg kg day femal hepatocellular hypertrophi increas rel liver weight loel 150 mg kg day noel 50 mg kg day observ chronic oncogen studi rat increas liver weight loel 150 mg kg day noel 45 mg kg day note anoth chronic oncogen feed studi mice epa believ suffici evid list phenothrin epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data chemic aquat acut toxic valu phenothrin includ rainbow trout 96hour lc 50 16 7 ppb goldfish 48hour lc 50 100 ppb epa believ suffici evid list phenothrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 194 1 2 phenylenediamin ca 000095 54 5 rcra app8 ref 8 epa classifi 1 2 phenylenediamin group b2 compound e probabl human carcinogen 1 2phenylenediamin dihydrochlorid appear carcinogen rat mice evidenc increas incid hepatocellular carcinoma speci significantli increas incid hepatocellular carcinoma observ high dose group male rat mice femal mice treat group epa believ suffici evid list 1 2 phenylenediamin epcra section 313 pursuant epcra section 313 2 b base carcinogen data 1 2phenylenediamin dihydrochlorid 195 1 3 phenylenediamin ca 000108 45 2 rcra app8 ref 8 increas absolut rel liver weight degen liver lesion loel 18 mg kg day noel 6 0 mg kg day note 90day oral studi rat expos 1 3 phenylenediamin epa believ suffici evid list 1 3 phenylenediamin epcra section 313 pursuant epcra section 313 2 b base hepatotox data chemic 196 1 2 phenylenediamin dihydrochlorid ca 000615 28 1 rcra app8 ref 8 epa classifi 1 2phenylenediamin group b2 compound e probabl human carcinogen 1 2 phenylenediamin dihydrochlorid appear carcinogen rat mice evidenc increas incid hepatocellular carcinoma speci significantli increas incid hepatocellular carcinoma observ high dose group male rat mice femal mice treat group epa believ suffici evid list 1 2 phenylenediamin dihydrochlorid epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 197 1 4 phenylenediamin dihydrochlorid ca 000624 18 0 rcra app8 ref 8 measur aquat acut toxic 1 4 phenylenediamin includ fish 96hour lc 50 60 ppb epa believ suffici evid list 1 4 phenylenediamin dihydrochlorid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 1 4 phenylenediamin 198 phenytoin ca 000057 41 0 cal iarc ntp ref 8 phenytoin hydantoin type anticonvuls use mainli prophylact manag tonic clonic grand mal seizur partial seizur complex symptomatolog dose use treat seizur disord e 300 mg day adult 5 mg kg day children phenytoin caus advers effect constip dysphagia nausea vomit anorexia weight loss ingest 4 5 g 64 mg kg day adult 0 6 g 60 mg kg day children produc transient coma motor restless ingest 11 mg kg day produc chang motor activ child durat studi report oral administr 7 8 mg kg day 4 day produc enceph hallucin irrit man ingest 7 6 mg kg day 2 week caus enceph hallucin ataxia woman phenytoin classifi group 2b compound iarc e possibl human carcinogen ingest 16 5 mg kg day 1year produc lymphoma includ hodgkin diseas skin tumor child oral exposur phenytoin produc lymphoma mice dose durat studi report oral administr 5 9 mg kg day woman first 39 week pregnanc induc kidney tumor offspr anoth studi oral administr 5 9 mg kg day woman first 39 week pregnanc induc brain tumor offspr oral administr 2 mg kg day woman 1year produc lymphoma includ hodgkin diseas congenit malform report 6 12 percent birth 98 epilept mother receiv phenytoin regularli first 4 month pregnanc hypothrombinemia hemorrhag occur newborn mother receiv phenytoin pregnanc oral dose 4 0 5 9 mg kg day administ women first 39 week pregnanc produc craniofaci abnorm nervou system disord delay physic effect children dose 2 0 mg kg day given woman first 39 week pregnanc produc abnorm skin appendag musculoskelet system child well development abnorm oral dose 5 0 mg kg day produc biochem metabol abnorm offspr higher dose phenytoin 130 mg kg day oral administ rat produc behavior growth musculoskelet nervou system abnorm offspr epa believ suffici evid list phenytoin epcra section 313 pursuant epcra section 313 2 b base chronic neurolog development toxic data carcinogen data chemic 199 phosphin ca 007803 51 2 caa hap ref 7 avail data phosphin indic inhal lc 50 rat 4 40 ppm exposur time 4 hour phosphin highli toxic ga probabl oral lethal dose 5 mg kg air concentr 3 ppm safe long term exposur 500 ppm lethal 30 minut concentr 1 000 ppm lethal breath epa exposur analysi indic phosphin concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list phosphin epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 200 phosphoru oxychlorid ca 010025 87 3 cercla epcra eh ref 5 8 phosphoru oxychlorid react water yield phosphor acid hydrochlor acid phosphor acid well phosphat potenti caus increas algal growth lead eutroph aquat environ eutroph may result nutrient especi phosphat enter aquat ecosystem presenc sunlight nitrogen phosphat ion plant nutrient major limit factor plant growth freshwat environ excess phosphat caus algal bloom toxic effect result oxygen deplet alga die decay toxic effect also relat releas decay product direct excret toxic substanc sourc blue green alga laboratori studi indic eutroph may occur phosphat concentr low 50 ppb lake result oxygen deplet toxic decay product e g hydrogen sulfid kill mani invertebr fish although green alga sensit growth stimul phosphat fresh water blue green algal bloom may caus greater damag least three speci blue green alga known excret toxin secret cyanobacteria dyalyz metabolit inhibit growth speci alga may result algal monocultur algal bloom toxic speci occur reservoir lake slough pond cell toxin becom suffici concentr caus ill death invertebr vertebr major loss report cattl sheep hog bird domest wild fish minor loss dog hors small wild anim amphibian invertebr eutroph may occur slow move river less like swift river rapid mix occur light import limit factor river murkier lake thu chanc eutroph swift river slight howev lake reservoir collect phosphat influent stream store fraction within consolid sediment thu serv phosphat sink avail inform deriv anim control human studi clearli indic exposur acid aerosol produc health effect concern particularli sensit subgroup popul chronic exposur bulk studi howev examin sulfur acid exposur data acid speci mixtur extrem limit howev effect appear due acid speci data pertain acid aerosol consist miner acid hydrochlor acid effect seen rang mild transient chang small revers function effect exercis asthmat substanti effect may acut chronic health consequ persist alter clearanc structur chang may suggest chronic lung diseas addit notabl consist health effect inform across variou studi disciplin epa believ suffici evid list phosphor oxychlorid epcra section 313 pursuant epcra section 313 2 b c base avail chronic human environment toxic data degrad product phoshor acid hydrochlor acid 201 phosphoru pentachlorid ca 010026 13 8 epcra eh ref 5 8 phosphoru pentachlorid react water yield phosphor acid hydrochlor acid describ unit iv b 200 preambl phosphat includ phosphor acid potenti caus increas algal growth lead eutroph fish kill aquat environ avail inform deriv anim control human studi clearli indic exposur acid aerosol produc health effect concern particularli sensit subgroup popul chronic exposur bulk studi howev examin sulfur acid exposur data acid speci mixtur extrem limit howev effect appear due acid speci data pertain acid aerosol consist miner acid hydrochlor acid effect seen rang mild transient chang small revers function effect exercis asthmat substanti effect may acut chronic health consequ persist alter clearanc structur chang may suggest chronic lung diseas addit notabl consist health effect inform across variou studi disciplin epa believ suffici evid list phosphoru pentachlorid epcra section 313 pursuant epcra section 313 2 b c base avail chronic human environment toxic data degrad product phoshor acid hydrochlor acid 202 phosphoru pentasulfid ca 001314 80 3 cercla ref 5 8 phosphoru pentasulfid react water yield phosphor acid hydrogen sulfid describ unit iv b 200 preambl phosphat includ phosphor acid potenti caus increas algal growth lead eutroph fish kill aquat environ acut exposur larg amount hydrogen sulfid approxim 250 ppm produc pulmonari edema unconsci respiratori paralysi asphyxi death individu similar effect also note anim subchron studi inflamm nasal mucosa occur mice follow 90day inhal hydrogen sulfid result noael 42 5 mg 3 30 5 ppm human equival concentr hec 0 93 mg 3 loael 110 mg 3 80 ppm hec 2 4 mg 3 respiratori effect alveolar edema infiltr bronchiol cellular necrosi hyperplasia exfoli variou respiratori tissu report rat aquat toxic test data hydrogen sulfid show measur fish 96hour lc 50 valu rang 7 776 ppb epa believ suffici evid list phosphoru pentasulfid epcra section 313 pursuant epcra section 313 2 b c base avail chronic human environment toxic data degrad product phosphor acid hydrogen sulfid 203 phosphoru pentoxid ca 001314 56 3 epcra eh ref 5 8 phosphoru pentoxid rapidli hydrolyz presenc water yield phosphor acid describ unit iv b 200 preambl phosphat includ phosphor acid potenti caus increas algal growth lead eutroph fish kill aquat environ epa believ suffici evid list phosphor pentoxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data degrad product phosphor acid 204 picloram ca 001918 02 1 fifra ai sdwa ref 8 anim studi dog rat mice variou durat 2 week 2 year indic liver primari target picloram toxic 6month feed studi beagl dog loael 35 mg kg day noael 7 mg kg day determin increas liver weight rel absolut higher dose 175 mg kg day increas serum alkalin phosphatas concomit increas liver weight toxic effect higher dose anim includ reduc food consumpt bodi weight epa deriv oral rfd 0 07 mg kg day chemic base find studi hepatotox also report 2year rat feed studi loael 60 mg kg day base chang liver histopatholog noael 20 mg kg day hepatotox also observ 90day rat feed studi loael 150 mg kg day base chang liver histopatholog necrosi bile duct prolifer noael 50 mg kg day increas liver weight also report mice follow dietari exposur picloram 13 week loael 1 000 mg kg day liver swell report rat administ picloram feed 13 week loael 150 mg kg day epa believ suffici evid list picloram epcra section 313 pursuant epcra section 313 2 b base avail hepatotox data chemic 205 piperonyl butoxid ca 000051 03 6 fifra sr ref 8 measur aquat acut toxic data piperonyl butoxid includ 96hour lc 50 3 4 ppb rainbow trout 96hour lc 50 4 2 ppb bluegil epa believ suffici evid list piperonyl butoxid epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 206 pirimipho methyl 2 diethylamino 6 methyl 4 pyrimidinyl dimethyl phosphorothio ca 029232 93 7 fifra ai ref 3 pirimipho methyl cholinesteras inhibitor human mammalian speci mild transient decreas plasma cholinesteras activ observ 2 4 femal human given pirimipho methyl daili capsul dose level 0 25 mg kg day 56 day effect seen 3 3 male dose level 0 25 mg kg day consid noel plasma cholinesteras inhibit base noel oral rfd 0 01 mg kg day deriv find 56day studi corrobor 28day feed studi capsul 5 male human volunt 1 individu show borderlin cholinesteras depress inhibit brain cholinesteras loel 0 5 mg kg day noel cholinesteras inhibit determin observ 2year feed studi dog inhibit plasma cholinesteras activ loel 2 5 mg kg day noel 0 5 mg kg day seen 2year feed studi rat clinic sign report studi epa believ suffici evid list pirimipho methyl epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic 207 polycycl aromat compound pac ca na caa hap ref 7 polycycl aromat compound class chemic includ polycycl aromat hydrocarbon azapolycycl aromat hydrocarbon thio polycycl aromat hydrocarbon nitroaren other pac form combust process involv burn fuel gener materi contain carbon hydrogen industri sourc includ coke oven catalyt crack crude oil carbon black product iron steel process materi contain mixtur pac shown carcinogen sever epidemiolog studi shown increas mortal due lung cancer human expos coke oven emiss roof tar emiss cigarett smoke mixtur contain benzo pyren benzo anthracen benzo b fluoranthen benzo phenanthren dibenzo h anthracen well potenti carcinogen pac carcinogen potenti carcinogen chemic tumor promotor initi co carcinogen nitrosoamin coal tar pitch creosot although imposs evalu contribut individu pac total carcinogen mixtur human report natur provid qualit evid potenti mixtur contain pac caus cancer human addit sever pac caus cancer anim oral e g benz anthracen benzo pyren dibenz h anthracen dermal e g benz anthracen benzo phenanthren benzo b fluoranthen benzo pyren dibenz h anthracen indeno 1 2 3 cd pyren inhal e g benzo pyren expos epa believ suffici evid list pac epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic epa propos creat delimit categori pac includ chemic discuss benzo b fluoranthen ca 000205 99 2 benzo b fluoranthen classifi group b2 compound epa e compound probabl human carcinogen classifi group 2b compound iarc e compound possibl human carcinogen benzo b fluoranthen produc tumor mice lung implant intraperiton subcutan inject skin paint epa believ suffici evid list benzo b fluoranthen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic b benzo j fluoranthen ca 000205 82 3 benzo j fluoranthen classifi group 2b compound iarc e compound possibl human carcinogen multipl skin paint assay mous skin initi promot assay benzo j fluoranthen produc tumor femal mice epa believ suffici evid list benzo j fluoranthen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic c benzo k fluoranthen ca 000207 08 9 benzo k fluoranthen classifi group b2 compound epa e compound probabl human carcinogen also classifi group 2b compound iarc e compound possibl human carcinogen benzo k fluoranthen produc tumor lung implant mice administ promot agent skin paint studi equivoc result found lung adenoma assay mice benzo k fluoranthen mutagen bacteria epa believ suffici evid list benzo k fluoranthen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic carbazol ca 000086 74 8 mice fed basal diet contain carbazol show dose relat increas liver nodul hepatocellular carcinoma oral administr epa believ suffici evid list carbazol epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic e cyclopenta cd pyren ca 027208 37 3 skin paint assay sever mous skin initi promot assay cyclopenta cd pyren produc tumor femal mice cyclopenta cd pyren also mutagen salmonella mammalian cell vitro induc morpholog transform c3h10t1 2 cell vitro epa believ suffici evid list cyclopenta cd pyren epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic f dibenz c anthracen ca 000215 58 7 skin paint assay sever mous skin initi promot assay dibenz c anthracen produc tumor femal mice epa believ suffici evid list dibenz c anthracen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic g dibenz h acridin ca 000226 36 8 dibenz h acridin classifi group 2a compound iarc e compound probabl human carcinogen dibenz h acridin shown carcinogen anim epa believ suffici evid list dibenz h acridin epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic h dibenz j acridin ca 000224 42 0 dibenz j acridin classifi group 2b compound iarc e compound possibl human carcinogen dibenz j acridin shown carcinogen anim epa believ suffici evid list dibenz j acridin epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic dibenz j anthracen ca 000224 41 9 dibenz j anthracen produc tumor subcutan inject skin paint femal mice epa believ suffici evid list dibenz j anthracen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic j dibenzo e fluoranthen ca 005385 75 1 dibenzo e fluoranthen produc tumor femal mice mous skin initi promot assay skin paint dibenzo e fluoranthen also produc tumor male femal mice subcutan inject epa believ suffici evid list dibenzo e fluoranthen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic k dibenzo e pyren ca 000192 65 4 dibenzo e pyren classifi group 2b compound iarc e compound possibl human carcinogen dibenzo e pyren shown carcinogen anim epa believ suffici evid list dibenzo e pyren epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic l dibenzo h pyren ca 000189 64 0 dibenzo h pyren classifi group 2b compound iarc e compound possibl human carcinogen dibenzo h pyren shown carcinogen anim epa believ suffici evid list dibenzo h pyren epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic dibenzo l pyren ca 000191 30 0 dibenzo l pyren classifi group 2b compound iarc e compound possibl human carcinogen dibenzo l pyren produc tumor male femal mice subcutan c inject tumor femal mice skin paint epa believ suffici evid list dibenzo l pyren epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic n 7h dibenzo c g carbazol ca 000194 59 2 7h dibenzo c g carbazol classifi group 2b compound iarc e compound possibl human carcinogen 7h dibenzo c g carbazol shown carcinogen anim epa believ suffici evid list 7h dibenzo c g carbazol epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 2 methylchrysen ca 003351 32 4 skin paint assay mous skin initi promot assay 2 methylchrysen produc tumor femal mice epa believ suffici evid list 2 methylchrysen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic p 3 methylchrysen ca 003351 31 3 skin paint assay mous skin initi promot assay 3 methylchrysen produc tumor femal mice epa believ suffici evid list 3 methylchrysen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic q 4 methylchrysen ca 003351 30 2 skin paint assay mous skin initi promot assay 4 methylchrysen produc tumor femal mice epa believ suffici evid list 4 methylchrysen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic r 5 methylchrysen ca 003697 24 3 5 methylchrysen classifi group 2b compound iarc e compound possibl human carcinogen skin paint assay mous skin initi promot assay 5 methylchrysen produc tumor femal mice epa believ suffici evid list 5 methylchrysen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 6 methylchrysen ca 001705 85 7 skin paint assay mous skin initi promot assay 6 methylchrysen produc tumor femal mice epa believ suffici evid list 6 methylchrysen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 2 methylfluoranthen ca 033543 31 6 skin paint assay 2 methylfluoranthen produc benign malign skin tumor femal mice femal mous skin initi promot assay 2 methylfluoranthen produc skin papilloma epa believ suffici evid list 2 methylfluoranthen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic u 1 nitropyren ca 005522 43 0 1 nitropyren classifi group 2b compound iarc e compound possibl human carcinogen 1 nitropyren produc mammari adenocarcinoma squamou cell carcinoma dose depend manner oral administr rat papilloma statist signific skin applic mice lung adenoma intratrach instil hamster c inject studi 1 nitropyren produc tumor e one extraskelet osteosarcoma seven malign fibrou histiocytoma inject site male fisher rat anoth c inject studi 1 nitropyren produc tumor inject site male femal cd rat mammari tumor femal epa believ suffici evid list 1 nitropyren epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic addit compound epa propos pac categori also includ follow seven pac benz anthracen ca 000056 55 3 benzo phenanthren ca 000218 01 9 benzo pyren ca 000050 32 8 benzo rst pentaphen ca 000189 55 9 dibenzo h anthracen ca 000053 70 3 7 12 dimethylbenz anthracen ca 000057 97 6 indeno 1 2 3 cd pyren ca 000193 39 5 pac propos list individu epa respons petit add certain chemic appear rcra list toxic wast 40 cfr 261 33 f epcra section 313 57 fr 41020 septemb 8 1992 chemic propos addit base avail carcinogen data due similar seven pac chemic list unit iv b 207 iv b 207 u preambl epa believ chemic ad epcra section 313 part delin pac categori rather list individu epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form case delimit pac categori 28 chemic list would includ purpos make threshold determin file report releas clean air act amend section 112 b hazard air pollut list includ list polycycl organ matter pom includ pac definit given pom categori broad chemic non specif may delin test method purpos list epcra section 313 epa consid follow chemic specif definit pac categori includ chemic speci polycycl aromat hydrocarbon aza polycycl thio polycycl nitroaren famili polycycl mean three fuse ring specif mean combin three fuse six five member hydrocarbon ring least two ring aromat structur may contain fuse non aromat five member ring ring nitrogen ring sulfur one attach nitro group one attach alkyl group altern delimit categori epa propos add pac categori base broad definit although definit may includ chemic low concern may less burden facil report total pac rather tri determin much specif pac cover delimit categori produc releas epa request comment addit delimit pac categori versu altern pac categori base broader definit 208 potassium bromat ca 007758 01 2 iarc ref 8 iarc assign potassium bromat group 2b e possibl carcinogen human male femal rat oral expos 250 500 ppm 35 70 mg kg day potassium bromat drink water 110 week increas incid renal cell adenoma adenocarcinoma male also increas incid mesothelioma periton caviti epa believ suffici evid list potassium bromat epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data chemic 209 potassium dimethyldithiocarbam ca 000128 03 0 fifra ai ref 3 new zealand white rabbit given 38 mg kg day gavag day 6 18 gestat exhibit malalign sternebra total postimplant loss fetal weight decrement also dose level variou malform includ adactyli gastroschisi short tail anal atresia spina bifida atelectasi costal cartilag anomali vertebr anomali without rib caudal vertebrea anomali sever sternebra malalign observ 6 52 fetus 5 11 litter 77 mg kg day dose level sever fetal embryo lethal noel 12 8 mg kg day epa believ suffici evid list potassium dimethyldithiocarbam epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 210 potassium n methyldithiocarbam ca 000137 41 7 fifra ai ref 3 analog analogu potassium dimethyldithiocarbam potassium n methyldithiocarbam reason anticip caus fetotox postimplant loss malform data potassium dimethyldithiocarbam follow new zealand white rabbit given 38 mg kg day gavag day 6 18 gestat exhibit malalign sternebra total postimplant loss fetal weight decrement also dose level variou possibl malform includ adactyli gastroschisi short tail anal atresia spina bifida atelectasi costal cartilag anomali vertebr anomali without rib caudal vertebrea anomali sever sternebra malalign 6 52 fetus 5 11 litter 77 mg kg day dose level sever fetal embryo lethal noel 12 8 mg kg day epa believ suffici evid list potassium n methyldithiocarbam epcra section 313 pursuant epcra section 313 2 b base avail development toxic data potassium dimethyldithiocarbam 211 primisulfuron methyl 2 4 6 bi difluoromethoxi 2 pyrimidinyl amino carbonyl amino sulfonyl benzoat ca 086209 51 0 fifra ai ref 3 90day dog feed studi reduc thyroid weight accompani colloid deplet parafollicular hyperplasia anemia observ loel 25 mg kg day noel 0 625 mg kg day 1 year dog studi dietari administr 250 125 mg kg day loel dose chang week 10 studi produc thyroid hyperplasia anemia increas platelet level vacuolar chang increas absolut rel liver weight noel 25 mg kg day 18month studi mice dietari administr 1 7 mg kg day produc increas absolut rel liver weight femal noel establish base studi oral rfd 0 006 mg kg day deriv 2year mous studi increas absolut rel liver weight observ 408 mg kg day male 1 7 mg kg day femal system loel noel male 408 mg kg day 40 2 mg kg day respect system loel femal 1 7 mg kg day noel could establish epa believ suffici evid list primisulfuron epcra section 313 pursuant epcra section 313 2 b base avail thyroid liver toxic data chemic plant toxic valu includ duckwe 14day ec 50 0 27 ppb alga 7day ec 50 24 ppb epa believ suffici evid list primisulfuron epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 212 profenofo 4 bromo 2 chlorophenyl ethyl spropyl phosphorothio ca 041198 08 7 fifra ai ref 3 6month feed studi dog inhibit plasma red blood cell cholinesteras activ observ 2 ppm 0 05 mg kg day noel 0 2 ppm 0 005 mg kg day base noel epa deriv oral rfd 0 00005 mg kg day studi 21 28 90day studi rat rabbit dog also demonstr cholinesteras plasma red blood cell brain inhibit rat mice epa believ suffici evid list profenofo epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data 213 prometryn n n bi 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin ca 007287 19 6 fifra ai ref 3 degen chang liver kidney bone marrow atrophi loel 37 5 mg kg day noel 3 75 mg kg day observ dog fed prometryn 2 year base noel epa deriv oral rfd 0 004 mg kg day fatti liver degener loel 500 mg kg noel 250 mg kg observ rat fed prometryn 28 day teratolog studi rabbit test materi administ gavag gestat day 7 19 increas abort late resorpt occur 72 mg kg day noel 12 mg kg day epa believ suffici evid list prometryn epcra section 313 pursuant epcra section 313 2 b base avail hepat renal bone marrow development toxic data 214 propachlor 2 chloro n 1 methylethyl n phenylacetamid ca 001918 16 7 fifra ai ref 3 evid matern toxic seen rabbit administ propachlor gavag 0 5 15 50 mg kg day day 7 19 gestat statist signific increas mean resorpt postimplant loss correspond decreas mean number viabl fetus report 15 50 mg kg day compar control epa believ suffici evid list propachlor epcra section 313 pursuant epcra section 313 2 b base avail development toxic data 215 propanil n 3 4 dichlorophenyl propanamid ca 000709 98 8 fifra ai ref 3 result sever subchron chronic toxic studi indic liver spleen target organ propanil increas rel spleen weight loel 20 mg kg day noel 5 mg kg day note femal rat fed propanil 2 year base noel epa deriv oral rfd 0 005 mg kg day histopatholog chang loel 30 mg kg day noel 25 mg kg day liver spleen observ mice oral administ propanil 90 day higher dose level e 240 1 920 mg kg day cyanosi methemoglobinemia increas liver spleen weight note 90day rat studi increas spleen weight loel 50 mg kg day noel 16 5 mg kg day seen femal decreas hemoglobin level seen male increas sgot sap activ loel 100 mg kg day noel 15 mg kg day observ dog oral administ propanil 2 year epa believ suffici evid list propanil epcra section 313 pursuant epcra section 313 2 b base avail hepat toxic data 216 propargit ca 002312 35 8 cercla ref 8 development toxic studi rabbit expos via oral gavag dose greater equal 6 mg kg day fetotox loael propargit gestat day 6 18 delay ossif increas fetal resorpt decreas fetal viabil reduct fetal bodi weight note matern loael studi also 6 mg kg day base bodi weight reduct noel matern fetal toxic 2 mg kg day development effect increas incid miss sternebra also report offspr rat expos oral gestat day 6 15 fetotox loael 25 mg kg day noael 6 mg kg day epa believ suffici evid list propargit epcra section 313 pursuant epcra section 313 2 b base development toxic data chemic measur aquat acut toxic data propargit includ bluegil sunfish lc 50 31 ppb epa believ suffici evid list propargit epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 217 propargyl alcohol ca 000107 19 7 cercla rcra app8 rcra p ref 8 histopatholog chang liver kidney report subchron rat feed studi follow exposur propargyl alcohol diet littl 4 week liver chang includ increas organ weight hepatocyt megalocytosi prolifer bile duct cytoplasm vacuol hepatocyt well hematolog serum enzym chang indic liver damag kidney weight increas femal sex karyomegali renal tubular epitheli cell loael chang 15 mg kg day noael 5 mg kg day epa deriv oral rfd 0 002 mg kg day studi epa believ suffici evid list propargyl alcohol epcra section 313 pursuant epcra section 313 2 b base hepatotox nephrotox data chemic 218 propetampho 3 ethylamino methoxyphosphinothioyl oxi 2 buteno acid 1 methylethyl ester ca 031218 83 4 fifra ai ref 3 purebr beagl dog given propetampho 52 week feed dose 2 5 mg kg day caus increas rel liver weight increas liver enzym dog given 12 5 mg kg day develop hepatocellular necrosi noel 0 5 mg kg day red blood cell plasma cholinesteras inhibit seen 2 week rat inhal studi 1 mg kg day loel noel could establish cholinesteras inhibit observ 0 4 mg kg day 13week rat dietari studi noel 0 2 mg kg day cholinesteras inhibit also observ 0 1 mg kg day loel 6month dog dietari studi noel 0 05 mg kg day 92week mous feed studi red blood cell brain plasma cholinesteras inhibit 1 0 mg kg day loel noel 0 5 mg kg day base studi oral rfd 0 005 mg kg day deriv 2year dietari rat studi plasma cholinesteras depress observ 0 6 mg kg day loel cholinesteras noel 0 3 mg kg day alopecia hyperflexia observ 6 mg kg day system loel system noel 0 6 mg kg day lifetim mous studi dietari administr 1 mg kg day produc plasma red blood cell liver brain cholinesteras depress noel 0 05 mg kg day epa believ suffici evid list propetampho epcra section 313 pursuant epcra section 313 2 b base avail hepat neurolog toxic data chemic 219 propiconazol 1 2 2 4 dichlorophenyl 4 propyl 1 3 dioxolan 2 yl methyl 1h 1 2 4 triazol ca 060207 90 1 fifra ai ref 3 2 gener rat reproduct studi dietari administr 25 mg kg day produc increas incid hepat clear cell chang parent anim administr 125 mg kg day produc increas incid hepat lesion offspr parent noel 5 mg kg day development noel 25 mg kg day 2year mous studi dietari administr 65 mg kg day loel produc increas liver lesion liver weight male wherea administr 325 mg kg day produc increas liver tumor increas sgpt sgot level increas liver weight hepatocyt enlarg vacuol fat deposit liver sex noel 13 mg kg day 3month dog dietari studi lymphoid follicl observ mucou membran pylor part stomach 6 25 mg kg day noel 1 25 mg kg day 1year dog studi dietari administr 6 25 mg kg day produc mild gastric mucos irrit noel 1 25 mg kg day base noel studi oral rfd 0 013 mg kg day deriv epa believ suffici evid list propiconazol epcra section 313 pursuant epcra section 313 2 b base avail hepat gastrointestin toxic data chemic 220 quizalofop ethyl 2 4 6 chloro 2 quinoxalinyl oxi phenoxi propano acid ethyl ester ca 076578 14 8 fifra ai ref 3 3month rat studi dietari administr 6 4 mg kg day produc chang liver weight liver lesion noel 2 mg kg day 6month dietari dog studi 10 mg kg day produc testicular atrophi male noel 2 5 mg kg day liver cell enlarg observ 3 7 mg kg day male 4 6 mg kg day femal loel 2year rat dietari studi noel male femal 0 9 mg kg day 1 1 mg kg day respect base studi oral rfd 0 009 mg kg day deriv increas liver weight observ pregnant rat teratolog studi matern loel 100 mg kg day noel 30 mg kg day teratogen noel could establish 2 gener rat reproduct studi increas liver weight increas incid eosinophil chang liver observ offspr 5 mg kg day loel noel 1 25 mg kg day epa believ suffici evid list quizalofop ethyl epcra section 313 pursuant epcra section 313 2 b base avail reproduct hepat toxic data chemic 221 resmethrin 5 phenylmethyl 3 furanyl methyl 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl ca 010453 86 8 fifra ai ref 3 oral administr 30 mg kg day loel capsul 6 month produc increas liver weight femal dog noel 10 mg kg day 2year rat studi dietari administr 125 mg kg day produc increas liver weight patholog lesion noel 25 mg kg day one gener reproduct rat studi administr 25 mg kg day loel diet produc increas dead pup lower pup weight among survivor noel could establish 3 gener reproduct rat studi dietari administr 25 mg kg day loel produc increas pup cast dead lower pup weight among survivor noel could establish base noel studi oral rfd 0 03 mg kg day deriv sign neurotox includ piloerect ataxia sensori chang peripher nerv chang locomotor activ saliv tremor convuls observ rat dog mice rabbit given acut oral intraven intraperiton inject greater equal 160 mg kg 3month rat inhal studi 0 1 mg l loel produc behavior effect 1 mg l produc decreas locomotor activ tremor behavior chang noel could establish epa believ suffici evid list resmethrin epcra section 313 pursuant epcra section 313 2 b base avail hepat reproduct neurolog toxic data chemic aquat acut toxic valu resmethrin includ rainbow trout 96hour lc 50 0 275 ppb 89 percent bluegil sunfish 96hour lc 50 0 750 ppb 89 percent lake trout 96hour lc 50 1 7 ppb 84 5 percent fathead minnow 96hour lc 50 3 0 ppb epa believ suffici evid list resmethrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 222 sethoxydim 2 1 ethoxyimino butyl 5 2 ethylthio propyl 3 hydroxi 2 cyclohexen 1 one ca 074051 80 2 fifra ai ref 3 mild anemia loel 17 5 mg kg day noel 8 9 mg kg day observ male dog fed sethoxydim 1year base noel epa deriv oral rfd 0 09 mg kg day swollen liver cell loel 117 mg kg day noel 45 mg kg day seen mice fed sethoxydim 14 week patholog effect liver loel 45 mg kg day noel 15 mg kg day note rat fed sethoxydim 14 week nonneoplast liver lesion loel 54 mg kg day noel 18 mg kg day observ mice fed sethoxydim 2 year decreas phenosulfophthalein psp clearanc noel greater 3 mg kg day loel determin note dog given sethoxydim diet 26 week decreas psp clearanc loel 20 mg kg day noel 2 mg kg day also note 6month feed studi dog epa believ suffici evid list sethoxydim epcra section 313 pursuant epcra section 313 2 b base avail hematolog hepat renal toxic data 223 simazin ca 000122 34 9 fifra sr sdwa ref 8 simazin triazin type herbicid chronic exposur sheep low dose approxim 1 4 6 mg kg day simazin caus fatti granular degener liver increas sgot alkalin phosphatas neuronophagia diffus kidney degener diffus glial prolifer degener ganglion cell cerebrum medulla also report anim dog receiv 1 500 ppm 37 5 mg kg day simazin 2year feed studi also slight increas serum alkalin phosphatas sgot indic liver damag sheep receiv 1 4 mg kg day simazin 37 111 day necrot chang germin epithelium testi disturb spermatogenesi epa believ suffici evid list simazin epcra section 313 pursuant epcra section 313 2 b base hepat renal neurolog reproduct toxic chemic 224 sodium azid ca 026628 22 8 cercla epcra eh rcra p ref 8 although use clinic sodium azid direct act vasodil reduct blood pressur note hypertens patient oral expos sodium azid investig substanc treat cancer reduct blood pressur also report anim follow acut exposur minim hypotens dose human estim approxim 0 2 0 4 g kg 0 0002 0 0004 mg kg epa believ suffici evid list sodium azid epcra section 313 pursuant epcra section 313 2 b base abil substanc lower blood pressur 225 sodium chlorit ca 007758 19 2 fifra ai ref 3 decreas erythrocyt half life loel 100 ppm 7 3 mg kg day noel 50 ppm 3 65 mg kg day observ cat administ sodium chlorit drink water 90 day increas glucos 6 phosphatas dehydrogenas activ mean corpuscular volum mcv osmot fragil acanthocyt observ mice administ 100 ppm 19 mg kg day drink water 30 day anoth 30day drink water studi increas glucos 6 phosphatas dehydrogenas activ mcv osmot fragil note mice administ 100 ppm 19 mg kg day noel 1 9 mg kg day result vitro studi show sodium chlorit result oxid damag erythrocyt epa believ suffici evid list sodium chlorit epcra section 313 pursuant epcra section 313 2 b base avail hematolog toxic data 226 sodium dicamba 3 6 dichloro 2 methoxybenzo acid sodium salt ca 001982 69 0 fifra ai ref 3 toxic data avail sodium dicamba howev data avail dicamba discuss solut sodium dicamba dissoci sodium ion dicamba anion decreas fetal bodi weight increas postimplant loss observ offspr rabbit receiv 10 mg kg day day 6 18 gestat loel 10 mg kg day noel 3 mg kg day base noel epa deriv oral rfd valu 0 03 mg kg day separ studi disord oxid phosphoryl focal necrosi heart observ newborn rat follow transplacent exposur dicamba development toxic studi increas skelet malform seen offspr rat oral administ 64 mg kg day day 6 19 gestat epa believ suffici evid list sodium dicamba epcra section 313 pursuant epcra section 313 2 b base avail development toxic data dicamba 227 sodium dimethyldithiocarbam ca 000128 04 1 fifra ai ref 3 analog potassium dimethyldithiocarbam sodium dimethyldithiocarbam reason anticip caus fetotox postimplant loss malform data potassium dimethyldithiocarbam follow new zealand white rabbit given 38 mg kg day gavag day 6 18 gestat exhibit malalign sternebra total postimplant loss fetal weight decrement also dose level variou possibl malform includ adactyli gastroschisi short tail anal atresia spina bifida atelectasi costal cartilag anomali vertebr anomali without rib caudal vertebrea anomali sever sternebra malalign 6 52 fetus 5 11 litter 77 mg kg day dose level sever fetal embryo lethal noel 12 8 mg kg day epa believ suffici evid list sodium dimethyldithiocarbam epcra section 313 pursuant epcra section 313 2 b base avail development toxic data analogu potassium dimethyldithiocarbam 228 sodium fluoroacet ca 000062 74 8 cercla epcra eh fifra sr rcra app8 rcra p ref 8 13week oral studi rat gavag administr sodium fluoroacet 0 02 mg kg day result decreas testi weight alter spermatogenesi male noael 0 05 mg kg day addit increas heart weight note femal male administ 0 20 mg kg day sodium fluoroacet increas heart weight howev accompani subacut minim inflamm dose relat also fluorocitr level significantli increas 4 week male administ 0 50 mg kg day 13 week male femal rat administ 0 20 0 50 mg kg day testicular cardiac effect report consist note literatur case studi report deliber ingest unspecifi dose sodium fluroacet healthi femal woman experienc nausea vomit abdomin pain 30 minut ingest subsequ seizur occur 60 minut initi onset symptom neurolog examin 2 week reveal sever cerebellar dysfunct 18 month memori disturb depress behavior persist inhal exposur unspecifi level sodium fluoroacet caus saliv loss speech violent convuls coma male worker patient ultim recov neurolog effect also report rat 13week oral studi four 20 femal rat treat 0 50 mg kg day highest dose test exhibit convuls day 79 recurr remaind studi estim lethal dose sodium fluoroacet human rang 5 10 mg kg epa believ suffici evid list sodium fluoroacet epcra section 313 pursuant epcra section 313 2 b base neurolog reproduct myocardi toxic data chemic measur oral ld 50 valu fluoroacet hous sparrow redwing blackbird starl golden eagl 3 0 4 22 2 37 1 25 5 mg kg respect addit measur acut toxic data mammalian wildlif includ oral ld 50 0 22 0 44 mg kg mule deer oral ld 50 1 41 mg kg male ferret oral ld 50 0 5 1 0 mg kg bear epa believ suffici evid list sodium fluoroacet epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 229 sodium hypochlorit ca 007681 52 9 cercla ref 8 aquat acut toxic data sodium hypochlorit includ 96hour measur lc 50 100 ppb bluegil 96hour measur lc 50 80 ppb fathead minnow addit 96hour measur lc 50 valu non standard test speci rang 32 ppb coho salmon 82 ppb pacif sand lanc epa believ suffici evid list sodium hypochlorit epcra section 313 2 c base avail ecotox data chemic 230 sodium nitrit ca 007632 00 0 cercla ref 8 sodium nitrit caus convers oxid hemoglobin methemoglobin methemoglobin cannot combin revers oxygen format caus anem hypoxia may lead intens cyanosi infant particularli suscept effect higher stomach ph immatur enzym system reduc capac newborn erythrocyt reduc methemoglobin hemoglobin increas rate nitrit induc oxid fetal hemoglobin methemoglobin approxim twice rate adult hemoglobin oxid coma methemoglobinemia carboxyhemoglobinemia report human receiv sodium nitrit 71 mg kg oral anim studi methemoglobinemia report dog receiv intraven dose 30 mg kg sodium nitrit rat administ 10 mg kg dose sodium nitrit subcutan fetotox fetal death report follow oral exposur pregnant rat sodium nitrit 30 mg kg day gestat day 1 22 mice expos oral 80 mg kg day gestat day 6 15 increas preimplant loss fetal death mice expos lower dose 20 mg kg day gestat day 1 14 abnorm blood lymphat system report offspr offspr rat oral expos 26 256 mg kg day pregnanc gestat day 1 22 lactat 20 21 day birth effect growth includ biochem metabol chang note epa believ suffici evid list sodium nitrit epcra section 313 pursuant epcra section 313 2 b base avail chronic hematolog development toxic data chemic 231 sodium pentachlorophen ca 000131 52 2 fifra ai ref 3 pentachlorophenol classifi epa group b2 compound e probabl human carcinogen base occurr increas combin incid hemangiosarcoma liver tumor pheochromocytoma femal mice epa believ suffici evid list sodium pentachlorophen epcra section 313 pursuant epcra section 313 2 b base avail carcinogen data parent compound pentachlorophenol aquat acut toxic valu sodium pentachlorophen includ rainbow trout 96hour lc 50 55 ppb bluegil 96hour lc 50 44 ppb fathead minnow 96hour lc 50 20 ppb shrimp 96hour lc 50 84 ppb epa believ suffici evid list sodium pentachlorophen epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 232 sodium phenylphenoxid ca 000132 27 4 cercla iarc ref 8 sodium phenylphenoxid classifi iarc group 2b compound e substanc possibl carcinogen human epa believ suffici evid list sodium phenylphenoxid epcra section 313 pursuant epcra section 313 2 b base carcinogen data chemic 233 sodium 2 pyridinethiol 1 oxid ca 015922 78 8 fifra ai ref 3 new zealand white rabbit test test materi dermal day 6 18 gestat 0 5 mg kg day pup exhibit miss defect vertebra rib sternebra noel establish epa believ suffici evid list sodium 2 pyridinethiol 1 oxid epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 234 strychnin salt cercla epcra eh fifra sr rcra app8 rcra p ref 8 strychnin salt dissoci aqueou solut yield solubl strychnin strychnin alkaloid caus violent convuls human effect includ agit hyperton muscl pain muscl spasm renal failur respiratori paralysi gener ensu sever prolong convuls potenti lethal oral dose small child 5 10 mg lethal oral dose adult may low 30 mg similar effect also report anim expos lethal dose rang 0 25 2 35 mg kg via oral parenter rout exposur epa exposur analysi indic strychnin strychnin salt concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list strychnin salt categori epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic epcra section 313 requir threshold determin chemic categori base total chemic categori manufactur process otherwis use exampl facil manufactur three member chemic categori would count total amount three chemic manufactur toward manufactur threshold categori file report chemic categori releas determin manner threshold one report file categori releas report form 235 sulfur dioxid ca 007446 09 5 cercla epcra eh ref 8 acid precipit occur larg region eastern unit state canada europ japan widespread occurr acid precipit dri deposit result larg part man made emiss oxid sulfur e g sulfur dioxid oxid nitrogen substanc transform atmospher sulfur acid nitric acid transport great distanc deposit veget soil surfac water materi substanc transfer atmospher ecosystem absorpt gase impact gravit settl fine aerosol coars particl precipit acid contain pollut snow releas contamin meltwat result releas pollut caus major rapid chang acid stream lake water interfer normal reproduct fish popul induc acid lake stream water reproduct frog salamand also inhibit atmospher acidif surfac water atmospher deposit sulfur acid nitric acid caus seriou damag crop forest biolog effect includ induct necrot lesion loss nutrient due leach foliar organ acceler eros wax leaf surfac interfer normal reproduct process acidif decreas rate mani soil process nitrogen fixat breakdown organ matter epa believ suffici evid list sulfur dioxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic limit data long term human exposur sulfur acid respect occup set avail recent studi suggest sulfur acid aerosol level low 0 02 0 04 mg 3 may caus signific effect lung function human effect note includ increas risk chronic bronchiti smoker reduc tracheobronchi clearanc rate studi suggest sulfur acid concentr low 0 04 mg 3 may act synergist copollut ozon 2 metal particul caus decreas pulmonari diffus capac bronchial hypersensit effect presum attribut acid oxid properti sulfur acid therefor ph concentr depend epa believ suffici evid list sulfur dioxid epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data sulfur acid hydrolysi product sulfur dioxid sulfur dioxid regul titl caa provis attain mainten nation ambient air qualiti standard titl iv caa acid deposit control addit propos add sulfur dioxid epcra section 313 unit iv b 36 179 epa propos add two chemic carbon monoxid nitrogen dioxid regul titl caa extens data highli technic collect chemic requir caa epa request comment follow 1 inform collect caa suffici public right know purpos 2 suggest data collect chemic pursuant caa titl iv could use meet purpos epcra section 313 236 sulfur trioxid ca 007446 11 9 epcra eh ref 8 iarc classifi sulfur trioxid group 1 e chemic carcinogen human base suffici evid carcinogen human epa believ suffici evid list sulfur trioxid epcra section 313 pursuant section 313 2 b base carcinogen data chemic acid precipit occur larg region eastern unit state canada europ japan widespread occurr acid precipit dri deposit result larg part man made emiss oxid sulfur e g sulfur trioxid oxid nitrogen substanc transform atmospher sulfur acid nitric acid transport great distanc deposit veget soil surfac water materi substanc transfer atmospher ecosystem absorpt gase impact gravit settl fine aerosol coars particl precipit acid contain pollut snow releas contamin meltwat result releas pollut caus major rapid chang acid stream lake water interfer normal reproduct fish popul induc acid lake stream water reproduct frog salamand also inhibit atmospher acidif surfac water atmospher deposit sulfur acid nitric acid caus seriou damag crop forest biolog effect includ induct necrot lesion loss nutrient due leach foliar organ acceler eros wax leaf surfac interfer normal reproduct process acidif decreas rate mani soil process nitrogen fixat breakdown organ matter epa believ suffici evid list sulfur trioxid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic limit data long term human exposur sulfur acid respect occup set avail recent studi suggest sulfur acid aerosol level low 0 02 0 04 mg 3 may caus signific effect lung function human effect note includ increas risk chronic bronchiti smoker reduc tracheobronchi clearanc rate studi suggest sulfur acid concentr low 0 04 mg 3 may act synergist copollut ozon 2 metal particul caus decreas pulmonari diffus capac bronchial hypersensit effect presum attribut acid oxid properti sulfur acid therefor ph concentr depend epa believ suffici evid list sulfur trioxid epcra section 313 pursuant epcra section 313 2 b base avail chronic toxic data sulfur acid hydrolysi product sulfur trioxid 237 sulfuryl fluorid vikan ca 002699 79 8 fifra ai ref 3 primari effect sulfuryl fluorid human respiratori irrit central nervou system depress follow excit possibl convuls rabbit expos via inhal 6 hour day 5 day week 2 week sulfuryl fluorid show hyperact convuls vacuol cerebrum 600 ppm 2 5 mg l renal lesion present rat expos inhal 6 hour day 5 day week 2 week 600 ppm 2 5 mg l sulfuryl fluorid minim renal chang note rat expos 300 ppm 1252 mg l wherea effect occur 100 ppm 4 2 mg l convuls near lethal concentr report rabbit mice rat 30 day inhal studi loss control tremor hind quarter histopatholog chang lung liver kidney report rabbit expos 400 ppm 1 6 mg l 7 hour day 5 day week 5 week noel 200 ppm 0 83 mg l cerebr vacuol malacia inflamm nasal tissu observ rabbit expos inhal 100 300 ppm 0 4 1 25 mg l 13 week noel 30 ppm 0 125 mg l rat expos inhal 100 600 ppm 0 4 0 25 mg l sulfuryl fluorid 13 week develop mottl teeth indic fluorid toxic renal respiratori effect cerebr vacuol epa believ suffici evid list sulfuryl fluorid epcra section 313 pursuant epcra section 313 2 b base avail neurolog renal respiratori toxic data chemic 238 sulprofo ethyl 4 methylthio phenyl phosphorodithio acid propyl ester ca 035400 43 2 fifra ai ref 3 acut dermal rabbit ld 50 745 mg kg 994 mg kg ataxia tremor diarrhea observ 28day dietari studi administr 1 mg kg day produc decreas red blood cell brain cholinesteras activ noel 0 1 mg kg dietari administr 15 mg kg day 3 month produc hyperact femal rat noel 5 mg kg day studi 5 mg kg day produc red blood cell brain cholinesteras inhibit sex cholinesteras noel 1 5 mg kg day red blood cell brain cholinesteras inhibit diarrhea vomit hind limb paralysi seen dog oral administ 5 mg kg day loel 3 month noel 0 5 mg kg day 22month dietari mous studi plasma red blood cell cholinesteras inhibit 3 25 mg kg day noel 0 325 mg kg day plasma red blood cell brain cholinesteras inhibit seen dietari administr 2 5 mg kg day loel 2year dog studi noel 0 25 mg kg day base studi oral rfd 0 003 mg kg day deriv dietari administr 3 mg kg day loel produc plasma red blood cell cholinesteras depress 2year rat studi noel 0 3 mg kg day increas unossifi sternebra observ offspr rat given 10 mg kg day loel gavag day 6 15 gestat noel establish epa believ suffici evid list sulprofo epcra section 313 pursuant epcra section 313 2 b base avail neurolog development toxic data chemic aquat acut valu sulprofo includ bluegil 96hour lc 50 valu 1 03 ppm 11 ppm technic product channel catfish bioconcentr factor whole fish 704 1006 epa believ suffici evid list sulprofo epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data potenti bioconcentr 239 tebuthiuron n 5 1 1 dimethylethyl 1 3 4 thiadiazol 2 yl n n dimethylurea ca 034014 18 1 fifra ai ref 3 administr 25 mg kg day loel day 6 18 gestat produc reduc bodi weight offspr rabbit noel 10 mg kg day 3month rat studi dietari administr 125 mg kg day loel produc growth suppress pancreat lesion noel 50 mg kg day 2 gener rat reproduct studi depress bodi weight gain observ femal parent gener 14 mg kg day noel 7 mg kg day base noel studi oral rfd 0 07 mg kg day deriv 3 gener rat reproduct studi decreas bodi weight observ offspr anim administ 20 mg kg day loel noel establish dietari administr 40 mg kg day rat 2 year produc growth suppress noel 20 mg kg day epa believ suffici evid list tebuthiuron epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 240 tefluthrin ca 079538 32 2 fifra ai ref 3 delay ossif seen offspr rat administ 5 mg kg day loel oral day 7 16 gestat noel 3 mg kg day 3month rat studi dietari administr 10 mg kg day produc plasma red blood cell brain cholinesteras inhibit noel 5 mg kg day 6month dog studi dietari administr 10 mg kg day loel produc plasma cholinesteras inhibit noel 1 mg kg day 21 day rat dietari studi administr 20 mg kg day loel femal produc decreas platelet count increas white blood cell lymphocyt neutrophil count male femal noel femal 5 mg kg day increas absolut rel liver weight observ 5 mg kg day male thu noel could establish male dietari administr 10 mg kg day loel 3 month rat produc increas absolut liver weight decreas bilirubin level hepatocellular hypertrophi noel 5 mg kg day 6month dog studi dietari administr 10 mg kg day loel produc hepatotox effect report noel 1 mg kg day 2year mous studi dietari administr 13 5 mg kg day produc liver necrosi noel 3 4 mg kg day epa believ suffici evid list tefluthrin epcra section 313 pursuant epcra section 313 2 b base avail development neurolog hepat hematolog toxic data chemic aquat acut toxic valu tefluthrin includ rainbow trout 96hour lc 50 0 06 ppb bluegil 96hour lc 50 0 13 ppb sheepshead minnow 96hour lc 50 0 13 ppb daphnid 48hour ec 50 0 07 ppb mysid 96hour ec 50 0 053 ppb epa believ suffici evid list teflurin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 241 temepho ca 003383 96 8 fifra ai ref 3 temepho cholinesteras inhibitor mani mammalian speci loel cholinesteras inhibit observ rang 0 3 10 mg kg day howev human subject ingest 256 mg day 5 day 64 mg day 4 week show clinic sign effect plasma red blood cell cholinesteras activ dietari exposur rat 350 mg kg day 90 day result cholinesteras inhibit clinic sign report rabbit guinea pig toler 10 mg kg day extend period without clinic effect dog toler 3 4 mg kg day highest dose test epa believ suffici evid list temepho epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data 242 terbacil 5 chloro 3 1 1 dimethylethyl 6 methyl 2 4 1h 3h pyrimidinedion ca 005902 51 2 fifra ai ref 3 decreas number implant live fetus observ rat administ 62 5 mg kg day loel oral day 6 15 noel 12 5 mg kg day significantli reduc bodi weight observ offspr rabbit oral administ 600 mg kg day loel oral day 6 18 gestat noel 200 mg kg day 2week rat dietari studi administr 1 000 mg kg day produc increas absolut rel liver weight 3month rat dietari studi administr 25 mg kg day loel produc increas liver weight vacuol hypertophi hepatocyt noel 5 mg kg day 1 year dog studi dietari administr 48 mg kg day male 12 loel 48 mg kg day femal produc increas alkalin phosphatas alanin transaminas level noel 3 mg kg day 2year dog studi dietari administr 6 25 mg kg day loel produc slight increas liver weight elev alkalin phosphatas level increas thyroid bodi weight ratio noel 1 25 mg kg day base noel oral rfd 0 013 mg kg day establish hypertrophi centrilobular hepatocyt observ male mice administ 162 5 mg kg day loel diet noel 6 5 mg kg day epa believ suffici evid list terbacil epcra section 313 pursuant epcra section 313 2 b base avail hepat development toxic data chemic 243 tetracyclin hydrochlorid ca 000064 75 5 cal ref 8 tetracyclin hydrochlorid wide use antibiot treatment mani common infect averag oral adult dose infect 1 2 gram per day equal divid dose frequent advers reaction oral administ tetracyclin hydrochlorid gastrointestin effect includ nausea vomit diarrhea bulki loos stool abdomin discomfort photosensit manifest exagger sunburn reaction sun expos area bodi occur follow oral therapi tetracyclin hydrochlorid photosensit reaction type gener develop within minut sever hour sun exposur usual persist 1 2 day discontinu tetracyclin hydrochlorid manufactur tetracyclin hydrochlorid state substanc use women last half pregnanc children younger 8 year age unless appropri drug ineffect contraind american academi pediatr recommend tetracyclin hydrochlorid use children 9 year age older except unusu circumst use tetracyclin hydrochlorid pregnant women infant result retard skelet develop bone growth fetu child tetracyclin hydrochlorid local dentin enamel develop teeth use substanc tooth develop may caus enamel hypoplasia perman yellow gray brown discolor teeth use tetracyclin hydrochlorid may result discolor decidu teeth children substanc use pregnanc children 4 6 month age effect common follow long term use tetracyclin hydrochlorid occur follow repeat short term use prematur infant treat tetracyclin demonstr 40 percent depress bone growth effect readili revers exposur substanc short intraperiton inject 85 mg kg day day 14 18 gestat result abort extra embryon structur rat offspr subcutan inject 48 mg kg day day 16 20 gestat intramuscular inject 40 mg kg day rat day 10 15 gestat result embryo fetotox exposur 50 mg kg day day 7 15 pregnanc result postimplant loss fetotox rat exposur 85 mg kg day day 7 15 pregnanc result abort rat fetotox observ mice receiv 86 mg kg day tetracyclin hydrochlorid day 8 13 gestat epa believ suffici evid list tetracyclin hydrochlorid epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chronic toxic data chemic 244 tetramethrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 1 3 4 5 6 7 hexahydro 1 3 dioxo 2 h isoindol 2 yl methyl ester ca 007696 12 0 fifra ai ref 3 depress saliv ataxia lethargi convuls observ acut rat studi oral ld 50 valu greater equal 4 400 mg kg tremor excit increas urin volum observ acut dermal rat studi ld 50 greater 2 500 mg kg tremor ataxia dyspnea gastointestin hypermotil diarrhea observ rat mice administ tetramethrin subcutan intraperitoneali ld 50 greater 500 mg kg 6month dog dietari studi administr 62 5 mg kg day produc nervous tremor noel 31 25 mg kg day epa believ suffici evid list tetramethrin epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic aquat acut toxic valu tetramethrin includ bluegil 96hour lc 50 21 ppb mix isom technic product 69 ppb epa believ suffici evid list tetramethrin epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 245 tetrasodium ethylenediaminetetraacet ca 000064 02 8 fifra ai ref 3 increas occurr 13th rudimentari rib observ offspr rat oral administ 5 mg kg day loel noel establish dose durat report epa believ suffici evid list tetrasodium ethylenediaminetetraacet epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 246 thiabendazol 2 4 thiazolyl 1h benzimidazol ca 000148 79 8 fifra ai ref 3 oral administr 600 mg kg day loel rat day 6 15 gestat produc cleft palat open eye musculoskelet abnorm observ offspr mice oral administ 240 mg kg day 9 gestat musculoskelet abnorm also observ offspr rat oral administ 296 mg kg day day 8 15 gestat decreas litter size skin abnorm observ offspr rat oral administ 667 mg kg day day 8 15 gestat oral administr 1 300 mg kg day produc musculoskelet abnorm fetal death offspr mice oral administr 2 400 mg kg day day 11 gestat produc craniofaci abnorm offspr mice epa believ suffici evid list thiabendazol epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic aquat acut toxic valu thiabendazol includ rainbow trout 96hour lc 50 560 ppb daphnid 48hour ec 50 0 31 ppb mysid 96hour lc 50 340 ppb epa believ suffici evid list thiabendazol epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 247 thiabendazol hypophosphit salt 2 4 thiazolyl benzimidazol hypophosphit salt ca 028558 32 9 fifra ai ref 3 toxic data avail thiabendazol hypophosphit salt howev data avail parent compound thiabendazol discuss oral administr 600 mg kg day loel rat day 6 15 gestat produc cleft palat open eye musculoskelet abnorm observ offspr mice oral administ 240 mg kg day 9 gestat musculoskelet abnorm also observ offspr rat oral administ 296 mg kg day day 8 15 gestat decreas litter size skin abnorm observ offspr rat oral administ 667 mg kg day day 8 15 gestat oral administr 1 300 mg kg day produc musculoskelet abnorm fetal death offspr mice oral administr 2 400 mg kg day day 11 gestat produc craniofaci abnorm offspr mice epa believ suffici evid list thiabendazol hypophosphit salt epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic laboratori data avail thiabendazol hypophosphit salt ecotox data avail parent compound thiabendazol aquat acut toxic valu thiabendazol includ rainbow trout 96hour lc 50 560 ppb daphnid 48hour ec 50 0 31 ppb mysid 96hour lc 50 340 ppb epa believ suffici evid list thiabendazol hypophosphit salt epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data chemic 248 thiobencarb carbam acid diethylthio p chlorobenzyl ca 028249 77 6 fifra ai ref 3 measur aquat acut toxic valu thiobencarb includ chinook salmon 96hour lc 50 760 ppb stripe bass 96hour lc 50 760 ppb rainbow trout 96hour lc 50 790 ppb green alga 72hour ec 50 30 ppb popul reduct epa believ suffici evid list thiobencarb epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 249 thiodicarb ca 059669 26 0 fifra ai ref 3 thiodicarb cholinesteras inhibitor mammalian speci addit hematolog effect observ variou speci tremor pinpoint pupil noel less 0 043 mg l note rat expos inhal thiodicarb 9 day macrocyt anemia loel 2 g kg noel 1 g kg observ 21day dermal studi rabbit anoth 21day dermal studi decreas red blood cell count decreas hemoglobin level loel 4 g kg day noel 1 g kg day report decreas plasma red blood cell cholinesteras activ loel 30 mg kg day noel 10 mg kg day observ rat fed thiodicarb 28 day decreas red blood cell cholinesteras activ decreas hemoglobin level loel 10 mg kg day noel 3 mg kg day seen 13week feed studi rat inhibit plasma red blood cell cholinesteras activ loel 45 mg kg day noel 15 mg kg day note dog fed thiodicarb 6 month signific hematolog clinic chemistri valu also seen 45 mg kg day noel 15 mg kg day reduct red blood cell cholinesteras activ loel 12 8 mg kg day noel 4 5 mg kg day also seen 1 year feed studi dog addit decreas red blood cell decreas hemoglobin hematocrit level increas rel spleen liver weight loel 38 3 mg kg day noel 12 8 mg kg day report epa believ suffici evid list thiodicarb epcra section 313 pursuant epcra section 313 2 b base avail neurolog hematolog toxic data aquat acut toxic valu thiodicarb includ bluegil 96hour lc 50 1 47 ppm rainbow trout 96hour lc 50 2 65 ppm sheepshead minnow 96hour lc 50 530 ppb daphnid 48hour ec 50 27 ppb mysid 96hour lc 50 29 3 ppb eastern oyster 96hour lc 50 1 0 ppb alga 96hour ec 50 450 ppb epa believ suffici evid list thiodicarb epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 250 thiophan ethyl 1 2 phenylenebi iminocarbonothioyl biscarbam acid diethyl ester ca 023564 06 9 fifra ai ref 3 6month dog studi dietari administr 500 mg kg day loel produc thyroid chang noel 50 mg kg day thyroid follicular hypertrophi observ 50 mg kg day loel rat 2year dietari studi noel 10 mg kg day epa believ suffici evid list thiophan ethyl epcra section 313 pursuant epcra section 313 2 b base avail thyroid toxic data chemic 251 thiophan methyl ca 023564 05 8 fifra sr ref 8 decreas spermatogenesi observ male rat fed 32 mg kg day thiophan methyl noel 8 mg kg day effect note 32 mg kg day dose level includ decreas bodi weight histolog evid hyperthyroid 3 gener reproduct studi rat reduc litter weight seen daili dietari dose 32 mg kg thiophan methyl noel 8 mg kg day decreas number implant observ mice administ limit dose 1 000 mg kg day epa believ suffici evid list thiophan methyl epcra section 313 pursuant epcra section 313 2 b base reproduct toxic data chemic 252 thiosemicarbazid ca 000079 19 6 cercla epcra eh rcra app8 rcra p ref 8 oral ld 50 thiosemicarbazid rat dog 9 16 10 mg kg respect ldlo mous 94 mg kg cat oral administ thiosemicarbazid experienc convuls saliv vomit ld 50 20 mg kg intraperiton inject 2 5 mg kg thiosemicarbazid produc restless run fit convuls rabbit epa exposur analysi indic thiosemicarbazid concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list thiosemicarbazid epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 253 triadimefon 1 4 chlorophenoxi 3 3 dimethyl 1 1h 1 2 4 triazol 1 yl 2 butanon ca 043121 43 3 fifra ai ref 3 decreas hematocrit red blood cell count hemoglobin volum observ dog oral administ 60 mg kg day loel 13 week noel establish 2year dietari rat studi decreas hemoglobin erythrocyt count observ 25 mg kg day loel noel 2 5 mg kg day base noel studi oral rfd 0 03 mg kg day deriv dietari administr 25 mg kg day loel 2 year dog produc increas serum alkalin phosphatas n demethylas activ increas liver weight noel 2 5 mg kg day increas erythrocyt count thrombocyt count hemoglobin hematocrit level femal increas serum alkalin phosphatas serum glutam pyruv transaminas serum glutam oxaloacet transaminas liver weight hyperplast nodul sex observ 234 mg kg day 2year mous dietari studi noel 6 5 mg kg day loel 39 mg kg day anoth 2year mous dietari studi administr 234 mg kg day produc hepatocellular adenoma dose 39 mg kg day male loel 6 5 mg kg day femal loel produc nonneoplast preneoplast chang liver increas liver weight correl effect serum enzym hepatocellular hypertrophi noel male 6 5 mg kg day noel femal could establish cleft palat observ offspr rat oral administ 75 mg kg day loel noel 30 mg kg day increas incid abnorm rib extra rib distend urinari bladder observ offspr rat oral administ 90 mg kg day loel noel 30 mg kg day increas fetal resorpt observ rabbit given 100 mg kg day gavag loel noel 30 mg kg day increas incid incomplet ossif pelvic pube phalang irregular spinou process observ offspr rabbit oral administ 50 mg kg day loel day 6 18 gestat noel 20 mg kg day 3 gener rat reproduct studi decreas fertil decreas litter size observ 90 mg kg day loel noel 15 mg kg day 2 gener reproduct studi rat decreas pup weight decreas litter size decreas pup viabil observ 90 mg kg day loel noel 2 5 mg kg day epa believ suffici evid list triadimefon epcra section 313 pursuant epcra section 313 2 b base avail hepat hematolog development reproduct toxic data chemic 254 triallat ca 002303 17 5 fifra sr ref 8 triallat dithiocarbam insecticid cholinesteras inhibitor triallat administ rat dose 147 1 mg kg day oral cat dose 0 028 mg l day via aerosol 2 month anim develop fatal morpholog chang neuron cerebr cortex subcort area cerebellum spinal cord dose 30 mg kg day caus head bob circl pregnant rat noel 7 5 mg kg day loel noel liver effect 2year studi dog fed diet contain triallat 4 25 mg kg day 1 28 mg kg day respect 4 25 mg kg day increas hemosiderin deposit serum alkalin phosphatas observ sex increas liver weight observ femal base noel oral rfd 0 013 mg kg day deriv hamster chronic feed studi decreas triglycerid seen male loel 30 mg kg day noel 5 mg kg day nineti day feed studi rat 10 mg kg day dog 5 mg kg day show treatment relat advers effect except increas liver bodi weight ratio dog epa believ suffici evid list triallat epcra section 313 pursuant epcra section 313 2 b base chronic neurolog hepat toxic data chemic 255 tribenuron methyl 2 4 methoxi 6 methyl 1 3 5 triazin 2 yl methylamino carbonyl amino sulfonyl methyl ester ca 101200 48 0 fifra ai ref 3 1 year feed studi dog elev serum bilirubin aspart aminotransferas ast level increas urinari volum report male receiv 8 16 mg kg day loel noel male 0 79 mg kg day loel femal 52 02 mg kg day highest dose test base increas serum creatinin transient increas ast globulin serum bilirubin femal 18 2 percent decreas bodi weight gain noel femal 8 18 mg kg day highest dose male 51 46 mg kg day caus increas serum creatinin 20 percent decreas bodi weight gain oral rfd deriv noel male 0 008 mg kg day 90day feed studi decreas absolut rel liver kidney weight serum glucos globulin cholesterol level observ rat 87 5 mg kg day loel noel 5 mg kg day epa believ suffici evid list tribenuron methyl epcra section 313 pursuant epcra section 313 2 b base avail hepat renal toxic data chemic 256 tributyltin fluorid ca 001983 10 4 fifra ai ref 3 aquat acut toxic valu tributyltin fluorid includ bleak fish 96hour lc 50 2 3 ppb alga 72hour ec 50 9 3 ppb harpacticoid copepod 96hour lc 50 0 8 ppb epa believ suffici evid list tributyltin fluorid epcra section 313 pursuant epcra section 313 2 c base avail environment toxic data 257 tributyltin methacryl ca 002155 70 6 fifra ai ref 3 pregnant rat given tributyltin methacryl gavag day 6 19 gestat mean fetal weight matern bodi weight gain decreas 18 mg kg day fetal resorpt also significantli increas fetotox noel studi 9 mg kg day epa believ suffici evid list tributyltin methacryl epcra section 313 pursuant epcra section 313 2 b base avail development toxic data chemic 258 tributyltrithiophosph def ca 000078 48 8 fifra ai ref 8 tributyltrithiophosph def cholinesteras inhibitor immedi delay neurotox effect report human follow exposur def exposur level effect occur howev report 3month hen feed studi noel neurotox effect 0 1 mg kg day loel 0 5 mg kg day 0 5 mg kg day hen show delay neurotox ataxia equivoc chang spinal cord peripher nerv base noel epa deriv oral rfd 0 00003 mg kg day chemic 12week dog feed studi anim show sensit stimuli 0 62 mg kg day noel 0 12 mg kg day studi loel cholinesteras inhibit 0 12 mg kg day noel establish brain cholinesteras inhibit observ chronic rat feed studi 1 25 mg kg day noel 0 25 mg kg day epa believ suffici evid list tributyltrithiophosph epcra section 313 pursuant epcra section 313 2 b base chronic neurotox data chemic measur acut aquat toxic data stributyltrithiophosph includ rainbow trout 96hour lc 50 660 ppb 0 660 ppm bluegil 96hour lc 50 620 ppb 0 620 ppm measur log k ow 5 7 epa believ suffici evid list tributyltrithiophosph epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic potenti bioaccumul 259 trichloroacetyl chlorid ca 000076 02 8 epcra eh ref 8 trichloroacetyl chlorid highli toxic human oral inhal rout exposur numer case strong irrit eye skin respiratori tract fever nausea vomit follow exposur trichloroacetyl chlorid report acut inhal lc 50 valu mice rat 0 445 mg l 0 475 mg l respect indic trichloroacetyl chlorid highli toxic inhal speci epa exposur analysi indic trichloroacetyl chlorid concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list trichloroacetyl chlorid epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 260 trichloroethylsilan ca 000115 21 9 epcra eh ref 8 chlorin silan corros skin mucou membran liber hydrochlor acid presenc water trichloroethylsilan caus sever burn vapor harm human mous 2hour inhal lc 50 valu 0 30 mg l epa exposur analysi indic trichloroethylsilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list trichloroethylsilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 261 trichlorophenylsilan ca 000098 13 5 epcra eh ref 8 chlorin silan corros skin mucou membran liber hydrochlor acid presenc water trichlorophenylsilan caus sever burn vapor harm human concentr specifi 2hour mous inhal lc 50 valu 0 33 mg l epa exposur analysi indic trichlorophenylsilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list trichlorophenylsilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 262 1 2 3 trichloropropan ca 000096 18 4 rcra app8 ref 8 result subchron oral toxic studi rat mice reveal primari target organ 1 2 3 trichloropropan liver kidney renal hepat necrosi observ rat administ 1 2 3 trichloropropan gavag 17 week loael 16 mg kg day noael 8 mg kg day hepat effect loael 32 mg kg day noael 16 mg kg day renal effect hepat necrosi mice occur 125 mg kg day noael 63 mg kg day less sever renal necrot chang seen 250 mg kg day noael 125 mg kg day renal hepat lesion accompani increas organ weight alter serum enzym indic hepat renal toxic lower dose level loael 16 mg kg day nonregen anemia decreas hematocrit hemoglobin erythrocyt count observ rat noael 8 mg kg day nonregen anemia consid one sensit effect 1 2 3 trichloropropan respiratori tract princip target inhal 1 2 3 trichloropropan human anim irrit eye throat report human acut expos 15 minut 100 ppm 0 602 mg l 1 2 3 trichloropropan via inhal irrit effect olfactori epithelium observ rat expos inhal 3 ppm loael 0 018 mg l noael 0 006 mg l 1 2 3 trichloropropan 11 day histolog effect also seen nasal caviti loel 125 mg kg day noael 63 mg kg day rat bronchiolar epithelium loel 63 mg kg day noael 32 mg kg day mice expos 1 2 3 trichloropropan oral intub 17 week epa believ suffici evid list 1 2 3 trichloropropan epcra section 313 pursuant epcra section 313 2 b base hematolog respiratori hepat renal toxic data chemic 263 triclopyr triethylammonium salt ca 057213 69 1 fifra ai ref 3 degener proxim tubul loel 20 mg kg day noel 5 mg kg day note male femal rat fed triclopyr 3 month loel 2 5 mg kg day base phenosulfophthalein psp excret report dog fed triclopyr 6 month similar effect also note loel 5 mg kg day determin dog fed triclopyr 8 month noel greater 5 mg kg day signific increas absolut rel kidney weight observ rat fed 36 mg kg day 2 year noel 12 mg kg day pharmacokinet studi reduc psp excret seen dog administ 5 mg kg day wherea effect psp excret seen monkey administ 20 mg kg day detail rout length exposur provid epa believ suffici evid list triclopyr triethylammonium salt epcra section 313 pursuant epcra section 313 2 b base avail renal toxic data 264 triethylamin ca 000121 44 8 caa hap ref 7 triethylamin acut irrit caus eye nasal irrit pulmonari toxic mice rat acut eye toxic man survey worker expos triethylamin none worker report effect 5 ppm slight mild effect note concentr 5 10 ppm 10 ppm worker report visual disturb includ halo vision irrit eye nose throat separ report eye irrit visual disturb consist foggi vision blue haze halo vision halo around light report 19 worker expos triethylamin exact exposur level determin twa work place individu complain blue haze 11 mg 3 rang 4 24 mg 3 american council govern industri hygienist acgih set threshold limit valu time weight averag tlv twa 10 ppm threshold limit valu short term exposur limit tlv stel 15 ppm base upon inhal toxic guinea pig rat skin irrit eye injuri rabbit epa exposur analysi indic triethylamin concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list triethylamin epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 265 triforin n n 1 4 piperazinediylbi 2 2 2 trichloroethyliden bisformamid ca 026644 46 2 fifra ai ref 3 2year feed studi rat anemia report loel base effect 3 125 ppm 156 mg kg day noel 625 ppm 31 25 mg kg day siderosi kupffer cell bone marrow cell report dog expos triforin diet 2 year loel studi 1 000 ppm 25 mg kg day noel 100 ppm 2 5 mg kg day effect red blood cell hematocrit hemoglobin also note dog rat sever 13week feed studi exampl dog expos 20 6 percent formul compound 13 week dose level includ 600 ppm loel equival 15 mg kg day 3 1 mg kg day 100 ppm noel equival 2 5 mg kg day 0 5 mg kg day siderosi liver spleen bone marrow decreas mean rel weight offspr observ rabbit expos 25 mg kg triforin fetotox loel fetotox noel 5 mg kg loel noel matern toxic development toxic studi also 25 mg kg 5 mg kg respect base reduc food intak bodi weight loss fetotox decreas number fetus increas resorpt also report offspr rat fed 1 600 mg kg fetotox loel unspecifi durat fetotox noel 800 mg kg epa believ suffici evid list triforin epcra section 313 pursuant epcra section 313 2 b base avail hematolog development toxic data chemic 266 trimethylchlorosilan ca 000075 77 4 epcra eh ref 8 chlorin silan corros skin mucou membran liber hydrochlor acid presenc water trimethylchlorosilan caus sever burn vapor harm human mous inhal lclo valu 0 10 mg l epa exposur analysi indic trimethylchlorosilan concentr like exist beyond facil site boundari result continu frequent recur releas level reason anticip caus signific advers acut human health effect epa believ suffici evid list trimethylchlorosilan epcra section 313 pursuant epcra section 313 2 base avail acut toxic exposur data chemic 267 2 3 5 trimethylphenyl methylcarbam ca 002655 15 4 fifra ai ref 3 cholinesteras inhibit report seri studi carbam pesticid dog receiv 2 000 ppm 50 mg kg day 2 3 5 trimethylphenyl methylcarbam diet 14 day inhibit plasma red blood cell cholinesteras also weight loss brain cholinesteras slightli decreas rat 2year feed studi 200 ppm 10 mg kg day 800 ppm 40 mg kg day fatti chang liver disappear 7 5 month epa believ suffici evid list 2 3 5 trimethylphenyl methylcarbam epcra section 313 pursuant epcra section 313 2 b base avail neurolog toxic data chemic 268 triphenyltin chlorid ca 000639 58 7 epcra eh ref 8 oral exposur male rat 380 mg kg triphenyltin chlorid 19 day caus advers effect test epididymi sperm duct prostat gland semin vesicl cowper gland accessori gland epa believ suffici evid list triphenyltin chlorid epcra section 313 pursuant epcra section 313 2 b base reproduct toxic data chemic measur aquat acut toxic data triphenyltin chlorid includ 48hour lc 50 carp 55 ppb 72hour ec 50 growth marin green alga 0 92 ppb addit measur aquat toxic inform indic freshwat green alga 8day ec 50 growth 2 ppb epa believ suffici evid list triphenyltin chlorid epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 269 triphenyltin hydroxid ca 000076 87 9 fifra sr ref 8 triphenyltin hydroxid classifi epa group b2 compound e probabl carcinogen base signific increas fetal pituitari gland adenoma femal wistar rat leydig cell tumor male wistar rat fed 1 4 mg kg day triphenyltin hydroxid 2 year signific increas hepatocellular adenoma combin hepatocellular adenoma carcinoma tumar male femal nmri mice fed 0 65 2 6 10 4 mg kg day 80 week development toxic studi rat oral dose 15 mg kg triphenyltin hydroxid gestat day 1 7 prevent implant administ day 8 onward compound fetoleth epa believ suffici evid list triphenyltin hydroxid epcra section 313 pursuant epcra section 313 2 b base carcinogen data development toxic data chemic measur aquat acut toxic data triphenyltin hydroxid includ fathead minnow 96hour lc 50 5 4 ppb bluegil 96hour lc 50 23 ppb rainbow trout 96hour lc 50 15 ppb marin green alga 72hour lc 50 13 9 ppb epa believ suffici evid list triphenyltin hydroxid epcra section 313 pursuant epcra section 313 2 c base environment toxic data chemic 270 vanadium pentoxid ca 001314 62 1 cercla epcra eh rcra app8 ref 8 eighteen worker expos vanadium pentoxid dust concentr excess 0 5 mg 3 0 0005 mg l period 2 week develop respiratori symptom persist nearli 2 week remov exposur inhal unspecifi level vanadium pentoxid 1 5 year produc asthma 3 20 worker mice rat expos 1 3 mg 3 0 001 0 003 mg l vanadium pentoxid 6 hour day 3 month develop histopatholog chang lung decreas growth rate epa believ suffici evid list vanadium pentoxid epcra section 313 pursuant epcra section 313 2 b base avail chronic respiratori toxic data chemic 271 vinclozolin 3 3 5 dichlorophenyl 5 ethenyl 5 methyl 2 4 oxazolidinedion ca 050471 44 8 fifra ai ref 3 result 3month feed studi wistar rat administ 4 500 ppm 225 mg kg day dose test indic vinclozolin interact numer steroid hormon male femal anim broad spectrum steroid hormon affect anim includ increas adrenocorticotrop hormon luten hormon follicl stimul hormon testosteron corticosteron aldosteron dehydroepiandrosteron slight decreas estradiol level male femal rat elev adrenocorticotrop hormon lutein level depress corticosteron aldosteron level follicl stimul hormon testosteron dehydroepiandrosteron estradiol level compar control 2month recoveri period postdos male hormon level normal except slight elev fsh femal hormon level normal except slight elev estradiol endocrin chang also report development subchron chronic toxic studi broad spectrum organ chang occur dog expos vinclozolin 1 year feed studi male administ 4 8 mg kg day loel male increas test weight increas bilirubin prostat atrophi noel male 2 4 mg kg day femal studi increas adren weight lipid accumul adren gland margin increas hemosiderin liver 5 1 mg kg day loel femal noel femal 2 5 mg kg day higher dose 47 mg kg day male 53 mg kg day femal increas weight liver spleen test adren thyroid effect includ increas diffus hyperplasia leydig cell lipid accumul adren cortex increas platelet male femal slight increas mean corpuscular volum mean corpuscular hemoglobin concentr oral rfd compound 0 025 mg kg day base find 6month feed studi beagl dog adren weight absolut rel significantli increas 7 5 mg kg day loel noel 2 5 mg kg day male femal expos higher dose 600 2 000 ppm 15 50 mg kg day histolog chang adren gland includ vacuol zona fasciculata addit effect adren gland male expos loel dose higher decreas absolut kidney weight 600 ppm fat droplet distal tubul observ pseudohermaphrodit decreas anal genit distanc occur male offspr rat administ dose 50 mg kg loel higher gavag development noel 15 mg kg effect note offspr rat receiv dermal applic 180 mg kg day loel development noel 60 mg kg day gestat also 2 gener reproduct studi rat loel 86 mg kg day noel 25 mg kg day development effect observ latter studi includ development delay reduc male femal pup weight increas stillbirth increas pup mortal throughout lactat epa believ suffici evid list vinclozolin epcra section 313 pursuant epcra section 313 2 b base avail endocrin adren renal hepat development toxic data v rational list epa propos add chemic substanc identifi unit iv b preambl epa believ chemic meet statutori criteria list section 313 2 epcra base determin specif toxic effect summar unit iv b preambl set forth detail rulemak record epa intend evalu public comment propos rule issu final rule novemb 30 1994 report chemic identifi final rule would requir activ 1995 calendar year report would submit epa state juli 1 1996 vi rulemak record record support propos rule contain docket number oppts400082 nonconfidenti document includ index docket avail public tsca nonconfidenti inform center ncic also known tsca public docket offic 12 noon 4 p monday friday exclud legal holiday tsca public docket offic locat epa headquart rm eg102 401 st sw washington dc 20460 person submit comment claim cbi must mark comment confidenti cbi appropri design comment claim confidenti time submiss place public file comment mark confidenti treat accord procedur 40 cfr part 2 person submit comment claim confidenti must prepar submit nonconfidenti public version comment triplic epa place public file vii request public comment epa request comment aspect propos epa request specif comment detail follow paragraph epa request comment suffici evid chemic propos addit unit iv b preambl addit epa request comment issu may specif individu chemic chemic categori epa request comment whether would appropri list persist bioaccumul toxic chemic manufactur process otherwis use current report threshold epcra section 313 epa add type chemic epcra section 313 modif epcra section 313 lower report threshold modifi de minimi mixtur exempt would requir insur releas transfer inform would collect unit iv b 132 iv b 144 iv b 158 preambl epa propos add individu three diisocyan hexamethylen 1 6 diisocyant isophoron diisocyan 1 1 methylen bi 4 isocyanatocyclohexan epa request comment altern propos unit iv b 132 preambl creat diisocyan categori rather ad diisocyan individu epcra section 313 epa also request comment diisocyan list iv b 132 preambl includ categori epa request comment propos definit man made miner fiber given unit iv b 149 preambl option defin fiber categori unit iv b 166 172 preambl epa propos add two ethylen bisdithiocarbam ebdc metiram nabam addit two ebdc zineb maneb current list epcra section 313 list toxic chemic categori ebdc recent ad epcra section 313 decemb 1 1993 58 fr 63500 epa request comment follow 1 individu ebdc metiram nabam ad individu epcra section 313 even though member ebdc categori list epcra section 313 2 individu list two ebdc zineb maneb delet ad member newli creat ebdc categori epa request comment whether polycycl aromat compound pac ad delin categori consist pac list unit iv b 207 preambl categori definit given unit iv b 207 preambl epa request comment approach consid exposur part evalu certain chemic section 313 2 c unit iv b 36 179 235 preambl epa propos add three chemic sulfur dioxid nitrogen dioxid carbon monoxid regul titl caa provis attain mainten nation ambient air qualiti standard addit sulfur dioxid regul titl iv caa acid deposit control extens data highli technic collect chemic requir caa epa request comment follow 1 inform collect caa suffici public right know purpos 2 suggest data collect chemic pursuant caa titl iv could use meet purpos epcra section 313 comment submit address list address unit comment must receiv april 12 1994 viii public meet epa hold 1day public meet discuss issu present tent agenda public meet includ discuss issu present unit vii preamabl schedul oral statement first come first serv basi call telephon number list inform contact statement made part public record consid develop final rule ix refer 1 u congress hous repres confer report 962 99th cong 2nd session 294 1986 2 usepa ohea risk assess guidelin carcinogen risk u environment protect agenc cincinnati oh 1987 3 usepa opp support document addit chemic feder insecticid fungicid rodenticid act fifra activ ingredi epcra section 313 u environment protect agenc washington dc 1993 4 usepa oppt issu paper prepar public meet expans toxic releas inventori u environment protect agenc washington dc 1993 5 usepa oppt physic properti environment fate tri expans chemic u environment protect agenc washington dc 1993 6 usepa oppt revis draft hazard assess guidelin list chemic toxic releas inventori u environment protect agenc washington dc 1992 7 usepa oppt support document addit chemic section 112 b clean air act amend chlorin paraffin epcra section 313 u environment protect agenc washington c 1993 8 usepa oppt support document health ecolog toxic review tri expans chemic u environment protect agenc washington dc 1993 x regulatori assess requir execut order 12866 execut order 12866 58 fr 51735 octob 4 1993 agenc must determin whether regulatori action signific therefor subject offic manag budget omb requir execut order section 3 f order defin signific regulatori action action like result rule 1 annual effect economi 100 million advers materi affect sector economi product competit job environ public health safeti state local tribal govern commun also refer econom signific 2 creat seriou inconsist otherwis interf action taken plan anoth agenc 3 materi alter budgetari impact entitl grant user fee loan program 4 rais novel legal polici issu aris legal mandat presid prioriti principl set forth execut order pursuant term execut order determin propos rule signific regulatori action action submit omb review comment chang made respons omb suggest recommend document public record b regulatori flexibl act regulatori flexibl act 1980 requir feder agenc perform regulatori flexibl analysi rule like signific impact substanti number small entiti analysi support propos rule estim maximum cost small busi might incur calcul cost impact percentag report cost divid averag valu shipment employe size class sic code report cost estim less one percent averag valu shipment per report first year less one half one percent valu shipment per report subsequ year precis impact depend mani report individu small busi submit howev experi current report indic small busi gener submit fewer report per facil larger one report anticip submit industri lowest impact segment manufactur sector like suffer signific advers effect due rule therefor epa certifi propos rule signific impact substanti number small entiti c paperwork reduct act collect inform requir section 313 epcra section 6607 ppa cover omb approv number 20700093 issu may 14 1992 approv normal would expir novemb 30 1992 remain effect pursuant 1993 depart veteran affair hous urban develop independ agenc appropri act pub l 102389 sign octob 6 1992 state notwithstand paperwork reduct act 1980 requir thereund environment protect agenc toxic chemic releas inventori form r instruct revis 1991 version issu may 19 1992 relat requir omb 20700093 shall effect report section 6607 pollut prevent act 1990 public law 101508 section 313 superfund amend reauthor act 1986 public law 99 499 time revis promulg pursuant law propos rule add chemic list toxic chemic subject report section 313 epcra section 6607 ppa chang element tri report form instruct relat requir accordingli form r instruct relat requir remain effect provid pub l 102 389 industri report burden collect inform estim averag 53 hour per respond annual includ time review instruct search exist data sourc gather maintain data need complet review collect inform actual burden specif facil may deviat estim depend complex facil oper profil releas send comment regard collect inform includ suggest reduc burden chief inform polici branch 2131 u environment protect agenc 401 st sw washington dc 20460 offic inform regulatori affair offic manag budget 726 jackson place nw washington dc 20503 mark attent desk offic epa final rule respond omb public comment collect inform list subject 40 cfr part 372 environment protect commun right know report recordkeep requir toxic chemic date januari 6 1994 supplem signer carol browner signer signjob administr therefor propos 40 cfr part 372 amend read follow part 372_ amend 1 author citat part 372 would continu read follow author 42 u c 11013 11028 2 372 65 ad chemic paragraph alphabet paragraph b ca sequenc paragraph c alphabet ad four categori read follow 372 65 chemic chemic categori part appli tabl 1chemic name 1ca 1effect date labamectin avermectin b1 l71751 41 2 l1 1 95 laceph acetylphosphoramidothio acid dimethyl ester l30560 19 1 l1 1 95 lacifluorfen sodium salt 5 2 chloro 4 triflouromethyl phenoxi 2 nitro benzoic acid sodium salt l62476 59 9 l1 1 95 lalachlor l15972 60 8 l1 1 95 laldicarb l116 06 3 l1 1 95 ld tran allethrin tran chrysanthem acid allethron l28057 48 9 l1 1 95 lallylamin l107 11 9 l1 1 95 laluminum phosphid l20859 73 8 l1 1 95 lametryn n ethyl n 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin l834 12 8 l1 1 95 lamitraz l33089 61 1 l1 1 95 lanilazin 4 6 dichloro n 2 chlorophenyl 1 3 5 triazin 2 amin l101 05 3 l1 1 95 latrazin 6 chloro n ethyl n 1 methylethyl 1 3 5 triazin 2 4 diamin l1912 24 9 l1 1 95 lbendiocarb 2 2 dimethyl 1 3 benzodioxol 4 ol methylcarbam l22781 23 3 l1 1 95 lbenfluralin n butyl n ethyl 2 6 dinitro 4 trifluoromethyl benzenamin l1861 40 1 l1 1 95 lbenomyl l17804 35 2 l1 1 95 lo benzyl p chlorophenol l120 32 1 l1 1 95 lbifenthrin l82657 04 3 l1 1 95 lbi tributylin oxid l56 35 9 l1 1 95 lboron trichlorid l10294 34 5 l1 1 95 lboron trifluorid l7637 07 2 l1 1 95 lbromacil 5 bromo 6 methyl 3 1 methylpropyl 2 4 1h 3h pyrimidinedion l314 40 9 l1 1 95 lbromacil lithium salt 2 4 1h 3h pyrimidinedion 5 bromo 6 methyl 3 1 methylpropyl lithium salt l53404 19 6 l1 1 95 lbromin l7726 95 6 l1 1 95 l1 bromo 1 bromomethyl 1 3 propanedicarbonitril l35691 65 7 l1 1 95 l2 bromo 2 nitropropan 1 3 diol bronopol l52 51 7 l1 1 95 lbromoxynil 3 5 dibromo 4 hydroxybenzonitril l1689 84 5 l1 1 95 lbromoxynil octano octano acid 2 6 dibromo 4 cyanophenyl ester l1689 99 2 l1 1 95 lbrucin l357 57 3 l1 1 95 lbutyl bi 2 methylpropyl carbamothio acid ethyl ester l2008 41 5 l1 1 95 lbutyl hydroxyanisol l25013 16 5 l1 1 95 lc acid red 114 l6459 94 5 l1 1 95 lc direct blue 218 l28407 37 6 l1 1 95 lcalcium hypochlorit l7778 54 3 l1 1 95 lcaprolactam l105 60 2 l1 1 95 lcarbofuran l1563 66 2 l1 1 95 lcarbon monoxid l630 08 0 l1 1 95 lcarboxin 5 6 dihydro 2 methyl n phenyl 1 4 oxathiin 3 carboxamid l5234 68 4 l1 1 95 lchinomethionat 6 methyl 1 3 dithiolo 4 5 b quinoxalin 2 one l2439 01 2 l1 1 95 lchlorend acid l115 28 6 l1 1 95 lchlorimuron ethyl ethyl 2 4 chloro 6 methoxyprimidin 2 yl carbonyl amino sulfonyl benzoat l90982 32 4 l1 1 95 l1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan chlorid l4080 31 3 l1 1 95 lp chloroanilin l106 47 8 l1 1 95 l5 chloro 2 2 4 dichlorophenoxi phenol l3380 34 5 l1 1 95 l3 chloro 2 methyl 1 propen l563 47 3 l1 1 95 lp chlorophenyl isocyan l104 12 1 l1 1 95 lchloropicrin l76 06 2 l1 1 95 l3 chloropropionitril l542 76 7 l1 1 95 lp chloro toluidin l95 69 2 l1 1 95 l2 chloro 1 1 1 trifluoro ethan hcfc 133a l75 88 7 l1 1 95 lchlorotrifluoromethan cfc 13 l75 72 9 l1 1 95 l3 chloro 1 1 1 trifluoro propan hcfc 253fb l460 35 5 l1 1 95 lchlorpyrifo methyl dimethyl 3 5 6 trichloro 2 pyridyl phosphorothio l5598 13 0 l1 1 95 lchlorsulfuron 2 chloro n 4 methoxi 6 methyl 1 3 5 triazin 2 yl amino carbonyl benzenesulfonamid l64902 72 3 l1 1 95 lclomazon 2 2 chlorophenyl methyl 4 4 dimethyl 3 isoxazolidinon l81777 89 1 l1 1 95 lcrotonaldehyd l4170 30 3 l1 1 95 lcyanazin l21725 46 2 l1 1 95 lcycloat l1134 23 2 l1 1 95 lcyclohexanol l108 93 0 l1 1 95 lcyfluthrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 4 fluoro 3 phenoxyphenyl methyl ester l68359 37 5 l1 1 95 lcyhalothrin 3 2 chloro 3 3 3 trifluoro 1 propenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 3 phenoxyphenyl methyl ester l68085 85 8 l1 1 95 lcyromazin n cyclopropyl 1 3 5 triazin 2 4 6 triamin l66215 27 8 l1 1 95 ldazomet tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion l533 74 4 l1 1 95 ldazomet sodium salt tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion ion 1 sodium l53404 60 7 l1 1 95 l2 4 db l94 82 6 l1 1 95 l2 4 butoxyethyl ester l1929 73 3 l1 1 95 l2 4 butyl ester l94 80 4 l1 1 95 l2 4 chlorocrotyl ester l2971 38 2 l1 1 95 ldesmedipham l13684 56 5 l1 1 95 l2 4 2 ethylhexyl ester l1928 43 4 l1 1 95 l2 4 2 ethyl 4 methylpentyl ester l53404 37 8 l1 1 95 ldiazinon l333 41 5 l1 1 95 l2 2 dibromo 3 nitrilopropionamid l10222 01 2 l1 1 95 ldicamba 3 6 dichloro 2 methyoxybenzo acid l1918 00 9 l1 1 95 ldichloran 2 6 dichloro 4 nitroanilin l99 30 9 l1 1 95 l3 3 dichlorobenzidin dihydrochlorid l612 83 9 l1 1 95 l3 3 dichlorobenzidin sulfat l64969 34 2 l1 1 95 ltran 1 4 dichloro 2 buten l110 57 6 l1 1 95 l1 2 dichloro 1 1 difluoroethan hcfc 132b l1649 08 7 l1 1 95 ldichlorofluoromethan hcfc 21 l75 43 4 l1 1 95 ldichloromethylphenylsilan l149 74 6 l1 1 95 ldichloropentafluoropropan l127564 92 5 l1 1 95 l1 1 dichloro 1 2 2 3 3 pentafluoropropan hcfc 225cc l13474 88 9 l1 1 95 l1 1 dichloro 1 2 3 3 3 pentafluoropropan hcfc 225eb l111512 56 2 l1 1 95 l1 2 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225bb l422 44 6 l1 1 95 l1 2 dichloro 1 1 3 3 3 pentafluoropropan hcfc 225da l431 86 7 l1 1 95 l1 3 dichloro 1 1 2 2 3 pentafluoropropan hcfc 225cb l507 55 1 l1 1 95 l1 3 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225ea l136013 79 1 l1 1 95 l2 2 dichloro 1 1 1 3 3 pentafluoropropan hcfc 225aa l128903 21 9 l1 1 95 l2 3 dichloro 1 1 1 2 3 pentafluoropropan hcfc 225ba l422 48 0 l1 1 95 l3 3 dichloro 1 1 1 2 2 pentafluoropropan hcfc 225ca l422 56 0 l1 1 95 ldichlorophen 2 2 methylen bi 4 chlorophenol l97 23 4 l1 1 95 ltran 1 3 dichloropropen l10061 02 6 l1 1 95 ldiclofop methyl 2 4 2 4 dichlorophenoxi phenoxi propano acid methyl ester l51338 27 3 l1 1 95 ldicyclopentadien l77 73 6 l1 1 95 ldiethatyl ethyl l38727 55 8 l1 1 95 ldiflubenzuron l35367 38 5 l1 1 95 ldiglycidyl resorcinol ether l101 90 6 l1 1 95 ldimethipin 2 3 dihydro 5 6 dimethyl 1 4 dithiin 1 1 4 4 tetraoxid l55290 64 7 l1 1 95 ldimetho l60 51 5 l1 1 95 l3 3 dimethoxybenzidin dihydrochlorid dianisidin dihydrochlorid l20325 40 0 l1 1 95 l3 3 dimethoxybenzidin hydrochlorid dianisidin hydrochlorid l111984 09 9 l1 1 95 ldimethylamin l124 40 3 l1 1 95 ldimethylamin dicamba l2300 66 5 l1 1 95 l3 3 dimethylbenzidin dihydrochlorid tolidin dihydrochlorid l612 82 8 l1 1 95 l3 3 dimethylbenzidin dihydrofluorid tolidin dihydrofluorid l41766 75 0 l1 1 95 ldimethyl chlorothiophosph l2524 03 0 l1 1 95 ldimethyldichlorosilan l75 78 5 l1 1 95 ln n dimethylformamid l68 12 2 l1 1 95 l2 6 dimethylphenol l576 26 1 l1 1 95 ldinocap l39300 45 3 l1 1 95 ldinoseb l88 85 7 l1 1 95 ldiphenamid l957 51 7 l1 1 95 ldiphenylamin l122 39 4 l1 1 95 ldipotassium endothal 7 oxabicyclo 2 2 1 heptan 2 3 dicarboxyl acid dipotassium salt l2164 07 0 l1 1 95 ldipropyl isocinchomeron l136 45 8 l1 1 95 ldisodium cyanodithioimidocarbon l138 93 2 l1 1 95 l2 4 isopropyl ester l94 11 1 l1 1 95 l2 4 dithiobiuret l541 53 7 l1 1 95 ldithiopyr 2 difluoromethyl 4 2 methylpropyl 6 trifluoromethyl 3 5 pyridinedicarbothio acid dimethyl ester l97886 45 8 l1 1 95 ldiuron l330 54 1 l1 1 95 l2 4 2 octyl ester l1917 97 1 l1 1 95 ldodin dodecylguanidin monoacet l2439 10 3 l1 1 95 l2 4 dp l120 36 5 l1 1 95 l2 4 propylen glycol butyl ether ester l1320 18 9 l1 1 95 l2 4 sodium salt l2702 72 9 l1 1 95 lethoprop phosphorodithio acid ethyl dipropyl ester l13194 48 4 l1 1 95 lethyl dipropylthiocarbam eptc l759 94 4 l1 1 95 lfamphur l52 85 7 l1 1 95 lfenarimol alpha 2 chlorophenyl alpha 4 chlorophenyl 5 pyrimidinemethanol l60168 88 9 l1 1 95 lfenbutatin oxid hexaki 2 methyl 2 phenyl propyl distannoxan l13356 08 6 l1 1 95 lfenoxaprop ethyl 2 4 6 chloro 2 benzoxazolylen oxi phenoxi propano acid ethyl ester l66441 23 4 l1 1 95 lfenoxycarb 2 4 phenoxyphenoxi ethyl carbam acid ethyl ester l72490 01 8 l1 1 95 lfenpropathrin 2 2 3 3 tetramethylcyclopropan carboxyl acid cyano 3 phenoxi phenyl methyl ester l39515 41 8 l1 1 95 lfenthion dimethyl 3 methyl 4 methylthio phenyl ester phosphorothio acid l55 38 9 l1 1 95 lfenvaler 4 chloro alpha 1 methylethyl benzeneacet acid cyano 3 phenoxyphenyl methyl ester l51630 58 1 l1 1 95 lferbam tri dimethylcarbamo dithioato iron l14484 64 1 l1 1 95 lfluazifop butyl 2 4 5 trifluoromethyl 2 pyridinyl oxi phenoxi propano acid butyl ester l69806 50 4 l1 1 95 lflumetralin 2 chloro n 2 6 dinitro 4 trifluoromethyl phenyl n ethyl 6 fluorobenzenemethanamin l62924 70 3 l1 1 95 lfluorin l7782 41 4 l1 1 95 lfluorouracil 5 fluorouracil l51 21 8 l1 1 95 lfluvalin n 2 chloro 4 trifluoromethyl phenyl dl valin cyano 3 phenoxyphenyl methyl ester l69409 94 5 l1 1 95 lfolpet l133 07 3 l1 1 95 lfomesafen 5 2 chloro 4 trifluoromethyl phenoxi n methylsulfonyl 2 nitrobenzamid l72178 02 0 l1 1 95 lalpha hexachlorocyclohexan l319 84 6 l1 1 95 lhexamethylen 1 6 diisocyan l822 60 0 l1 1 95 ln hexan l110 54 3 l1 1 95 lhexazinon l51235 04 2 l1 1 95 lhydramethylnon tetrahydro 5 5 dimethyl 2 1h pyrimidinon 3 4 trifluoromethyl phenyl 1 2 4 trifluoromethyl phenyl ethenyl 2 propenyliden hydrazon l67485 29 4 l1 1 95 limazalil 1 2 2 4 dichlorophenyl 2 2 propenyloxi ethyl 1h imidazol l35554 44 0 l1 1 95 l3 iodo 2 propynyl butylcarbam l55406 53 6 l1 1 95 liprodion 3 3 5 dichlorophenyl n 1 methylethyl 2 4 dioxo 1 imidazolidinecarboxamid l36734 19 7 l1 1 95 liron pentacarbonyl l13463 40 6 l1 1 95 lisodrin l465 73 6 l1 1 95 lisofenpho 2 ethoxyl 1 methylethyl amino phosphinothioyl oxi benzoic acid 1 methylethyl ester l25311 71 1 l1 1 95 lisophoron l78 59 1 l1 1 95 lisophoron diisocyan l4098 71 9 l1 1 95 llactofen 5 2 chloro 4 trifluoromethyl phenoxi 2 nitro 2 ethoxi 1 methyl 2 oxoethyl ester l77501 63 4 l1 1 95 llinuron l330 55 2 l1 1 95 llithium carbon l554 13 2 l1 1 95 lmalathion l121 75 5 l1 1 95 lmecoprop l93 65 2 l1 1 95 l2 mercaptobenzothiazol mbt l149 30 4 l1 1 95 lmerpho l150 50 5 l1 1 95 lmetham sodium sodium methyldithiocarbam l137 42 8 l1 1 95 lmethazol 2 3 4 dichlorophenyl 4 methyl 1 2 4 oxadiazolidin 3 5 dion l20354 26 1 l1 1 95 lmethiocarb l2032 65 7 l1 1 95 lmethoxon 4 chloro 2 methylphenoxi acet acid mcpa l94 74 6 l1 1 95 lmethoxon sodium salt 4 chloro 2 methylphenoxi acet sodium salt l3653 48 3 l1 1 95 l1 1 methylen bi 4 isocyanatocyclohexan l5124 30 1 l1 1 95 lmethylen bi thiocyan l6317 18 6 l1 1 95 lmethyl isothiocyan isothiocyanatomethan l556 61 6 l1 1 95 l2 methyllactonitril l75 86 5 l1 1 95 ln methylolacrylamid l924 42 5 l1 1 95 lmethyl parathion l298 00 0 l1 1 95 ln methyl 2 pyrrolidon l872 50 4 l1 1 95 lmethyltrichlorosilan l75 79 6 l1 1 95 lmetiram l9006 42 2 l1 1 95 lmetribuzin l21087 64 5 l1 1 95 lmevinpho l7786 34 7 l1 1 95 lmolin 1h azepin 1 carbothio acid hexahydro ethyl ester l2212 67 1 l1 1 95 lmonuron l150 68 5 l1 1 95 lmyclobutanil alpha butyl alpha 4 chlorophenyl 1h 1 2 4 triazol 1 propanenitril l88671 89 0 l1 1 95 lnabam l142 59 6 l1 1 95 lnale l300 76 5 l1 1 95 lnitrapyrin 2 chloro 6 trichloromethyl pyridin l1929 82 4 l1 1 95 lnitrat ion l14797 55 8 l1 1 95 lnitric oxid l10102 43 9 l1 1 95 lp nitroanilin l100 01 6 l1 1 95 lnitrogen dioxid l10102 44 0 l1 1 95 lnorflurazon 4 chloro 5 methylamino 2 3 trifluoromethyl phenyl 3 2h pyridazinon l27314 13 2 l1 1 95 loryzalin 4 dipropylamino 3 5 dinitrobenzenesulfonamid l19044 88 3 l1 1 95 loxydemeton methyl 2 ethylsulfinyl ethyl dimethyl ester phosphorothio acid l301 12 2 l1 1 95 loxydiazon 3 2 4 dichloro 5 1 methylethoxi phenyl 5 1 1 dimethylethyl 1 3 4 oxadiazol 2 3h one l19666 30 9 l1 1 95 loxyfluorfen l42874 03 3 l1 1 95 lozon l10028 15 6 l1 1 95 lparaquat dichlorid l1910 42 5 l1 1 95 lpebul butylethylcarbamothio acid propyl ester l1114 71 2 l1 1 95 lpendimethalin n 1 ethylpropyl 3 4 dimethyl 2 6 dinitrobenzenamin l40487 42 1 l1 1 95 lpentobarbit sodium l57 33 0 l1 1 95 lperchloromethyl mercaptan l594 42 3 l1 1 95 lpermethrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester l52645 53 1 l1 1 95 lphenanthren l85 01 8 l1 1 95 lphenothrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester l26002 80 2 l1 1 95 l1 2 phenylenediamin l95 54 5 l1 1 95 l1 3 phenylenediamin l108 45 2 l1 1 95 l1 2 phenylenediamin dihydrochlorid l615 28 1 l1 1 95 l1 4 phenylenediamin dihydrochlorid l624 18 0 l1 1 95 lphenytoin l57 41 0 l1 1 95 lphosphin l7803 51 2 l1 1 95 lphosphor oxychlorid l10025 87 3 l1 1 95 lphosphor pentachlorid l10026 13 8 l1 1 95 lphosphor pentasulfid l1314 80 3 l1 1 95 lphosphor pentoxid l1314 56 3 l1 1 95 lpicloram l1918 02 1 l1 1 95 lpiperonyl butoxid l51 03 6 l1 1 95 lpirimipho methyl 2 diethylamino 6 methyl 4 pyrimidinyl dimethylphosphorothio l29232 93 7 l1 1 95 lpotassium bromat l7758 01 2 l1 1 95 lpotassium dimethyldithiocarbam l128 03 0 l1 1 95 lpotassium n methyldithiocarbam l137 41 7 l1 1 95 lprimisulfuron methyl 2 4 6 bi difluoromethoxi 2 pyrimidinyl amino carbonyl amino sulfonyl benzoat l86209 51 0 l1 1 95 lprofenofo 4 bromo 2 chlorophenyl ethyl propyl phosphorothio l41198 08 7 l1 1 95 lprometryn n n bi 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin l7287 19 6 l1 1 95 lpropachlor 2 chloro n 1 methylethyl n phenylacetamid l1918 16 7 l1 1 95 lpropanil n 3 4 dichlorophenyl propanamid l709 98 8 l1 1 95 lpropargit l2312 35 8 l1 1 95 lpropargyl alcohol l107 19 7 l1 1 95 lpropetampho 3 ethylamino methoxyphosphinothioyl oxi 2 buteno acid 1 methylethyl ester l31218 83 4 l1 1 95 lpropiconazol 1 2 2 4 dichlorophenyl 4 propyl 1 3 dioxolan 2 yl methyl 1h 1 2 4 triazol l60207 90 1 l1 1 95 lquizalofop ethyl 2 4 6 chloro 2 quinoxalinyl oxi phenoxi propano acid ethyl ester l76578 14 8 l1 1 95 lresmethrin 5 phenylmethyl 3 furanyl methyl 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl l10453 86 8 l1 1 95 lsethoxydim 2 1 ethoxyimino butyl 5 2 ethylthio propyl 3 hydroxi 2 cyclohexen 1 one l74051 80 2 l1 1 95 lsimazin l122 34 9 l1 1 95 lsodium azid l26628 22 8 l1 1 95 lsodium chlorit l7758 19 2 l1 1 95 lsodium dicamba 3 6 dichloro 2 methoxybenzo acid sodium salt l1982 69 0 l1 1 95 lsodium dimethyldithiocarbam l128 04 1 l1 1 95 lsodium fluoroacet l62 74 8 l1 1 95 lsodium hypochlorit l7681 52 9 l1 1 95 lsodium nitrit l7632 00 0 l1 1 95 lsodium pentachlorophen l131 52 2 lsodium phenylphenoxid l132 27 4 l1 1 95 lsodium 2 pyridinethiol 1 oxid l15922 78 8 l1 1 95 lsulfur dioxid l7446 09 5 l1 1 95 lsulfur trioxid l7446 11 9 l1 1 95 lsulfuryl fluorid vikan l2699 79 8 l1 1 95 lsulprofo ethyl 4 methylthio phenyl phosphorodithio acid propyl ester l35400 43 2 l1 1 95 ltebuthiuron n 5 1 1 dimethylethyl 1 3 4 thiadiazol 2 yl n n dimethylurea l34014 18 1 l1 1 95 ltefluthrin l79538 32 2 l1 1 95 ltemepho l3383 96 8 l1 1 95 lterbacil 5 chloro 3 1 1 dimethylethyl 6 methyl 2 4 1h 3h pyrimidinedion l5902 51 2 l1 1 95 l1 1 1 2 tetrachloro 2 fluoroethan hcfc 121a l354 11 0 l1 1 95 l1 1 2 2 tetrachloro 1 fluoroethan hcfc 121 l354 14 3 l1 1 95 ltetracyclin hydrochlorid l64 75 5 l1 1 95 ltetramethrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 1 3 4 5 6 7 hexahydro 1 3 dioxo 2h isoindol 2 yl methyl ester l7696 12 0 l1 1 95 ltetrasodium ethylenediaminetetraacet l64 02 8 l1 1 95 lthiabendazol 2 4 thiazolyl 1h benzimidazol l148 79 8 l1 1 95 lthiabendazol hypophosphit salt 2 4 thiazolyl benzimidazol hypophosphit salt l28558 32 9 l1 1 95 lthiobencarb carbam acid diethylthio p chlorobenzyl l28249 77 6 l1 1 95 lthiodicarb l59669 26 0 l1 1 95 lthiophan ethyl 1 2 phenylenebi iminocarbonothioyl biscarbam acid diethyl ester l23564 06 9 l1 1 95 lthiophan methyl l23564 05 8 l1 1 95 lthiosemicarbazid l79 19 6 l1 1 95 ltriadimefon 1 4 chlorophenoxi 3 3 dimethyl 1 1h 1 2 4 triazol 1 yl 2 butanon l43121 43 3 l1 1 95 ltriallat l2303 17 5 l1 1 95 ltribenuron methyl 2 4 methoxi 6 methyl 1 3 5 triazin 2 yl methylamino carbonyl amino sulfonyl methyl ester l101200 48 0 l1 1 95 ltributyltin fluorid l1983 10 4 l1 1 95 ltributyltin methacryl l2155 70 6 l1 1 95 ls tributyltrithiophosph def l78 48 8 l1 1 95 ltrichloroacetyl chlorid l76 02 8 l1 1 95 ltrichloroethylsilan l115 21 9 l1 1 95 ltrichlorophenylsilan l98 13 5 l1 2 3 trichloropropan l96 18 4 l1 1 95 ltriclopyr triethylammonium salt l57213 69 1 l1 1 95 ltriethylamin l121 44 8 l1 1 95 ltriforin n n 1 4 piperazinediyl bi 2 2 2 trichloroethyliden bisformamid l26644 46 2 l1 1 95 ltrimethylchlorosilan l75 77 4 l1 1 95 l2 3 5 trimethylphenyl methylcarbam l2655 15 4 l1 1 95 ltriphenyltin chlorid l639 58 7 l1 1 95 ltriphenyltin hydroxid l76 87 9 l1 1 95 lvanadium pentoxid l1314 62 1 l1 1 95 lvinclozolin 3 3 5 dichlorophenyl 5 ethenyl 5 methyl 2 4 oxazolidinedion l50471 44 8 l1 1 95 tabl b tabl 1ca 1chemic name 1effect date l51 03 6 lpiperonyl butoxid l1 1 95 l51 21 8 lfluorouracil 5 fluorouracil l1 1 95 l52 51 7 l2 bromo 2 nitropropan 1 3 diol bronopol l1 1 95 l52 85 7 lfamphur l1 1 95 l55 38 9 lfenthion dimethyl 3 methyl 4 methylthio phenyl ester phosphorothio acid l1 1 95 l56 35 9 lbi tributyltin oxid l1 1 95 l57 33 0 lpentobarbit sodium l1 1 95 l57 41 0 lphenytoin l1 1 95 l60 51 5 ldimetho l1 1 95 l62 74 8 lsodium fluoroacet l1 1 95 l64 02 8 ltetrasodium ethylenediaminetetraacet l1 1 95 l64 75 5 ltetracyclin hydrochlorid l1 1 95 l68 12 2 ln n dimethylformamid l1 1 95 l75 43 4 ldichlorofluoromethan hcfc 21 l1 1 95 l75 72 9 lchlorotrifluoromethan cfc 13 l1 1 95 l75 77 4 ltrimethylchlorosilan l1 1 95 l75 78 5 ldimethyldichlorosilan l1 1 95 l75 79 6 lmethyltrichlorosilan l1 1 95 l75 86 5 l2 methyllactonitril l1 1 95 l75 88 7 l2 chloro 1 1 1 trifluoroethan hcfc 133a l1 1 95 l76 02 8 ltrichloroacetyl chlorid l1 1 95 l76 06 2 lchloropicrin l1 1 95 l76 87 9 ltriphenyltin hydroxid l1 1 95 l77 73 6 ldicyclopentadien l1 1 95 l78 48 8 ls tributyltrithiophosph def l1 1 95 l78 59 1 lisophoron l1 1 95 l79 19 6 lthiosemicarbazid l1 1 95 l85 01 8 lphenanthren l1 1 95 l88 85 7 ldinoseb l1 1 95 l93 65 2 lmecoprop l1 1 95 l94 11 1 l2 4 isopropyl ester l1 1 95 l94 74 6 lmethoxon 4 chloro 2 methylphenoxi acet acid mcpa l1 1 95 l94 80 4 l2 4 butyl ester l1 1 95 l94 82 6 l2 4 db l1 1 95 l95 54 5 l1 2 phenylenediamin l1 1 95 l95 69 2 lp chloro toluidin l1 1 95 l96 18 4 l1 2 3 trichloropropan l1 1 95 l97 23 4 ldichlorophen 2 2 methylen bi 4 chlorophenol l1 1 95 l98 13 5 ltrichlorophenylsilan l1 1 95 l99 30 9 ldichloran 2 6 dichloro 4 nitroanilin l1 1 95 l100 01 6 lp nitroanilin l1 1 95 l101 05 3 lanilazin 4 6 dichloro n 2 chlorophenyl 1 3 5 triazin 2 amin l1 1 95 l101 90 6 ldiglycidyl resorcinol ether l1 1 95 l104 12 1 lp chlorophenyl isocyan l1 1 95 l105 60 2 lcaprolactam l1 1 95 l106 47 8 lp chloroanilin l1 1 95 l107 11 9 lallylamin l1 1 95 l107 19 7 lpropargyl alcohol l1 1 95 l108 45 2 l1 3 phenylenediamin l1 1 95 l108 93 0 lcyclohexanol l1 1 95 l110 54 3 ln hexan l1 1 95 l110 57 6 ltran 1 4 dichloro 2 buten l1 1 95 l115 21 9 ltrichloroethylsilan l1 1 95 l115 28 6 lchlorend acid l1 1 95 l116 06 3 laldicarb l1 1 95 l120 32 1 lo benzyl p chlorophenol l1 1 95 l120 36 5 l2 4 dp l1 1 95 l121 44 8 ltriethylamin l1 1 95 l121 75 5 lmalathion l1 1 95 l122 34 9 lsimazin l1 1 95 l122 39 4 ldiphenylamin l1 1 95 l124 40 3 ldimethylamin l1 1 95 l128 03 0 lpotassium dimethyldithiocarbam l1 1 95 l128 04 1 lsodium dimethyldithiocarbam l1 1 95 l131 52 2 lsodium pentachlorophen l1 1 95 l132 27 4 lsodium phenylphenoxid l1 1 95 l133 07 3 lfolpet l1 1 95 l136 45 8 ldipropyl isocinchomeron l1 1 95 l137 41 7 lpotassium n methyldithiocarbam l1 1 95 l137 42 8 lmetham sodium l1 1 95 l138 93 2 ldisodium cyanodithioimidocarbon l1 1 95 l142 59 6 lnabam l1 1 95 l148 79 8 lthiabendazol 2 4 thiazolyl 1h benzimidazol l1 1 95 l149 30 4 l2 mercaptobenzothiazol l1 1 95 l149 74 6 ldichloromethylphenylsilan l1 1 95 l150 50 5 lmerpho l1 1 95 l150 68 5 lmonuron l1 1 95 l298 00 0 lmethyl parathion l1 1 95 l300 76 5 lnale l1 1 95 l301 12 2 loxydemeton methyl 2 ethylsulfinyl ethyl dimethyl ester phosphorothio acid l1 1 95 l314 40 9 lbromacil 5 bromo 6 methyl 3 1 methylpropyl 2 4 1h 3h pyrimidinedion l1 1 95 l319 84 6 lalpha hexachlorocyclohexan l1 1 95 l330 54 1 ldiuron l1 1 95 l330 55 2 llinuron l1 1 95 l333 41 5 ldiazinon l1 1 95 l354 11 0 l1 1 1 2 tetrachloro 2 fluoroethan hcfc 121a l1 1 95 l354 14 3 l1 1 2 2 tetrachloro 1 fluoroethan hcfc 121 l1 1 95 l357 57 3 lbrucin l1 1 95 l422 44 6 l1 2 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225bb l1 1 95 l422 48 0 l2 3 dichloro 1 1 1 2 3 pentafluoropropan hcfc 225ba l1 1 95 l422 56 0 l3 3 dichloro 1 1 1 2 2 pentafluoropropan hcfc 225ca l1 1 95 l431 86 7 l1 2 dichloro 1 1 3 3 3 pentafluoropropan hcfc 225da l1 1 95 l460 35 5 l3 chloro 1 1 1 trifluoropropan hcfc 253fb l1 1 95 l465 73 6 lisodrin l1 1 95 l507 55 1 l1 3 dichloro 1 1 2 2 3 pentafluoropropan hcfc 225cb l1 1 95 l533 74 4 ldazomet tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion l1 1 95 l541 53 7 l2 4 dithiobiuret l1 1 95 l542 76 7 l3 chloropropionitril l1 1 95 l554 13 2 llithium carbon l1 1 95 l556 61 6 lmethyl isothiocyan isothiocyanatomethan l1 1 95 l563 47 3 l3 chloro 2 methyl 1 propen l1 1 95 l576 26 1 l2 6 dimethylphenol l1 1 95 l594 42 3 lperchloromethyl mercaptan l1 1 95 l612 82 8 l3 3 dimethylbenzidin dihydrochlorid tolidin dihydrochlorid l1 1 95 l612 83 9 l3 3 dichlorobenzidin dihydrochlorid l1 1 95 l615 28 1 l1 2 phenylenediamin dihydrochlorid l1 1 95 l624 18 0 l1 4 phenylenediamin dihydrochlorid l1 1 95 l630 08 0 lcarbon monoxid l1 1 95 l639 58 7 ltriphenyltin chlorid l1 1 95 l709 98 8 lpropanil n 3 4 dichlorophenyl propanamid l1 1 95 l759 94 4 lethyl dipropylthiocarbam eptc l1 1 95 l822 60 0 lhexamethylen 1 6 diisocyan l1 1 95 l834 12 8 lametryn n ethyl n 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin l1 1 95 l872 50 4 ln methyl 2 pyrrolidon l1 1 95 l924 42 5 ln methylolacrylamid l1 1 95 l957 51 7 ldiphenamid l1 1 95 l1114 71 2 lpebul butylethylcarbamo thioic acid propyl ester l1 1 95 l1134 23 2 lcycloat l1 1 95 l1314 56 3 lphosphor pentoxid l1 1 95 l1314 62 1 lvanadium pentoxid l1 1 95 l1314 80 3 lphosphor pentasulfid l1 1 95 l1320 18 9 l2 4 propylen glycol butyl ether ester l1 1 95 l1563 66 2 lcarbofuran l1 1 95 l1649 08 7 l1 2 dichloro 1 1 difluoroethan hcfc 132b l1 1 95 l1689 84 5 lbromoxynil 3 5 dibromo 4 hydroxybenzonitril l1 1 95 l1689 99 2 lbromoxynil octano octano acid 2 6 dibromo 4 cyanophenyl ester l1 1 95 l1861 40 1 lbenfluralin n butyl n ethyl 2 6 dinitro 4 trifluoromethyl benzenamin l1 1 95 l1910 42 5 lparaquat dichlorid l1 1 95 l1912 24 9 latrazin 6 chloro n ethyl n 1 methylethyl 1 3 5 triazin 2 4 diamin l1 1 95 l1917 97 1 l2 4 2 octyl ester l1 1 95 l1918 00 9 ldicamba 3 6 dichloro 2 methyoxybenzo acid l1 1 95 l1918 02 1 lpicloram l1 1 95 l1918 16 7 lpropachlor 2 chloro n 1 methylethyl n phenylacetamid l1 1 95 l1928 43 4 l2 4 2 ethylhexyl ester l1 1 95 l1929 73 3 l2 4 butoxyethyl ester l1 1 95 l1929 82 4 lnitrapyrin 2 chloro 6 trichloromethyl pyridin l1 1 95 l1982 69 0 lsodium dicamba 3 6 dichloro 2 methoxybenzo acid sodium salt l1 1 95 l1983 10 4 ltributyltin fluorid l1 1 95 l2008 41 5 lbutyl bi 2 methylpropyl carbamothio acid ethyl ester l1 1 95 l2032 65 7 lmethiocarb l1 1 95 l2155 70 6 ltributyltin methacryl l1 1 95 l2164 07 0 ldipotassium endothal 7 oxabicyclo 2 2 1 heptan 2 3 dicarboxyl acid dipotassium salt l1 1 95 l2212 67 1 lmolin 1h azepin 1 carbothio acid hexahydro ethyl ester l1 1 95 l2300 66 5 ldimethylamin dicamba l1 1 95 l2303 17 5 ltriallat l1 1 95 l2312 35 8 lpropargit l1 1 95 l2439 01 2 lchinomethionat 6 methyl 1 3 dithiolo 4 5 b quinoxalin 2 one l1 1 95 l2439 10 3 ldodin dodecylguanidin monoacet l1 1 95 l2524 03 0 ldimethyl chlorothiophosph l1 1 95 l2655 15 4 l2 3 5 trimethylphenyl methylcarbam l1 1 95 l2699 79 8 lsulfuryl fluorid vikan l1 1 95 l2702 72 9 l2 4 sodium salt l1 1 95 l2971 38 2 l2 4 chlorocrotyl ester l1 1 95 l3380 34 5 l5 chloro 2 2 4 dichlorophenoxi phenol l1 1 95 l3383 96 8 ltemepho l1 1 95 l3653 48 3 lmethoxon sodium salt 4 chloro 2 methylphenoxi acet sodium salt l1 1 95 l4080 31 3 l1 3 chloroallyl 3 5 7 triaza 1 azoniaadamantan chlorid l1 1 95 l4098 71 9 lisophoron diisocyan l1 1 95 l4170 30 3 lcrotonaldehyd l1 1 95 l5124 30 1 l1 1 methylen bi 4 isocyanatocyclohexan l1 1 95 l5234 68 4 lcarboxin 5 6 dihydro 2 methyl n phenyl 1 4 oxathiin 3 carboxamid l1 1 95 l5598 13 0 lchlorpyrifo methyl dimethyl 3 5 6 trichloro 2 pyridyl phosphorothio l1 1 95 l5902 51 2 lterbacil 5 chloro 3 1 1 dimethylethyl 6 methyl 2 4 1h 3h pyrimidinedion l1 1 95 l6317 18 6 lmethylen bi thiocyan l1 1 95 l6459 94 5 lc acid red 114 l1 1 95 l7287 19 6 lprometryn n n bi 1 methylethyl 6 methylthio 1 3 5 triazin 2 4 diamin l1 1 95 l7446 09 5 lsulfur dioxid l1 1 95 l7446 11 9 lsulfur trioxid l1 1 95 l7632 00 0 lsodium nitrit l1 1 95 l7637 07 2 lboron trifluorid l1 1 95 l7681 52 9 lsodium hypochlorit l1 1 95 l7696 12 0 ltetramethrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropan carboxyl acid 1 3 4 5 6 7 hexahydro 1 3 dioxo 2h isoindol 2 yl methyl ester l1 1 95 l7726 95 6 lbromin l1 1 95 l7758 01 2 lpotassium bromat l1 1 95 l7758 19 2 lsodium chlorit l1 1 95 l7778 54 3 lcalcium hypochlorit l1 1 95 l7782 41 4 lfluorin l1 1 95 l7786 34 7 lmevinpho l1 1 95 l7803 51 2 lphosphin l1 1 95 l9006 42 2 lmetiram l1 1 95 l10025 87 3 lphosphor oxychlorid l1 1 95 l10026 13 8 lphosphor pentachlorid l1 1 95 l10028 15 6 lozon l1 1 95 l10061 02 6 ltran 1 3 dichloropropen l1 1 95 l10222 01 2 l2 2 dibromo 3 nitrilopropionamid l1 1 95 l10102 43 9 lnitric oxid l1 1 95 l10102 44 0 lnitrogen dioxid l1 1 95 l10294 34 5 lboron trichlorid l1 1 95 l10453 86 8 lresmethrin 5 phenylmethyl 3 furanyl methyl 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl l1 1 95 l13194 48 4 lethoprop phosphorodithio acid ethyl dipropyl ester l1 1 95 l13356 08 6 lfenbutatin oxid hexaki 2 methyl 2 phenylpropyl distannoxan l1 1 95 l13463 40 6 liron pentacarbonyl l1 1 95 l13474 88 9 l1 1 dichloro 1 2 2 3 3 pentafluoropropan hcfc 225cc l1 1 95 l13684 56 5 ldesmedipham l1 1 95 l14484 64 1 lferbam tri dimethylcarbamo dithioato iron l1 1 95 l14797 55 8 lnitrat ion l1 1 95 l15922 78 8 lsodium 2 pyridinethiol 1 oxid l1 1 95 l15972 60 8 lalachlor l1 1 95 l17804 35 2 lbenomyl l1 1 95 l19044 88 3 loryzalin 4 dipropylamino 3 5 dinitrobenzen sulfonamid l1 1 95 l19666 30 9 loxydiazon 3 2 4 dichloro 5 1 methylethoxi phenyl 5 1 1 dimethylethyl 1 3 4 oxadiazol 2 3h one l1 1 95 l20325 40 0 l3 3 dimethoxybenzidin dihydrochlorid dianisidin dihydrochlorid l1 1 95 l20354 26 1 lmethazol 2 3 4 dichlorophenyl 4 methyl 1 2 4 oxadiazolidin 3 5 dion l1 1 95 l20859 73 8 laluminum phosphid l1 1 95 l21087 64 9 lmetribuzin l1 1 95 l21725 46 2 lcyanazin l1 1 95 l22781 23 3 lbendiocarb 2 2 dimethyl 1 3 benzodioxol 4 ol methylcarbam l1 1 95 l23564 05 8 lthiophan methyl l1 1 95 l23564 06 9 lthiophan ethyl 1 2 phenylenebi iminocarbonothioyl biscarbam acid diethyl ester l1 1 95 l25013 16 5 lbutyl hydroxyanisol l1 1 95 l25311 71 1 lisofenpho 2 ethoxyl 1 methylethyl amino phosphinothioyl oxi benzoic acid 1 methylethyl ester l1 1 95 l26002 80 2 lphenothrin 2 2 dimethyl 3 2 methyl 1 propenyl cyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester l1 1 95 l26628 22 8 lsodium azid l1 1 95 l26644 46 2 ltriforin n n 1 4 piperazinediylbi 2 2 2 trichloroethyliden bisformamid l1 1 95 l27314 13 2 lnorflurazon 4 chloro 5 methylamino 2 3 trifluoromethyl phenyl 3 2h pyridazinon l1 1 95 l28057 48 9 ld tran allethrin tran chrysanthem acid allethron l1 1 95 l28249 77 6 lthiobencarb carbam acid diethylthio p chlorobenzyl l1 1 95 l28407 37 6 lc direct blue 218 l1 1 95 l28558 32 9 lthiabendazol hypophosphit salt 2 4 thiazolyl benzimidazol hypophosphit salt l1 1 95 l29232 93 7 lpirimipho methyl 2 diethylamino 6 methyl 4 pyrimidinyl dimethyl phosphorothio l1 1 95 l30560 19 1 laceph acetylphosphoramidothio acid dimethyl ester l1 1 95 l31218 83 4 lpropetampho 3 ethylamino methoxyphosphino thioyl oxi 2 buteno acid 1 methylethyl ester l1 1 95 l33089 61 1 lamitraz l1 1 95 l34014 18 1 lterbuthiuron n 5 1 1 dimethylethyl 1 3 4 thiadiazol 2 yl n n dimethylurea l1 1 95 l35367 38 5 ldiflubenzuron l1 1 95 l35400 43 2 lsulprofo ethyl 4 methylthio phenyl phosphorodithio acid propyl ester l1 1 95 l35554 44 0 limazalil 1 2 2 4 dichlorophenyl 2 2 propenyloxi ethyl 1h imidazol l1 1 95 l35691 65 7 l1 bromo 1 bromomethyl 1 3 propanedicarbonitril l1 1 95 l36734 19 7 liprodion 3 3 5 dichlorophenyl n 1 methylethyl 2 4 dioxo 1 imidazolidin carboxamid l1 1 95 l38727 55 8 ldiethatyl ethyl l1 1 95 l39300 45 3 ldinocap l1 1 95 l39515 41 8 lfenpropathrin 2 2 3 3 tetramethylcyclopropan carboxyl acid cyano 3 phenoxyphenyl methyl ester l1 1 95 l40487 42 1 lpendimethalin n 1 ethylpropyl 3 4 dimethyl 2 6 dinitrobenzen amin l1 1 95 l41198 08 7 lprofenofo 4 bromo 2 chlorophenyl ethyl propyl phosphorothio l1 1 95 l41766 75 0 l3 3 dimethylbenzidin dihydrofluorid ortho tolidin dihydrofluorid l1 1 95 l42874 03 3 loxyfluorfen l1 1 95 l43121 43 3 ltriadimefon 1 4 chlorophenoxi 3 3 dimethyl 1 1h 1 2 4 triazol 1 yl 2 butanon l1 1 95 l50471 44 8 lvinclozolin 3 3 5 dichlorophenyl 5 ethenyl 5 methyl 2 4 oxazolidinedion l1 1 95 l51235 04 2 lhexazinon l1 1 95 l51338 27 3 ldiclofop methyl 2 4 2 4 dichlorophenoxi phenoxi propano acid methyl ester l1 1 95 l51630 58 1 lfenvaler l1 1 95 l52645 53 1 lpermethrin 3 2 2 dichloroethenyl 2 2 dimethylcyclopropanecarboxyl acid 3 phenoxyphenyl methyl ester l1 1 95 l53404 19 6 lbromacil lithium salt 2 4 1h 3h pyrimidinedion 5 bromo 6 methyl 3 1 methylpropyl lithium salt l1 1 95 l53404 37 8 l2 4 2 ethyl 4 methylpentyl ester l1 1 95 l53404 60 7 ldazomet sodium salt tetrahydro 3 5 dimethyl 2h 1 3 5 thiadiazin 2 thion ion 1 sodium l1 1 95 l55290 64 7 ldimethipin 2 3 dihydro 5 6 dimethyl 1 4 dithiin 1 1 4 4 tetraoxid l1 1 95 l55406 53 6 l3 iodo 2 propynyl butylcarbam l1 1 95 l57213 69 1 ltriclopyr triethylammonium salt l1 1 95 l59669 26 0 lthiodicarb l1 1 95 l60168 88 9 lfenarimol alpha 2 chlorophenyl alpha 4 chlorophenyl 5 pyrimidin methanol l1 1 95 l60207 90 1 lpropiconazol 1 2 2 4 dichlorophenyl 4 propyl 1 3 dioxolan 2 yl methyl 1h 1 2 4 triazol l1 1 95 l62476 59 9 lacifluorfen sodium salt 5 2 chloro 4 triflouromethyl phenoxi 2 nitro benzoic acid sodium salt l1 1 95 l62924 70 3 lflumetralin 2 chloro n 2 6 dinitro 4 trifluoromethyl phenyl n ethyl 6 fluorobenzenemethanamin l1 1 95 l64902 72 3 lchlorsulfuron 2 chloro n 4 methoxi 6 methyl 1 3 5 triazin 2 yl amino carbonyl benzenesulfonamid l1 1 95 l64969 34 2 l3 3 dichlorobenzidin sulfat l1 1 95 l66215 27 8 lcyromazin n cyclopropyl 1 3 5 triazin 2 4 6 triamin l1 1 95 l66441 23 4 lfenoxaprop ethyl 2 4 6 chloro 2 benzoxazolylen oxi phenoxi propano acid ethyl ester l1 1 95 l67485 29 4 lhydramethylnon tetrahydro 5 5 dimethyl 2 1h pyrimidinon 3 4 trifluoromethyl phenyl 1 2 4 trifluoromethyl phenyl ethenyl 2 propenyliden hydrazon l1 1 95 l68085 85 8 lcyhalothrin 3 2 chloro 3 3 3 trifluoro 1 propenyl 2 2 dimethylcyclopropanecarboxyl acid cyano 3 phenoxyphenyl methyl ester l1 1 95 l68359 37 5 lcyfluthrin 3 2 2 dichloro ethenyl 2 2 dimethylcyclo propanecarboxyl acid cyano 4 fluoro 3 phenoxyphenyl methyl ester l1 1 95 l69409 94 5 lfluvalin n 2 chloro 4 trifluoromethyl phenyl dl valin cyano 3 phenoxyphenyl methylest l1 1 95 l69806 50 4 lfluazifop butyl 2 4 5 trifluoromethyl 2 pyridinyl oxi phenoxi propano acid butyl ester l1 1 95 l71751 41 2 labamectin avermectin b1 l1 1 95 l72178 02 0 lfomesafen 5 2 chloro 4 trifluoromethyl phenoxi n methylsulfonyl 2 nitrobenzamid l1 1 95 l72490 01 8 lfenoxycarb 2 4 phenoxyphenoxi ethyl carbam acid ethyl ester l1 1 95 l74051 80 2 lsethoxydim 2 1 ethoxyimino butyl 5 2 ethylthio propyl 3 hydroxi 2 cyclohexen 1 one l1 1 95 l76578 14 8 lquizalofop ethyl 2 4 6 chloro 2 quinoxalinyl oxi phenoxi propano acid ethyl ester l1 1 95 l77501 63 4 llactofen 5 2 chloro 4 trifluoromethyl phenoxi 2 nitro 2 ethoxi 1 methyl 2 oxoethyl ester l1 1 95 l79538 32 2 ltefluthrin l81777 89 1 lclomazon 2 2 chlorophenyl methyl 4 4 dimethyl 3 isoxazolidinon l1 1 95 l82657 04 3 lbifenthrin l1 1 95 l86209 51 0 lprimisulfuron methyl 2 4 6 bi difluoromethoxi 2 pyrimidinyl amino carbonyl amino sulfonyl benzoat l1 1 95 l88671 89 0 lmyclobutanil alpha butyl alpha 4 chlorophenyl 1h 1 2 4 triazol 1 propanenitril l1 1 95 l90982 32 4 lchlorimuron ethyl ethyl 2 4 chloro 6 methoxyprimidin 2 yl carbonyl amino sulfonyl benzoat l1 1 95 l97886 45 8 ldithiopyr 2 difluoromethyl 4 2 methylpropyl 6 trifluoro methyl 3 5 pyridinedicarbothio acid dimethyl ester l1 1 95 l101200 48 0 ltribenuron methyl 2 4 methoxi 6 methyl 1 3 5 triazin 2 yl methylamino carbonyl amino sulfonyl methyl ester l1 1 95 l111512 56 2 l1 1 dichloro 1 2 3 3 3 pentafluoropropan hcfc 225eb l1 1 95 l111984 09 9 l3 3 dimethoxybenzidin hydrochlorid dianisidin dihydrochlorid l1 1 95 l127564 92 5 ldichloropentafluoropropan l1 1 95 l128903 21 9 l2 2 dichloro 1 1 1 3 3 pentafluoropropan hcfc 225aa l1 1 95 l136013 79 1 l1 3 dichloro 1 1 2 3 3 pentafluoropropan hcfc 225ea l1 1 95 tabl c tabl 1categori name 1effect date lchlorin paraffin includ chemic defin follow formula l1 1 95 lcxh2x 2cli lwhere x 10 30 3 26 lman made miner fiber includ glass microfib glass wool fiber rock wool fiber slag wool fiber refractori ceram fiber diamet less 3 5 micromet aspect ratio greater 3 l1 1 95 lnicotin salt l1 1 95 lpolycycl aromat compound pac categori includ chemic list l1 1 95 l00056 55 3 benz anthracen l00218 01 9 benzo phenanthren l00050 32 8 benzo pyren l00205 99 2 benzo b fluoranthen l00205 82 3 benzo j fluoranthen l00207 08 9 benzo k fluoranthen l00189 55 9 benzo rst pentaphen l00086 74 8 carbazol l27208 37 3 cyclopenta cd pyren l00226 36 8 dibenz h acridin l00224 42 0 dibenz j acridin l00215 58 7 dibenz c anthracen l00224 41 9 dibenz j anthracen l00053 70 3 dibenzo h anthracen l05385 75 1 dibenzo e fluoranthen l00192 65 4 dibenzo e pyren l00189 64 0 dibenzo h pyren l00191 30 0 dibenzo l pyren l00194 59 2 7h dibenzo c g carbazol l00057 97 6 7 12 dimethylbenz anthracen l00193 39 5 indeno 1 2 3 cd pyren l03351 32 4 2 methylchrysen l03351 31 3 3 methylchrysen l03351 30 2 4 methylchrysen l03697 24 3 5 methylchrysen l01705 85 7 6 methylchrysen l33543 31 6 2 methylfluoranthen l05522 43 0 1 nitropyren lstrychnin salt l1 1 95 tabl signjob frfile fr doc 94753 file 11194 3 34 pm frfile bill bill code 656050f bill